{"1c5m": {"describe_pdb": {"structureId": "1C5M", "title": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR", "pubmedId": "10779411", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.95", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "351", "nr_atoms": "2300", "deposition_date": "1999-12-22", "release_date": "2000-12-22", "last_modification_date": "2017-10-04", "structure_authors": "Katz, B.A., Mackman, R., Luong, C., Radika, K., Martelli, A., Sprengeler, P.A., Wang, J., Chan, H., Wong, L.", "citation_authors": "Katz, B.A., Mackman, R., Luong, C., Radika, K., Martelli, A., Sprengeler, P.A., Wang, J., Chan, H., Wong, L.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "D"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "F"}}], "structureId": "1c5m", "bioAssemblies": "1", "release_date": "Fri Dec 22 00:00:00 PST 2000", "resolution": "1.95"}, "ligs": null, "num_ligs": 0, "name_ligs": [], "seq": "", "chain_id": "D", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKA-------------K", "covertura": 49.385245901639344, "gaps": {"num_gaps": 2, "gap_lengths": [235, 14], "gap_list": [[1, 235], [475, 488]], "gap_window": [[1, 236], [474, 488]]}}, "1ezq": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1F0R", "@details": "human coagulation factor Xa with inhibitor RPR208815"}, {"@pdbId": "1F0S", "@details": "human coagulation factor Xa with inhibitor RPR208707"}, {"@pdbId": "1F0T", "@details": "bovine pancreatic trypsin with inhibitor RPR131247"}, {"@pdbId": "1F0U", "@details": "bovine pancreatic trypsin with inhibitor RPR128515"}], "structureId": "1EZQ", "title": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515", "pubmedId": "10966741", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2262", "deposition_date": "2000-05-11", "release_date": "2000-09-20", "last_modification_date": "2017-10-04", "structure_authors": "Maignan, S., Guilloteau, J.P., Pouzieux, S., Choi-Sledeski, Y.M., Becker, M.R., Klein, S.I., Ewing, W.R., Pauls, H.W., Spada, A.P., Mikol, V.", "citation_authors": "Maignan, S., Guilloteau, J.P., Pouzieux, S., Choi-Sledeski, Y.M., Becker, M.R., Klein, S.I., Ewing, W.R., Pauls, H.W., Spada, A.P., Mikol, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1ezq", "bioAssemblies": "1", "release_date": "Wed Sep 20 00:00:00 PDT 2000", "resolution": "2.20"}, "ligs": [{"@structureId": "1EZQ", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1EZQ", "@chemicalID": "RPR", "@type": "non-polymer", "@molecularWeight": "458.552", "chemicalName": "3-[(3'-AMINOMETHYL-BIPHENYL-4-CARBONYL)-AMINO]-2-(3-CARBAMIMIDOYL-BENZYL)-BUTYRIC ACID METHYL ESTER", "formula": "C27 H30 N4 O3", "InChIKey": "XFKVLKLCLYJKNF-MZNJEOGPSA-N", "InChI": "InChI=1S/C27H30N4O3/c1-17(24(27(33)34-2)15-18-5-3-8-23(13-18)25(29)30)31-26(32)21-11-9-20(10-12-21)22-7-4-6-19(14-22)16-28/h3-14,17,24H,15-16,28H2,1-2H3,(H3,29,30)(H,31,32)/t17-,24-/m1/s1", "smiles": "C[C@H]([C@@H](Cc1cccc(c1)C(=N)N)C(=O)OC)NC(=O)c2ccc(cc2)c3cccc(c3)CN"}], "num_ligs": 2, "name_ligs": ["CA", "RPR"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1f0r": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1EZQ", "@details": "human coagulation factor Xa with inhibitor RPR128515"}, {"@pdbId": "1F0S", "@details": "human coagulation factor Xa with inhibitor RPR208707"}, {"@pdbId": "1F0T", "@details": "bovine pancreatic trypsin with inhibitor RPR131247"}, {"@pdbId": "1F0U", "@details": "bovine pancreatic trypsin with inhibitor RPR128515"}], "structureId": "1F0R", "title": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815", "pubmedId": "10966741", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2259", "deposition_date": "2000-05-17", "release_date": "2000-09-20", "last_modification_date": "2011-07-13", "structure_authors": "Maignan, S., Guilloteau, J.P., Pouzieux, S., Choi-Sledeski, Y.M., Becker, M.R., Klein, S.I., Ewing, W.R., Pauls, H.W., Spada, A.P., Mikol, V.", "citation_authors": "Maignan, S., Guilloteau, J.P., Pouzieux, S., Choi-Sledeski, Y.M., Becker, M.R., Klein, S.I., Ewing, W.R., Pauls, H.W., Spada, A.P., Mikol, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1f0r", "bioAssemblies": "1", "release_date": "Wed Sep 20 00:00:00 PDT 2000", "resolution": "2.10"}, "ligs": [{"@structureId": "1F0R", "@chemicalID": "815", "@type": "non-polymer", "@molecularWeight": "453.537", "chemicalName": "THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE", "formula": "C21 H19 N5 O3 S2", "InChI": "InChI=1S/C21H19N5O3S2/c22-20-15-10-13(3-4-14(15)5-8-24-20)12-26-9-6-16(21(26)27)25-31(28,29)19-11-17-18(30-19)2-1-7-23-17/h1-5,7-8,10-11,16,25H,6,9,12H2,(H2,22,24)/t16-/m0/s1", "InChIKey": "NVKDOURNRJCKJE-INIZCTEOSA-N", "smiles": "c1cc2c(cc(s2)S(=O)(=O)N[C@H]3CCN(C3=O)Cc4ccc5ccnc(c5c4)N)nc1"}, {"@structureId": "1F0R", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["815", "CA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1f0s": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1EZQ", "@details": "human coagulation factor Xa with inhibitor RPR128515"}, {"@pdbId": "1F0R", "@details": "human coagulation factor Xa with inhibitor RPR208815"}, {"@pdbId": "1F0T", "@details": "bovine pancreatic trypsin with inhibitor RPR131247"}, {"@pdbId": "1F0U", "@details": "bovine pancreatic trypsin with inhibitor RPR128515"}], "structureId": "1F0S", "title": "Crystal Structure of Human Coagulation Factor XA Complexed with RPR208707", "pubmedId": "10966741", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2257", "deposition_date": "2000-05-17", "release_date": "2000-09-20", "last_modification_date": "2011-07-13", "structure_authors": "Maignan, S., Guilloteau, J.P., Pouzieux, S., Choi-Sledeski, Y.M., Becker, M.R., Klein, S.I., Ewing, W.R., Pauls, H.W., Spada, A.P., Mikol, V.", "citation_authors": "Maignan, S., Guilloteau, J.P., Pouzieux, S., Choi-Sledeski, Y.M., Becker, M.R., Klein, S.I., Ewing, W.R., Pauls, H.W., Spada, A.P., Mikol, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1f0s", "bioAssemblies": "1", "release_date": "Wed Sep 20 00:00:00 PDT 2000", "resolution": "2.10"}, "ligs": [{"@structureId": "1F0S", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1F0S", "@chemicalID": "PR2", "@type": "non-polymer", "@molecularWeight": "427.5", "chemicalName": "THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE", "formula": "C19 H17 N5 O3 S2", "InChI": "InChI=1S/C19H17N5O3S2/c25-19-14(23-29(26,27)18-9-15-17(28-18)2-1-5-21-15)4-7-24(19)11-13-8-12-3-6-20-10-16(12)22-13/h1-3,5-6,8-10,14,22-23H,4,7,11H2/t14-/m0/s1", "InChIKey": "PLXOQMHGHDZMSX-AWEZNQCLSA-N", "smiles": "c1cc2c(cc(s2)S(=O)(=O)N[C@H]3CCN(C3=O)Cc4cc5ccncc5[nH]4)nc1"}], "num_ligs": 2, "name_ligs": ["CA", "PR2"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1fax": {"describe_pdb": {"structureId": "1FAX", "title": "COAGULATION FACTOR XA INHIBITOR COMPLEX", "pubmedId": "8939944", "expMethod": "X-RAY DIFFRACTION", "resolution": "3.00", "keywords": "COAGULATION FACTOR", "nr_entities": "2", "nr_residues": "350", "nr_atoms": "2300", "deposition_date": "1996-08-23", "release_date": "1997-10-29", "last_modification_date": "2011-07-13", "structure_authors": "Brandstetter, H., Engh, R.A.", "citation_authors": "Brandstetter, H., Kuhne, A., Bode, W., Huber, R., von der Saal, W., Wirthensohn, K., Engh, R.A.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1fax", "bioAssemblies": "1", "release_date": "Wed Oct 29 00:00:00 PST 1997", "resolution": "3.00"}, "ligs": [{"@structureId": "1FAX", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1FAX", "@chemicalID": "DX9", "@type": "non-polymer", "@molecularWeight": "444.526", "chemicalName": "(2S)-3-(7-carbamimidoylnaphthalen-2-yl)-2-[4-({(3R)-1-[(1Z)-ethanimidoyl]pyrrolidin-3-yl}oxy)phenyl]propanoic acid", "formula": "C26 H28 N4 O3", "InChI": "InChI=1S/C26H28N4O3/c1-16(27)30-11-10-23(15-30)33-22-8-6-19(7-9-22)24(26(31)32)13-17-2-3-18-4-5-20(25(28)29)14-21(18)12-17/h2-9,12,14,23-24,27H,10-11,13,15H2,1H3,(H3,28,29)(H,31,32)/b27-16+/t23-,24-/m0/s1", "InChIKey": "AGRCGQSFFMCBRE-DGUCVARSSA-N", "smiles": "[H]/N=C(\\C)/N1CC[C@@H](C1)Oc2ccc(cc2)[C@H](Cc3ccc4ccc(cc4c3)/C(=N/[H])/N)C(=O)O"}], "num_ligs": 2, "name_ligs": ["CA", "DX9"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTAAEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1fjs": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1FAX", "@details": "Factor Xa complexed to DX-9065a"}, {"@pdbId": "1HCG", "@details": "des GLA Factor Xa"}, {"@pdbId": "1QB1", "@details": "Trypsin complexed to ZK806974"}, {"@pdbId": "1QBN", "@details": "Trypsin complexed to ZK806688"}, {"@pdbId": "1XKA", "@details": "Factor Xa complexed to FX-2212a"}, {"@pdbId": "1XKB", "@details": "Factor Xa complexed to FX-2212a"}], "structureId": "1FJS", "title": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA", "pubmedId": "11027132", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.92", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2312", "deposition_date": "2000-08-08", "release_date": "2000-10-04", "last_modification_date": "2017-10-04", "structure_authors": "Adler, M., Whitlow, M.", "citation_authors": "Adler, M., Davey, D.D., Phillips, G.B., Kim, S.H., Jancarik, J., Rumennik, G., Light, D.R., Whitlow, M.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1fjs", "bioAssemblies": "1", "release_date": "Wed Oct 04 00:00:00 PDT 2000", "resolution": "1.92"}, "ligs": [{"@structureId": "1FJS", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1FJS", "@chemicalID": "CL", "@type": "non-polymer", "@molecularWeight": "35.453", "chemicalName": "CHLORIDE ION", "formula": "Cl -1", "InChI": "InChI=1S/ClH/h1H/p-1", "InChIKey": "VEXZGXHMUGYJMC-UHFFFAOYSA-M", "smiles": "[Cl-]"}, {"@structureId": "1FJS", "@chemicalID": "GOL", "@type": "non-polymer", "@molecularWeight": "92.094", "chemicalName": "GLYCEROL", "formula": "C3 H8 O3", "InChIKey": "PEDCQBHIVMGVHV-UHFFFAOYSA-N", "InChI": "InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2", "smiles": "C(C(CO)O)O"}, {"@structureId": "1FJS", "@chemicalID": "Z34", "@type": "non-polymer", "@molecularWeight": "526.492", "chemicalName": "N-[2-[5-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-3,5-DIFLUORO-6-[3-(4,5-DIHYDRO-1-METHYL-1H-IMIDAZOL-2-YL)PHENOXY]PYRIDIN-4-YL]-N-METHYLGLYCINE", "formula": "C25 H24 F2 N6 O5", "InChI": "InChI=1S/C25H24F2N6O5/c1-32-9-8-30-23(32)14-4-3-5-15(10-14)37-24-19(26)21(33(2)12-18(35)36)20(27)25(31-24)38-17-11-13(22(28)29)6-7-16(17)34/h3-7,10-11,34H,8-9,12H2,1-2H3,(H3,28,29)(H,35,36)", "InChIKey": "NPNSVNGQJGRSNR-UHFFFAOYSA-N", "smiles": "[H]/N=C(\\c1ccc(c(c1)Oc2c(c(c(c(n2)Oc3cccc(c3)C4=NCCN4C)F)N(C)CC(=O)O)F)O)/N"}], "num_ligs": 4, "name_ligs": ["CA", "CL", "GOL", "Z34"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1g2l": {"describe_pdb": {"structureId": "1G2L", "title": "FACTOR XA INHIBITOR COMPLEX", "pubmedId": "11342132", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.90", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "329", "nr_atoms": "2307", "deposition_date": "2000-10-20", "release_date": "2001-10-20", "last_modification_date": "2011-07-13", "structure_authors": "Nar, H.", "citation_authors": "Nar, H., Bauer, M., Schmid, A., Stassen, J.M., Wienen, W., Priepke, H.W., Kauffmann, I.K., Ries, U.J., Hauel, N.H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1g2l", "bioAssemblies": "1", "release_date": "Sat Oct 20 00:00:00 PDT 2001", "resolution": "1.90"}, "ligs": [{"@structureId": "1G2L", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1G2L", "@chemicalID": "T87", "@type": "non-polymer", "@molecularWeight": "525.602", "chemicalName": "[(1-{2[(4-CARBAMIMIDOYL-PHENYLAMINO)-METHYL]-1-METHYL-1H-BENZOIMIDAZOL-5-YL}-CYCLOPROPYL)-PYRIDIN-2-YL-METHYLENEAMINOOXY]-ACETIC ACID ETHYL ESTER", "formula": "C29 H31 N7 O3", "InChI": "InChI=1S/C29H31N7O3/c1-3-38-26(37)18-39-35-27(22-6-4-5-15-32-22)29(13-14-29)20-9-12-24-23(16-20)34-25(36(24)2)17-33-21-10-7-19(8-11-21)28(30)31/h4-12,15-16,33H,3,13-14,17-18H2,1-2H3,(H3,30,31)/b35-27-", "InChIKey": "RNOYCNIZOAIUSV-LSWMGQQCSA-N", "smiles": "[H]/N=C(/c1ccc(cc1)NCc2nc3cc(ccc3n2C)C4(CC4)/C(=N\\OCC(=O)OCC)/c5ccccn5)\\N"}], "num_ligs": 2, "name_ligs": ["CA", "T87"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1g2m": {"describe_pdb": {"relatedPDB": {"@pdbId": "1g2l", "@details": "1g2l is factor XA inhibitor complex."}, "structureId": "1G2M", "title": "FACTOR XA INHIBITOR COMPLEX", "pubmedId": "11342132", "expMethod": "X-RAY DIFFRACTION", "resolution": "3.02", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "329", "nr_atoms": "2300", "deposition_date": "2000-10-20", "release_date": "2001-10-20", "last_modification_date": "2011-07-13", "structure_authors": "Nar, H.", "citation_authors": "Nar, H., Bauer, M., Schmid, A., Stassen, J.M., Wienen, W., Priepke, H.W., Kauffmann, I.K., Ries, U.J., Hauel, N.H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1g2m", "bioAssemblies": "1", "release_date": "Sat Oct 20 00:00:00 PDT 2001", "resolution": "3.02"}, "ligs": [{"@structureId": "1G2M", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1G2M", "@chemicalID": "R11", "@type": "non-polymer", "@molecularWeight": "423.513", "chemicalName": "4-{[1-METHYL-5-(2-METHYL-BENZOIMIDAZOL-1-YLMETHYL)-1H-BENZOIMIDAZOL-2-YLMETHYL]-AMINO}-BENZAMIDINE", "formula": "C25 H25 N7", "InChI": "InChI=1S/C25H25N7/c1-16-29-20-5-3-4-6-23(20)32(16)15-17-7-12-22-21(13-17)30-24(31(22)2)14-28-19-10-8-18(9-11-19)25(26)27/h3-13,28H,14-15H2,1-2H3,(H3,26,27)", "InChIKey": "IRKPNOLLMNHSOU-UHFFFAOYSA-N", "smiles": "[H]/N=C(/c1ccc(cc1)NCc2nc3cc(ccc3n2C)Cn4c(nc5c4cccc5)C)\\N"}], "num_ligs": 2, "name_ligs": ["CA", "R11"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1hcg": {"describe_pdb": {"structureId": "1HCG", "title": "STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 ANGSTROMS RESOLUTION", "pubmedId": "8355279", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "COAGULATION FACTOR", "nr_entities": "2", "nr_residues": "292", "nr_atoms": "2242", "deposition_date": "1993-05-05", "release_date": "1995-05-08", "last_modification_date": "2011-07-13", "structure_authors": "Tulinsky, A., Padmanabhan, K.", "citation_authors": "Padmanabhan, K., Padmanabhan, K.P., Tulinsky, A., Park, C.H., Bode, W., Huber, R., Blankenship, D.T., Cardin, A.D., Kisiel, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1hcg", "bioAssemblies": "1", "release_date": "Mon May 08 00:00:00 PDT 1995", "resolution": "2.20"}, "ligs": null, "num_ligs": 0, "name_ligs": [], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTH-----STRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKA-------------K", "covertura": 48.36065573770492, "gaps": {"num_gaps": 3, "gap_lengths": [235, 6, 14], "gap_list": [[1, 235], [369, 374], [475, 488]], "gap_window": [[1, 236], [368, 375], [474, 488]]}}, "1ioe": {"describe_pdb": {"structureId": "1IOE", "title": "Human coagulation factor Xa in complex with M55532", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.90", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "331", "nr_atoms": "2278", "deposition_date": "2001-03-08", "release_date": "2003-09-23", "last_modification_date": "2017-10-04", "structure_authors": "Shiromizu, I., Matsusue, T.", "citation_authors": "Matsusue, T., Shiromizu, I., Okamoto, A., Nakayama, K., Nishida, H., Mukaihira, T., Miyazaki, Y., Saitou, F., Morishita, H., Ohnishi, S., Mochizuki, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1ioe", "bioAssemblies": "1", "release_date": "Tue Sep 23 00:00:00 PDT 2003", "resolution": "2.90"}, "ligs": [{"@structureId": "1IOE", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1IOE", "@chemicalID": "XMA", "@type": "non-polymer", "@molecularWeight": "557.061", "chemicalName": "(-)-7-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]TETRAHYDRO-8A-(METHOXYMETHYL)-1'-(4-PYRIDINYL)-SPIRO[5H-OXAZOLO[3,2-A]PYRAZINE-2(3H),4'-PIPERIDIN]-5-ONE", "formula": "C27 H29 Cl N4 O5 S", "InChI": "InChI=1S/C27H29ClN4O5S/c1-36-19-27-18-31(38(34,35)24-5-3-20-14-22(28)4-2-21(20)15-24)16-25(33)32(27)17-26(37-27)8-12-30(13-9-26)23-6-10-29-11-7-23/h2-7,10-11,14-15H,8-9,12-13,16-19H2,1H3/t27-/m0/s1", "InChIKey": "OCCGRNQFQCNISA-MHZLTWQESA-N", "smiles": "COC[C@@]12C[N@@](CC(=O)N1CC3(O2)CCN(CC3)c4ccncc4)S(=O)(=O)c5ccc6cc(ccc6c5)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "XMA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1iqe": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1IOE", "@details": "1IOE contains the same protein complexed with M55532"}, {"@pdbId": "1IQF", "@details": "1IQF contains the same protein complexed with M55165"}, {"@pdbId": "1IQG", "@details": "1IQG contains the same protein complexed with M55159"}, {"@pdbId": "1IQH", "@details": "1IQH contains the same protein complexed with M55143"}, {"@pdbId": "1IQI", "@details": "1IQI contains the same protein complexed with M55125"}, {"@pdbId": "1IQJ", "@details": "1IQJ contains the same protein complexed with M55124"}, {"@pdbId": "1IQK", "@details": "1IQK contains the same protein complexed with M55113"}, {"@pdbId": "1IQL", "@details": "1IQL contains the same protein complexed with M54476"}, {"@pdbId": "1IQM", "@details": "1IQM contains the same protein complexed with M54471"}, {"@pdbId": "1IQN", "@details": "1IQN contains the same protein complexed with M55192"}], "structureId": "1IQE", "title": "Human coagulation factor Xa in complex with M55590", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.90", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "331", "nr_atoms": "2281", "deposition_date": "2001-07-23", "release_date": "2003-09-23", "last_modification_date": "2017-10-04", "structure_authors": "Shiromizu, I., Matsusue, T.", "citation_authors": "Matsusue, T., Shiromizu, I., Okamoto, A., Nakayama, K., Nishida, H., Mukaihira, T., Miyazaki, Y., Saitou, F., Morishita, H., Ohnishi, S., Mochizuki, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1iqe", "bioAssemblies": "1", "release_date": "Tue Sep 23 00:00:00 PDT 2003", "resolution": "2.90"}, "ligs": [{"@structureId": "1IQE", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1IQE", "@chemicalID": "XMB", "@type": "non-polymer", "@molecularWeight": "620.183", "chemicalName": "4-[(2R)-3-[[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]AMINO]-1-OXO-2-[[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]AMINO]PROPYL]-THIOMORPHOLINE-1,1-DIOXIDE", "formula": "C28 H34 Cl N5 O5 S2", "InChIKey": "PCKATVPAEVWNGE-MHZLTWQESA-N", "InChI": "InChI=1S/C28H34ClN5O5S2/c29-24-3-1-23-18-26(4-2-22(23)17-24)41(38,39)32-20-27(28(35)34-13-15-40(36,37)16-14-34)31-19-21-7-11-33(12-8-21)25-5-9-30-10-6-25/h1-6,9-10,17-18,21,27,31-32H,7-8,11-16,19-20H2/t27-/m0/s1", "smiles": "c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)NC[C@@H](C(=O)N3CCS(=O)(=O)CC3)NCC4CCN(CC4)c5ccncc5"}], "num_ligs": 2, "name_ligs": ["CA", "XMB"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1iqf": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1IOE", "@details": "1IOE contains the same protein complexed with M55532"}, {"@pdbId": "1IQE", "@details": "1IQE contains the same protein complexed with M55590"}, {"@pdbId": "1IQG", "@details": "1IQG contains the same protein complexed with M55159"}, {"@pdbId": "1IQH", "@details": "1IQH contains the same protein complexed with M55143"}, {"@pdbId": "1IQI", "@details": "1IQI contains the same protein complexed with M55125"}, {"@pdbId": "1IQJ", "@details": "1IQJ contains the same protein complexed with M55124"}, {"@pdbId": "1IQK", "@details": "1IQK contains the same protein complexed with M55113"}, {"@pdbId": "1IQL", "@details": "1IQL contains the same protein complexed with M54476"}, {"@pdbId": "1IQM", "@details": "1IQM contains the same protein complexed with M54471"}, {"@pdbId": "1IQN", "@details": "1IQN contains the same protein complexed with M55192"}], "structureId": "1IQF", "title": "Human coagulation factor Xa in complex with M55165", "expMethod": "X-RAY DIFFRACTION", "resolution": "3.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "331", "nr_atoms": "2279", "deposition_date": "2001-07-23", "release_date": "2003-09-23", "last_modification_date": "2017-10-04", "structure_authors": "Shiromizu, I., Matsusue, T.", "citation_authors": "Matsusue, T., Shiromizu, I., Okamoto, A., Nakayama, K., Nishida, H., Mukaihira, T., Miyazaki, Y., Saitou, F., Morishita, H., Ohnishi, S., Mochizuki, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1iqf", "bioAssemblies": "1", "release_date": "Tue Sep 23 00:00:00 PDT 2003", "resolution": "3.20"}, "ligs": [{"@structureId": "1IQF", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1IQF", "@chemicalID": "XMD", "@type": "non-polymer", "@molecularWeight": "571.088", "chemicalName": "(2R)-4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-6-OXO-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]-2-PIPERAZINECARBOXYLIC ACID ETHYL ESTER", "formula": "C28 H31 Cl N4 O5 S", "InChIKey": "BVVKZWAFUVRXPJ-AREMUKBSSA-N", "InChI": "InChI=1S/C28H31ClN4O5S/c1-2-38-28(35)26-18-32(39(36,37)25-6-4-21-15-23(29)5-3-22(21)16-25)19-27(34)33(26)17-20-9-13-31(14-10-20)24-7-11-30-12-8-24/h3-8,11-12,15-16,20,26H,2,9-10,13-14,17-19H2,1H3/t26-/m1/s1", "smiles": "CCOC(=O)[C@H]1C[N@](CC(=O)N1CC2CCN(CC2)c3ccncc3)S(=O)(=O)c4ccc5cc(ccc5c4)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "XMD"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1iqg": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1IOE", "@details": "1IOE contains the same protein complexed with M55532"}, {"@pdbId": "1IQE", "@details": "1IQE contains the same protein complexed with M55590"}, {"@pdbId": "1IQF", "@details": "1IQF contains the same protein complexed with M55165"}, {"@pdbId": "1IQH", "@details": "1IQH contains the same protein complexed with M55143"}, {"@pdbId": "1IQI", "@details": "1IQI contains the same protein complexed with M55125"}, {"@pdbId": "1IQJ", "@details": "1IQJ contains the same protein complexed with M55124"}, {"@pdbId": "1IQK", "@details": "1IQK contains the same protein complexed with M55113"}, {"@pdbId": "1IQL", "@details": "1IQL contains the same protein complexed with M54476"}, {"@pdbId": "1IQM", "@details": "1IQM contains the same protein complexed with M54471"}, {"@pdbId": "1IQN", "@details": "1IQN contains the same protein complexed with M55192"}], "structureId": "1IQG", "title": "Human coagulation factor Xa in complex with M55159", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.60", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "331", "nr_atoms": "2277", "deposition_date": "2001-07-23", "release_date": "2003-09-23", "last_modification_date": "2017-10-04", "structure_authors": "Shiromizu, I., Matsusue, T.", "citation_authors": "Matsusue, T., Shiromizu, I., Okamoto, A., Nakayama, K., Nishida, H., Mukaihira, T., Miyazaki, Y., Saitou, F., Morishita, H., Ohnishi, S., Mochizuki, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1iqg", "bioAssemblies": "1", "release_date": "Tue Sep 23 00:00:00 PDT 2003", "resolution": "2.60"}, "ligs": [{"@structureId": "1IQG", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1IQG", "@chemicalID": "XME", "@type": "non-polymer", "@molecularWeight": "542.05", "chemicalName": "4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[4-HYDROXYIMINOMETHYL-1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE", "formula": "C26 H28 Cl N5 O4 S", "InChI": "InChI=1S/C26H28ClN5O4S/c27-22-3-1-21-16-24(4-2-20(21)15-22)37(35,36)32-14-13-31(25(33)17-32)19-26(18-29-34)7-11-30(12-8-26)23-5-9-28-10-6-23/h1-6,9-10,15-16,18,34H,7-8,11-14,17,19H2/b29-18+", "InChIKey": "UELXXBOTHARRQL-RDRPBHBLSA-N", "smiles": "c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)[N@]3CCN(C(=O)C3)CC4(CCN(CC4)c5ccncc5)C=NO"}], "num_ligs": 2, "name_ligs": ["CA", "XME"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1iqh": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1IOE", "@details": "1IOE contains the same protein complexed with M55532"}, {"@pdbId": "1IQE", "@details": "1IQE contains the same protein complexed with M55590"}, {"@pdbId": "1IQF", "@details": "1IQF contains the same protein complexed with M55165"}, {"@pdbId": "1IQG", "@details": "1IQG contains the same protein complexed with M55159"}, {"@pdbId": "1IQI", "@details": "1IQI contains the same protein complexed with M55125"}, {"@pdbId": "1IQJ", "@details": "1IQJ contains the same protein complexed with M55124"}, {"@pdbId": "1IQK", "@details": "1IQK contains the same protein complexed with M55113"}, {"@pdbId": "1IQL", "@details": "1IQL contains the same protein complexed with M54476"}, {"@pdbId": "1IQM", "@details": "1IQM contains the same protein complexed with M54471"}, {"@pdbId": "1IQN", "@details": "1IQN contains the same protein complexed with M55192"}], "structureId": "1IQH", "title": "Human coagulation factor Xa in complex with M55143", "expMethod": "X-RAY DIFFRACTION", "resolution": "3.00", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "331", "nr_atoms": "2276", "deposition_date": "2001-07-23", "release_date": "2003-09-23", "last_modification_date": "2017-10-04", "structure_authors": "Shiromizu, I., Matsusue, T.", "citation_authors": "Matsusue, T., Shiromizu, I., Okamoto, A., Nakayama, K., Nishida, H., Mukaihira, T., Miyazaki, Y., Saitou, F., Morishita, H., Ohnishi, S., Mochizuki, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1iqh", "bioAssemblies": "1", "release_date": "Tue Sep 23 00:00:00 PDT 2003", "resolution": "3.00"}, "ligs": [{"@structureId": "1IQH", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1IQH", "@chemicalID": "XMF", "@type": "non-polymer", "@molecularWeight": "529.051", "chemicalName": "4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[4-HYDROXYMETHYL-1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE", "formula": "C26 H29 Cl N4 O4 S", "InChI": "InChI=1S/C26H29ClN4O4S/c27-22-3-1-21-16-24(4-2-20(21)15-22)36(34,35)31-14-13-30(25(33)17-31)18-26(19-32)7-11-29(12-8-26)23-5-9-28-10-6-23/h1-6,9-10,15-16,32H,7-8,11-14,17-19H2", "InChIKey": "ZRGAURKJCJQBQS-UHFFFAOYSA-N", "smiles": "c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)[N@@]3CCN(C(=O)C3)CC4(CCN(CC4)c5ccncc5)CO"}], "num_ligs": 2, "name_ligs": ["CA", "XMF"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1iqi": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1IOE", "@details": "1IOE contains the same protein complexed with M55532"}, {"@pdbId": "1IQE", "@details": "1IQE contains the same protein complexed with M55590"}, {"@pdbId": "1IQF", "@details": "1IQF contains the same protein complexed with M55165"}, {"@pdbId": "1IQG", "@details": "1IQG contains the same protein complexed with M55159"}, {"@pdbId": "1IQH", "@details": "1IQH contains the same protein complexed with M55143"}, {"@pdbId": "1IQJ", "@details": "1IQJ contains the same protein complexed with M55124"}, {"@pdbId": "1IQK", "@details": "1IQK contains the same protein complexed with M55113"}, {"@pdbId": "1IQL", "@details": "1IQL contains the same protein complexed with M54476"}, {"@pdbId": "1IQM", "@details": "1IQM contains the same protein complexed with M54471"}, {"@pdbId": "1IQN", "@details": "1IQN contains the same protein complexed with M55192"}], "structureId": "1IQI", "title": "Human coagulation factor Xa in complex with M55125", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.90", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "331", "nr_atoms": "2276", "deposition_date": "2001-07-23", "release_date": "2003-09-23", "last_modification_date": "2017-10-04", "structure_authors": "Shiromizu, I., Matsusue, T.", "citation_authors": "Matsusue, T., Shiromizu, I., Okamoto, A., Nakayama, K., Nishida, H., Mukaihira, T., Miyazaki, Y., Saitou, F., Morishita, H., Ohnishi, S., Mochizuki, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1iqi", "bioAssemblies": "1", "release_date": "Tue Sep 23 00:00:00 PDT 2003", "resolution": "2.90"}, "ligs": [{"@structureId": "1IQI", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1IQI", "@chemicalID": "XMG", "@type": "non-polymer", "@molecularWeight": "529.051", "chemicalName": "4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL] METHYL]-2-PIPERAZINECARBOXYLIC ACID", "formula": "C26 H29 Cl N4 O4 S", "InChIKey": "QLUPDKQDBWRPGQ-VWLOTQADSA-N", "InChI": "InChI=1S/C26H29ClN4O4S/c27-22-3-1-21-16-24(4-2-20(21)15-22)36(34,35)31-14-13-30(25(18-31)26(32)33)17-19-7-11-29(12-8-19)23-5-9-28-10-6-23/h1-6,9-10,15-16,19,25H,7-8,11-14,17-18H2,(H,32,33)/t25-/m0/s1", "smiles": "c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)[N@@]3CC[N@]([C@@H](C3)C(=O)O)CC4CCN(CC4)c5ccncc5"}], "num_ligs": 2, "name_ligs": ["CA", "XMG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1iqj": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1IOE", "@details": "1IOE contains the same protein complexed with M55532"}, {"@pdbId": "1IQE", "@details": "1IQE contains the same protein complexed with M55590"}, {"@pdbId": "1IQF", "@details": "1IQF contains the same protein complexed with M55165"}, {"@pdbId": "1IQG", "@details": "1IQG contains the same protein complexed with M55159"}, {"@pdbId": "1IQH", "@details": "1IQH contains the same protein complexed with M55143"}, {"@pdbId": "1IQI", "@details": "1IQI contains the same protein complexed with M55125"}, {"@pdbId": "1IQK", "@details": "1IQK contains the same protein complexed with M55113"}, {"@pdbId": "1IQL", "@details": "1IQL contains the same protein complexed with M54476"}, {"@pdbId": "1IQM", "@details": "1IQM contains the same protein complexed with M54471"}, {"@pdbId": "1IQN", "@details": "1IQN contains the same protein complexed with M55192"}], "structureId": "1IQJ", "title": "Human coagulation factor Xa in complex with M55124", "expMethod": "X-RAY DIFFRACTION", "resolution": "3.00", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "331", "nr_atoms": "2278", "deposition_date": "2001-07-23", "release_date": "2003-09-23", "last_modification_date": "2017-10-04", "structure_authors": "Shiromizu, I., Matsusue, T.", "citation_authors": "Matsusue, T., Shiromizu, I., Okamoto, A., Nakayama, K., Nishida, H., Mukaihira, T., Miyazaki, Y., Saitou, F., Morishita, H., Ohnishi, S., Mochizuki, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1iqj", "bioAssemblies": "1", "release_date": "Tue Sep 23 00:00:00 PDT 2003", "resolution": "3.00"}, "ligs": [{"@structureId": "1IQJ", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1IQJ", "@chemicalID": "XMH", "@type": "non-polymer", "@molecularWeight": "557.104", "chemicalName": "4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]-2-PIPERAZINECARBOXYLIC ACID ETHYL ESTER", "formula": "C28 H33 Cl N4 O4 S", "InChIKey": "KTOZABIXRDAUJO-HHHXNRCGSA-N", "InChI": "InChI=1S/C28H33ClN4O4S/c1-2-37-28(34)27-20-33(38(35,36)26-6-4-22-17-24(29)5-3-23(22)18-26)16-15-32(27)19-21-9-13-31(14-10-21)25-7-11-30-12-8-25/h3-8,11-12,17-18,21,27H,2,9-10,13-16,19-20H2,1H3/t27-/m1/s1", "smiles": "CCOC(=O)[C@H]1C[N@](CC[N@@]1CC2CCN(CC2)c3ccncc3)S(=O)(=O)c4ccc5cc(ccc5c4)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "XMH"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1iqk": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1IOE", "@details": "1IOE contains the same protein complexed with M55532"}, {"@pdbId": "1IQE", "@details": "1IQE contains the same protein complexed with M55590"}, {"@pdbId": "1IQF", "@details": "1IQF contains the same protein complexed with M55165"}, {"@pdbId": "1IQG", "@details": "1IQG contains the same protein complexed with M55159"}, {"@pdbId": "1IQH", "@details": "1IQH contains the same protein complexed with M55143"}, {"@pdbId": "1IQI", "@details": "1IQI contains the same protein complexed with M55125"}, {"@pdbId": "1IQJ", "@details": "1IQJ contains the same protein complexed with M55124"}, {"@pdbId": "1IQL", "@details": "1IQL contains the same protein complexed with M54476"}, {"@pdbId": "1IQM", "@details": "1IQM contains the same protein complexed with M54471"}, {"@pdbId": "1IQN", "@details": "1IQN contains the same protein complexed with M55192"}], "structureId": "1IQK", "title": "Human coagulation factor Xa in complex with M55113", "expMethod": "X-RAY DIFFRACTION", "resolution": "3.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "331", "nr_atoms": "2274", "deposition_date": "2001-07-23", "release_date": "2003-09-23", "last_modification_date": "2017-10-04", "structure_authors": "Shiromizu, I., Matsusue, T.", "citation_authors": "Matsusue, T., Shiromizu, I., Okamoto, A., Nakayama, K., Nishida, H., Mukaihira, T., Miyazaki, Y., Saitou, F., Morishita, H., Ohnishi, S., Mochizuki, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1iqk", "bioAssemblies": "1", "release_date": "Tue Sep 23 00:00:00 PDT 2003", "resolution": "3.20"}, "ligs": [{"@structureId": "1IQK", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1IQK", "@chemicalID": "XMI", "@type": "non-polymer", "@molecularWeight": "499.025", "chemicalName": "4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE", "formula": "C25 H27 Cl N4 O3 S", "InChI": "InChI=1S/C25H27ClN4O3S/c26-22-3-1-21-16-24(4-2-20(21)15-22)34(32,33)30-14-13-29(25(31)18-30)17-19-7-11-28(12-8-19)23-5-9-27-10-6-23/h1-6,9-10,15-16,19H,7-8,11-14,17-18H2", "InChIKey": "BKWIJYNQPXKNMH-UHFFFAOYSA-N", "smiles": "c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)[N@]3CCN(C(=O)C3)CC4CCN(CC4)c5ccncc5"}], "num_ligs": 2, "name_ligs": ["CA", "XMI"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1iql": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1IOE", "@details": "1IOE contains the same protein complexed with M55532"}, {"@pdbId": "1IQE", "@details": "1IQE contains the same protein complexed with M55590"}, {"@pdbId": "1IQF", "@details": "1IQF contains the same protein complexed with M55165"}, {"@pdbId": "1IQG", "@details": "1IQG contains the same protein complexed with M55159"}, {"@pdbId": "1IQH", "@details": "1IQH contains the same protein complexed with M55143"}, {"@pdbId": "1IQI", "@details": "1IQI contains the same protein complexed with M55125"}, {"@pdbId": "1IQJ", "@details": "1IQJ contains the same protein complexed with M55124"}, {"@pdbId": "1IQK", "@details": "1IQK contains the same protein complexed with M55113"}, {"@pdbId": "1IQM", "@details": "1IQM contains the same protein complexed with M54471"}, {"@pdbId": "1IQN", "@details": "1IQN contains the same protein complexed with M55192"}], "structureId": "1IQL", "title": "Human coagulation factor Xa in complex with M54476", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.70", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "331", "nr_atoms": "2272", "deposition_date": "2001-07-23", "release_date": "2003-09-23", "last_modification_date": "2017-10-04", "structure_authors": "Shiromizu, I., Matsusue, T.", "citation_authors": "Matsusue, T., Shiromizu, I., Okamoto, A., Nakayama, K., Nishida, H., Mukaihira, T., Miyazaki, Y., Saitou, F., Morishita, H., Ohnishi, S., Mochizuki, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1iql", "bioAssemblies": "1", "release_date": "Tue Sep 23 00:00:00 PDT 2003", "resolution": "2.70"}, "ligs": [{"@structureId": "1IQL", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1IQL", "@chemicalID": "XMJ", "@type": "non-polymer", "@molecularWeight": "475.003", "chemicalName": "4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE", "formula": "C23 H27 Cl N4 O3 S", "InChI": "InChI=1S/C23H27ClN4O3S/c24-21-3-1-19(2-4-21)9-16-32(30,31)28-15-14-27(23(29)18-28)17-20-7-12-26(13-8-20)22-5-10-25-11-6-22/h1-6,9-11,16,20H,7-8,12-15,17-18H2/b16-9+", "InChIKey": "QLHUDNKWOSQSMK-CXUHLZMHSA-N", "smiles": "c1cc(ccc1\\C=C\\S(=O)(=O)[N@]2CCN(C(=O)C2)CC3CCN(CC3)c4ccncc4)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "XMJ"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1iqm": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1IOE", "@details": "1IOE contains the same protein complexed with M55532"}, {"@pdbId": "1IQE", "@details": "1IQE contains the same protein complexed with M55590"}, {"@pdbId": "1IQF", "@details": "1IQF contains the same protein complexed with M55165"}, {"@pdbId": "1IQG", "@details": "1IQG contains the same protein complexed with M55159"}, {"@pdbId": "1IQH", "@details": "1IQH contains the same protein complexed with M55143"}, {"@pdbId": "1IQI", "@details": "1IQI contains the same protein complexed with M55125"}, {"@pdbId": "1IQJ", "@details": "1IQJ contains the same protein complexed with M55124"}, {"@pdbId": "1IQK", "@details": "1IQK contains the same protein complexed with M55113"}, {"@pdbId": "1IQL", "@details": "1IQL contains the same protein complexed with M54476"}, {"@pdbId": "1IQN", "@details": "1IQN contains the same protein complexed with M55192"}], "structureId": "1IQM", "title": "Human coagulation factor Xa in complex with M54471", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.60", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "331", "nr_atoms": "2271", "deposition_date": "2001-07-23", "release_date": "2003-09-23", "last_modification_date": "2017-10-04", "structure_authors": "Shiromizu, I., Matsusue, T.", "citation_authors": "Matsusue, T., Shiromizu, I., Okamoto, A., Nakayama, K., Nishida, H., Mukaihira, T., Miyazaki, Y., Saitou, F., Morishita, H., Ohnishi, S., Mochizuki, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1iqm", "bioAssemblies": "1", "release_date": "Tue Sep 23 00:00:00 PDT 2003", "resolution": "2.60"}, "ligs": [{"@structureId": "1IQM", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1IQM", "@chemicalID": "XMK", "@type": "non-polymer", "@molecularWeight": "461.02", "chemicalName": "1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE", "formula": "C23 H29 Cl N4 O2 S", "InChIKey": "ZOSSOFIFNGGDKG-GIJQJNRQSA-N", "InChI": "InChI=1S/C23H29ClN4O2S/c24-22-3-1-20(2-4-22)9-18-31(29,30)28-16-14-26(15-17-28)19-21-7-12-27(13-8-21)23-5-10-25-11-6-23/h1-6,9-11,18,21H,7-8,12-17,19H2/b18-9+", "smiles": "c1cc(ccc1\\C=C\\S(=O)(=O)N2CCN(CC2)CC3CCN(CC3)c4ccncc4)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "XMK"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1iqn": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1IOE", "@details": "1IOE contains the same protein complexed with M55532"}, {"@pdbId": "1IQE", "@details": "1IQE contains the same protein complexed with M55590"}, {"@pdbId": "1IQF", "@details": "1IQF contains the same protein complexed with M55165"}, {"@pdbId": "1IQG", "@details": "1IQG contains the same protein complexed with M55159"}, {"@pdbId": "1IQH", "@details": "1IQH contains the same protein complexed with M55143"}, {"@pdbId": "1IQI", "@details": "1IQI contains the same protein complexed with M55125"}, {"@pdbId": "1IQJ", "@details": "1IQJ contains the same protein complexed with M55124"}, {"@pdbId": "1IQK", "@details": "1IQK contains the same protein complexed with M55113"}, {"@pdbId": "1IQL", "@details": "1IQL contains the same protein complexed with M54476"}, {"@pdbId": "1IQM", "@details": "1IQM contains the same protein complexed with M54471"}], "structureId": "1IQN", "title": "Human coagulation factor Xa in complex with M55192", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.60", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "331", "nr_atoms": "2282", "deposition_date": "2001-07-23", "release_date": "2003-09-23", "last_modification_date": "2017-10-04", "structure_authors": "Shiromizu, I., Matsusue, T.", "citation_authors": "Matsusue, T., Shiromizu, I., Okamoto, A., Nakayama, K., Nishida, H., Mukaihira, T., Miyazaki, Y., Saitou, F., Morishita, H., Ohnishi, S., Mochizuki, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1iqn", "bioAssemblies": "1", "release_date": "Tue Sep 23 00:00:00 PDT 2003", "resolution": "2.60"}, "ligs": [{"@structureId": "1IQN", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1IQN", "@chemicalID": "XMC", "@type": "non-polymer", "@molecularWeight": "612.139", "chemicalName": "4-[[4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-6-OXO-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]-2-PIPERAZINYL]CARBONYL]MORPHOLINE", "formula": "C30 H34 Cl N5 O5 S", "InChIKey": "CJERKHNRUGRCIY-MUUNZHRXSA-N", "InChI": "InChI=1S/C30H34ClN5O5S/c31-25-3-1-24-18-27(4-2-23(24)17-25)42(39,40)35-20-28(30(38)34-13-15-41-16-14-34)36(29(37)21-35)19-22-7-11-33(12-8-22)26-5-9-32-10-6-26/h1-6,9-10,17-18,22,28H,7-8,11-16,19-21H2/t28-/m1/s1", "smiles": "c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)[N@]3C[C@@H](N(C(=O)C3)CC4CCN(CC4)c5ccncc5)C(=O)N6CCOCC6"}], "num_ligs": 2, "name_ligs": ["CA", "XMC"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1ksn": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1EZQ", "@details": "1ezq is HUMAN COAGULATION FACTOR XA WITH INHIBITOR RPR128515"}, {"@pdbId": "1F0R", "@details": "1f0r is HUMAN COAGULATION FACTOR XA WITH INHIBITOR RPR208815"}, {"@pdbId": "1F0S", "@details": "1f0s is HUMAN COAGULATION FACTOR XA WITH INHIBITOR RPR208707"}, {"@pdbId": "1F0T", "@details": "1fot is BOVINE PANCREATIC TRYPSIN WITH INHIBITOR RPR131247"}, {"@pdbId": "1F0U", "@details": "1f0u is BOVINE PANCREATIC TRYPSIN WITH INHIBITOR RPR128515"}], "structureId": "1KSN", "title": "Crystal Structure of Human Coagulation Factor XA Complexed with FXV673", "pubmedId": "12039587", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2270", "deposition_date": "2002-01-14", "release_date": "2002-06-19", "last_modification_date": "2011-07-13", "structure_authors": "Maignan, S., Guilloteau, J.P.", "citation_authors": "Guertin, K.R., Gardner, C.J., Klein, S.I., Zulli, A.L., Czekaj, M., Gong, Y., Spada, A.P., Cheney, D.L., Maignan, S., Guilloteau, J.P., Brown, K.D., Colussi, D.J., Chu, V., Heran, C.L., Morgan, S.R., Bentley, R.G., Dunwiddie, C.T., Leadley, R.J., Pauls, H.W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1ksn", "bioAssemblies": "1", "release_date": "Wed Jun 19 00:00:00 PDT 2002", "resolution": "2.10"}, "ligs": [{"@structureId": "1KSN", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1KSN", "@chemicalID": "FXV", "@type": "non-polymer", "@molecularWeight": "447.506", "chemicalName": "METHYL-3-(4'-N-OXOPYRIDYLPHENOYL)-3-METHYL-2-(M-AMIDINOBENZYL)-PROPIONATE", "formula": "C25 H27 N4 O4 1", "InChIKey": "PFGVNLZDWRZPJW-OPAMFIHVSA-O", "InChI": "InChI=1S/C25H26N4O4/c1-16(22(25(31)33-2)15-17-4-3-5-21(14-17)23(26)27)28-24(30)20-8-6-18(7-9-20)19-10-12-29(32)13-11-19/h3-14,16,22H,15H2,1-2H3,(H3,26,27)(H,28,30)/p+1/t16-,22-/m1/s1", "smiles": "C[C@H]([C@@H](Cc1cccc(c1)C(=[NH2+])N)C(=O)OC)NC(=O)c2ccc(cc2)c3cc[n+](cc3)[O-]"}], "num_ligs": 2, "name_ligs": ["CA", "FXV"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1lpg": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1LPK", "@details": "1LPK contains the crystal structure of the same protein complexed with a different inhibitor of the same series at 2.2 angstrom"}, {"@pdbId": "1LPZ", "@details": "1LPZ contains the crystal structure of the same protein complex with a different inhibitor of the same series at 2.4 angstrom"}, {"@pdbId": "1LQD", "@details": "1LQD contains the crystal structure of the same protein complex with a different inhibitor of the same series at 2.7 angstrom"}, {"@pdbId": "1LQE", "@details": "1LQE contains the crystal structure of the related protein trypsin complexed with the same inhibitor at 2.4 angstrom"}], "structureId": "1LPG", "title": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79.", "pubmedId": "12061878", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.00", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2289", "deposition_date": "2002-05-08", "release_date": "2003-05-08", "last_modification_date": "2011-07-13", "structure_authors": "Schreuder, H.A., Brachvogel, V., Liesum, A.", "citation_authors": "Matter, H., Defossa, E., Heinelt, U., Blohm, P.M., Schneider, D., Mueller, A., Herok, S., Schreuder, H., Liesum, A., Brachvogel, B., Loenze, P., Walser, A., Al-Obeidi, F., Wildgoose, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1lpg", "bioAssemblies": "2", "release_date": "Thu May 08 00:00:00 PDT 2003", "resolution": "2.00"}, "ligs": [{"@structureId": "1LPG", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1LPG", "@chemicalID": "IMA", "@type": "non-polymer", "@molecularWeight": "546.682", "chemicalName": "[4-({[5-BENZYLOXY-1-(3-CARBAMIMIDOYL-BENZYL)-1H-INDOLE-2-CARBONYL]-AMINO}-METHYL)-PHENYL]-TRIMETHYL-AMMONIUM", "formula": "C34 H36 N5 O2 1", "InChIKey": "UFKJQTGPBFWMGT-UHFFFAOYSA-O", "InChI": "InChI=1S/C34H35N5O2/c1-39(2,3)29-14-12-24(13-15-29)21-37-34(40)32-20-28-19-30(41-23-25-8-5-4-6-9-25)16-17-31(28)38(32)22-26-10-7-11-27(18-26)33(35)36/h4-20H,21-23H2,1-3H3,(H3-,35,36,37,40)/p+1", "smiles": "C[N+](C)(C)c1ccc(cc1)CNC(=O)c2cc3cc(ccc3n2Cc4cccc(c4)C(=N)N)OCc5ccccc5"}], "num_ligs": 2, "name_ligs": ["CA", "IMA"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1lpk": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1LPG", "@details": "1LPG contains crystal structure of the same protein complex with IMA at 2.0 angstrom"}, {"@pdbId": "1LPZ", "@details": "1LPZ contains crystal structure of the same protein complex with CBM at 2.4 angstrom"}, {"@pdbId": "1LQD", "@details": "1LQD contains crystal structure of the same protein complex with CMI at 2.7 angstrom."}, {"@pdbId": "1LQE", "@details": "1LQE contains CRYSTAL STRUCTURE OF BOVINE'S TRYPSINOGEN"}], "structureId": "1LPK", "title": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125.", "pubmedId": "12061878", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2312", "deposition_date": "2002-05-08", "release_date": "2003-05-08", "last_modification_date": "2011-07-13", "structure_authors": "Schreuder, H.A., Loenze, P., Brachvogel, V., Liesum, A.", "citation_authors": "Matter, H., Defossa, E., Heinelt, U., Blohm, P.M., Schneider, D., Mueller, A., Herok, S., Schreuder, H.A., Liesum, A., Brachvogel, V., Loenze, P., Walser, A., Al-Obeidi, F., Wildgoose, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1lpk", "bioAssemblies": "2", "release_date": "Thu May 08 00:00:00 PDT 2003", "resolution": "2.20"}, "ligs": [{"@structureId": "1LPK", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1LPK", "@chemicalID": "CBB", "@type": "non-polymer", "@molecularWeight": "433.546", "chemicalName": "1-(3-CARBAMIMIDOYL-BENZYL)-1H-INDOLE-2-CARBOXYLIC ACID 3-CARBAMIMIDOYL-BENZYLESTER", "formula": "C25 H31 N5 O2", "InChI": "InChI=1S/C25H31N5O2/c26-23(27)19-8-3-5-16(11-19)14-30-21-10-2-1-7-18(21)13-22(30)25(31)32-15-17-6-4-9-20(12-17)24(28)29/h1-3,5,7,10-11,13,17,19-20H,4,6,8-9,12,14-15H2,(H3,26,27)(H3,28,29)/t17-,19-,20+/m1/s1", "InChIKey": "SDPCOHPMBQGZNR-RLLQIKCJSA-N", "smiles": "[H]/N=C(\\C1CC=CC(=C1)Cn2c3ccccc3cc2C(=O)OCC4CCCC(C4)C(=N)N)/N"}], "num_ligs": 2, "name_ligs": ["CA", "CBB"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1lpz": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1LPG", "@details": "1LPG contains the crystal structure of the same protein complexed with a different inhibitor of the same series at 2.0 angstrom"}, {"@pdbId": "1LPK", "@details": "1LPK contains the crystal structure of the same protein complexed with a different inhibitor of the same series at 2.2 angstrom"}, {"@pdbId": "1LQD", "@details": "1LQD contains the crystal structure of the same protein complexed with a different inhibitor of the same series at 2.7 angstrom"}, {"@pdbId": "1LQE", "@details": "1LQE contains the crystal structure of the related protein trypsin complexed with a different inhibitor from the same series at 2.2 angstrom"}], "structureId": "1LPZ", "title": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.", "pubmedId": "12061878", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.40", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2280", "deposition_date": "2002-05-08", "release_date": "2003-05-08", "last_modification_date": "2011-07-13", "structure_authors": "Schreuder, H.A., Brachvogel, V., Liesum, A.", "citation_authors": "Matter, H., Defossa, E., Heinelt, U., Blohm, P.M., Schneider, D., Mueller, A., Herok, S., Schreuder, H.A., Liesum, A., Brachvogel, V., Loenze, P., Walser, A., Al-Obeidi, F., Wildgoose, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1lpz", "bioAssemblies": "2", "release_date": "Thu May 08 00:00:00 PDT 2003", "resolution": "2.40"}, "ligs": [{"@structureId": "1LPZ", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1LPZ", "@chemicalID": "CMB", "@type": "non-polymer", "@molecularWeight": "465.374", "chemicalName": "1-(3-carbamimidoylbenzyl)-N-(3,5-dichlorobenzyl)-4-methyl-1H-indole-2-carboxamide", "formula": "C25 H22 Cl2 N4 O", "InChI": "InChI=1S/C25H22Cl2N4O/c1-15-4-2-7-22-21(15)12-23(25(32)30-13-17-9-19(26)11-20(27)10-17)31(22)14-16-5-3-6-18(8-16)24(28)29/h2-12H,13-14H2,1H3,(H3,28,29)(H,30,32)", "InChIKey": "YAAKSJLUBVPBIM-UHFFFAOYSA-N", "smiles": "Cc1cccc2c1cc(n2Cc3cccc(c3)C(=N)N)C(=O)NCc4cc(cc(c4)Cl)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "CMB"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1lqd": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1LPG", "@details": "1LPG contains the crystal structure of the same protein complexed with a different inhibitor of the same series at 2.0 angstrom"}, {"@pdbId": "1LPK", "@details": "1LPK contains the crystal structure of the same protein complexed with a different inhibitor of the same series at 2.2 angstrom"}, {"@pdbId": "1LPZ", "@details": "1LPG contains the crystal structure of the same protein complexed with a different inhibitor of the same series at 2.4 angstrom"}, {"@pdbId": "1LQE", "@details": "1LQE contains the crystal structure of the related protein trypsin complexed with a different inhibitor of the same series at 2.2 angstrom"}], "structureId": "1LQD", "title": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.", "pubmedId": "12061878", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.70", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2280", "deposition_date": "2002-05-10", "release_date": "2003-05-10", "last_modification_date": "2011-07-13", "structure_authors": "Schreuder, H.A., Loenze, P., Brachvogel, V., Liesum, A.", "citation_authors": "Matter, H., Defossa, E., Heinelt, U., Blohm, P.M., Schneider, D., Mueller, A., Herok, S., Schreuder, H.A., Liesum, A., Brachvogel, V., Loenze, P., Walser, A., Al-Obeidi, F., Wildgoose, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1lqd", "bioAssemblies": "2", "release_date": "Sat May 10 00:00:00 PDT 2003", "resolution": "2.70"}, "ligs": [{"@structureId": "1LQD", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1LQD", "@chemicalID": "CMI", "@type": "non-polymer", "@molecularWeight": "424.537", "chemicalName": "1-(3-CARBAMIMIDOYL-BENZYL)-4-METHYL-1H-INDOLE-2-CARBOXYLIC ACID 3,5-DIMETHYL-BENZYLAMIDE", "formula": "C27 H28 N4 O", "InChI": "InChI=1S/C27H28N4O/c1-17-10-18(2)12-21(11-17)15-30-27(32)25-14-23-19(3)6-4-9-24(23)31(25)16-20-7-5-8-22(13-20)26(28)29/h4-14H,15-16H2,1-3H3,(H3,28,29)(H,30,32)", "InChIKey": "JSQZLEYFOOSZPU-UHFFFAOYSA-N", "smiles": "[H]/N=C(\\c1cccc(c1)Cn2c3cccc(c3cc2C(=O)NCc4cc(cc(c4)C)C)C)/N"}], "num_ligs": 2, "name_ligs": ["CA", "CMI"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1mq5": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1EZQ", "@details": "FACTOR XA COMPLEXED TO RPR128515"}, {"@pdbId": "1F0R", "@details": "FACTOR XA COMPLEXED TO RPR208815"}, {"@pdbId": "1F0S", "@details": "FACTOR XA COMPLEXED TO RPR208707"}, {"@pdbId": "1FJS", "@details": "FACTOR XA COMPLEXED TO ZK807834"}, {"@pdbId": "1mq6", "@details": "Crystal Structure of 3-chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide Complexed with human Factor Xa"}, {"@pdbId": "1QL7", "@details": "TRYSPIN COMPLEXED TO FACTOR XA INHIBITOR"}, {"@pdbId": "1QL9", "@details": "TRYSPIN COMPLEXED TO FACTOR XA INHIBITOR"}], "structureId": "1MQ5", "title": "Crystal Structure of 3-chloro-N-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa", "pubmedId": "12501180", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "284", "nr_atoms": "2273", "deposition_date": "2002-09-13", "release_date": "2003-01-28", "last_modification_date": "2017-10-11", "structure_authors": "Adler, M., Whitlow, M.", "citation_authors": "Adler, M., Kochanny, M.J., Bin, Y., Rumennik, G., Light, D.L., Biancalana, S., Whitlow, M.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1mq5", "bioAssemblies": "1", "release_date": "Tue Jan 28 00:00:00 PST 2003", "resolution": "2.10"}, "ligs": [{"@structureId": "1MQ5", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1MQ5", "@chemicalID": "GOL", "@type": "non-polymer", "@molecularWeight": "92.094", "chemicalName": "GLYCEROL", "formula": "C3 H8 O3", "InChIKey": "PEDCQBHIVMGVHV-UHFFFAOYSA-N", "InChI": "InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2", "smiles": "C(C(CO)O)O"}, {"@structureId": "1MQ5", "@chemicalID": "XLC", "@type": "non-polymer", "@molecularWeight": "537.889", "chemicalName": "3-CHLORO-N-[4-CHLORO-2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE", "formula": "C24 H23 Cl3 N4 O2 S", "InChI": "InChI=1S/C24H23Cl3N4O2S/c1-30-8-10-31(11-9-30)13-15-14-34-22(21(15)27)24(33)29-20-7-4-17(26)12-19(20)23(32)28-18-5-2-16(25)3-6-18/h2-7,12,14H,8-11,13H2,1H3,(H,28,32)(H,29,33)", "InChIKey": "FIZKTFMGWNHPMZ-UHFFFAOYSA-N", "smiles": "CN1CCN(CC1)Cc2csc(c2Cl)C(=O)Nc3ccc(cc3C(=O)Nc4ccc(cc4)Cl)Cl"}], "num_ligs": 3, "name_ligs": ["CA", "GOL", "XLC"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "1mq6": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1EZQ", "@details": "FACTOR XA COMPLEXED TO RPR128515"}, {"@pdbId": "1F0R", "@details": "FACTOR XA COMPLEXED TO RPR208815"}, {"@pdbId": "1F0S", "@details": "FACTOR XA COMPLEXED TO RPR208707"}, {"@pdbId": "1FJS", "@details": "FACTOR XA COMPLEXED TO ZK807834"}, {"@pdbId": "1MQ5", "@details": "Crystal Structure of 3-chloro-N-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa"}, {"@pdbId": "1QL7", "@details": "TRYSPIN COMPLEXED TO FACTOR XA INHIBITOR"}, {"@pdbId": "1QL9", "@details": "TRYSPIN COMPLEXED TO FACTOR XA INHIBITOR"}], "structureId": "1MQ6", "title": "Crystal Structure of 3-chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa", "pubmedId": "12501180", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "284", "nr_atoms": "2275", "deposition_date": "2002-09-13", "release_date": "2003-01-28", "last_modification_date": "2017-10-11", "structure_authors": "Adler, M., Whitlow, M.", "citation_authors": "Adler, M., Kochanny, M.J., Bin, Y., Rumennik, G., Light, D.L., Biancalana, S., Whitlow, M.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1mq6", "bioAssemblies": "1", "release_date": "Tue Jan 28 00:00:00 PST 2003", "resolution": "2.10"}, "ligs": [{"@structureId": "1MQ6", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1MQ6", "@chemicalID": "GOL", "@type": "non-polymer", "@molecularWeight": "92.094", "chemicalName": "GLYCEROL", "formula": "C3 H8 O3", "InChIKey": "PEDCQBHIVMGVHV-UHFFFAOYSA-N", "InChI": "InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2", "smiles": "C(C(CO)O)O"}, {"@structureId": "1MQ6", "@chemicalID": "XLD", "@type": "non-polymer", "@molecularWeight": "568.86", "chemicalName": "3-CHLORO-N-[4-CHLORO-2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2-THIOPHENECARBOXAMIDE", "formula": "C23 H20 Cl3 N5 O4 S", "InChIKey": "FBXIHZSULWMHJY-UHFFFAOYSA-N", "InChI": "InChI=1S/C23H20Cl3N5O4S/c1-31(23-27-5-6-35-23)10-12-11-36-20(18(12)26)22(33)30-19-15(7-14(25)8-16(19)34-2)21(32)29-17-4-3-13(24)9-28-17/h3-4,7-9,11H,5-6,10H2,1-2H3,(H,30,33)(H,28,29,32)", "smiles": "CN(Cc1csc(c1Cl)C(=O)Nc2c(cc(cc2OC)Cl)C(=O)Nc3ccc(cn3)Cl)C4=NCCO4"}], "num_ligs": 3, "name_ligs": ["CA", "GOL", "XLD"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "1nfu": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1EZQ", "@details": "The same protein complexed with RPR128515"}, {"@pdbId": "1F0R", "@details": "The same protein complexed with RPR208815"}, {"@pdbId": "1F0S", "@details": "The same protein complexed with RPR208707"}, {"@pdbId": "1NFW", "@details": ""}, {"@pdbId": "1NFX", "@details": ""}, {"@pdbId": "1NFY", "@details": ""}], "structureId": "1NFU", "title": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747", "pubmedId": "12593649", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.05", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "449", "nr_atoms": "2269", "deposition_date": "2002-12-16", "release_date": "2003-02-25", "last_modification_date": "2011-07-13", "structure_authors": "Maignan, S., Guilloteau, J.P.", "citation_authors": "Maignan, S., Guilloteau, J.P., Choi-Sledeski, Y.M., Becker, M.R., Ewing, W.R., Pauls, H.W., Spada, A.P., Mikol, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1nfu", "bioAssemblies": "1", "release_date": "Tue Feb 25 00:00:00 PST 2003", "resolution": "2.05"}, "ligs": [{"@structureId": "1NFU", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1NFU", "@chemicalID": "RRP", "@type": "non-polymer", "@molecularWeight": "462.973", "chemicalName": "3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE", "formula": "C20 H19 Cl N4 O3 S2", "InChIKey": "PRMSFVUWLBPPLY-UHFFFAOYSA-N", "InChI": "InChI=1S/C20H19ClN4O3S2/c21-16-5-4-14-9-19(29-17(14)10-16)30(27,28)25-7-6-24(18(26)12-25)11-13-2-1-3-15(8-13)20(22)23/h1-5,8-10H,6-7,11-12H2,(H3,22,23)", "smiles": "c1cc(cc(c1)C(=N)N)CN2CC[N@@](CC2=O)S(=O)(=O)c3cc4ccc(cc4s3)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "RRP"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1nfw": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1EZQ", "@details": "The same protein complexed with RPR128515"}, {"@pdbId": "1FOR", "@details": "The same protein complexed with RPR208815"}, {"@pdbId": "1FOS", "@details": "The same protein complexed with RPR208707"}, {"@pdbId": "1NFU", "@details": ""}, {"@pdbId": "1NFX", "@details": ""}, {"@pdbId": "1NFY", "@details": ""}], "structureId": "1NFW", "title": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685", "pubmedId": "12593649", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2256", "deposition_date": "2002-12-16", "release_date": "2003-02-25", "last_modification_date": "2011-07-13", "structure_authors": "Maignan, S., Guilloteau, J.P.", "citation_authors": "Maignan, S., Guilloteau, J.P., Choi-Sledeski, Y.M., Becker, M.R., Ewing, W.R., Pauls, H.W., Spada, A.P., Mikol, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1nfw", "bioAssemblies": "1", "release_date": "Tue Feb 25 00:00:00 PST 2003", "resolution": "2.10"}, "ligs": [{"@structureId": "1NFW", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1NFW", "@chemicalID": "RRR", "@type": "non-polymer", "@molecularWeight": "436.936", "chemicalName": "4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE", "formula": "C18 H17 Cl N4 O3 S2", "InChIKey": "PLWVUIRWJVKSSD-XBXARRHUSA-N", "InChI": "InChI=1S/C18H17ClN4O3S2/c19-17-2-1-15(27-17)4-8-28(25,26)23-7-6-22(18(24)12-23)11-14-9-13-10-20-5-3-16(13)21-14/h1-5,8-10,21H,6-7,11-12H2/b8-4+", "smiles": "c1cc(sc1\\C=C\\S(=O)(=O)[N@]2CCN(C(=O)C2)Cc3cc4cnccc4[nH]3)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "RRR"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1nfx": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1EZQ", "@details": "The same protein complexed with RPR128515"}, {"@pdbId": "1F0R", "@details": "The same protein complexed with RPR208815"}, {"@pdbId": "1F0S", "@details": "The same protein complexed with RPR208707"}, {"@pdbId": "1NFU", "@details": ""}, {"@pdbId": "1NFW", "@details": ""}, {"@pdbId": "1NFY", "@details": ""}], "structureId": "1NFX", "title": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944", "pubmedId": "12593649", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.15", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2281", "deposition_date": "2002-12-16", "release_date": "2003-02-25", "last_modification_date": "2011-07-13", "structure_authors": "Maignan, S., Guilloteau, J.P.", "citation_authors": "Maignan, S., Guilloteau, J.P., Choi-Sledeski, Y.M., Becker, M.R., Ewing, W.R., Pauls, H.W., Spada, A.P., Mikol, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1nfx", "bioAssemblies": "1", "release_date": "Tue Feb 25 00:00:00 PST 2003", "resolution": "2.15"}, "ligs": [{"@structureId": "1NFX", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1NFX", "@chemicalID": "RDR", "@type": "non-polymer", "@molecularWeight": "505.01", "chemicalName": "4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-1-{[1-(2-HYDROXYETHYL)-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]METHYL}PIPERAZIN-2-ONE", "formula": "C22 H21 Cl N4 O4 S2", "InChIKey": "NZNFLUOJACWZKX-UHFFFAOYSA-N", "InChI": "InChI=1S/C22H21ClN4O4S2/c23-17-2-1-15-10-22(32-20(15)11-17)33(30,31)26-6-5-25(21(29)14-26)13-18-9-16-12-24-4-3-19(16)27(18)7-8-28/h1-4,9-12,28H,5-8,13-14H2", "smiles": "c1cc(cc2c1cc(s2)S(=O)(=O)[N@]3CCN(C(=O)C3)Cc4cc5cnccc5n4CCO)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "RDR"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1nfy": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1EZQ", "@details": "The same protein complexed with RPR128515"}, {"@pdbId": "1F0R", "@details": "The same protein complexed with RPR208815"}, {"@pdbId": "1F0S", "@details": "The same protein complexed with RPR208707"}, {"@pdbId": "1NFU", "@details": ""}, {"@pdbId": "1NFW", "@details": ""}, {"@pdbId": "1NFX", "@details": ""}], "structureId": "1NFY", "title": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095", "pubmedId": "12593649", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2278", "deposition_date": "2002-12-16", "release_date": "2003-02-25", "last_modification_date": "2011-07-13", "structure_authors": "Maignan, S., Guilloteau, J.P.", "citation_authors": "Maignan, S., Guilloteau, J.P., Choi-Sledeski, Y.M., Becker, M.R., Ewing, W.R., Pauls, H.W., Spada, A.P., Mikol, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1nfy", "bioAssemblies": "1", "release_date": "Tue Feb 25 00:00:00 PST 2003", "resolution": "2.10"}, "ligs": [{"@structureId": "1NFY", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1NFY", "@chemicalID": "RTR", "@type": "non-polymer", "@molecularWeight": "462.973", "chemicalName": "4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE", "formula": "C20 H19 Cl N4 O3 S2", "InChI": "InChI=1S/C20H19ClN4O3S2/c21-16-6-5-15-9-19(29-17(15)10-16)30(27,28)25-8-7-24(18(26)12-25)11-13-1-3-14(4-2-13)20(22)23/h1-6,9-10H,7-8,11-12H2,(H3,22,23)", "InChIKey": "VXONTEUOQXFJJS-UHFFFAOYSA-N", "smiles": "c1cc(ccc1CN2CC[N@@](CC2=O)S(=O)(=O)c3cc4ccc(cc4s3)Cl)C(=N)N"}], "num_ligs": 2, "name_ligs": ["CA", "RTR"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "1p0s": {"describe_pdb": {"structureId": "1P0S", "title": "Crystal Structure of Blood Coagulation Factor Xa in Complex with Ecotin M84R", "pubmedId": "12834348", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.80", "keywords": "HYDROLASE", "nr_entities": "3", "nr_residues": "534", "nr_atoms": "3792", "deposition_date": "2003-04-10", "release_date": "2003-08-26", "last_modification_date": "2011-07-13", "structure_authors": "Wang, S.X., Hur, E., Sousa, C.A., Brinen, L., Slivka, E.J., Fletterick, R.J.", "citation_authors": "Wang, S.X., Hur, E., Sousa, C.A., Brinen, L., Slivka, E.J., Fletterick, R.J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "L"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "H"}}, {"@id": "3", "@type": "protein", "Chain": {"@id": "E"}}], "structureId": "1p0s", "bioAssemblies": "1", "release_date": "Tue Aug 26 00:00:00 PDT 2003", "resolution": "2.80"}, "ligs": [{"@structureId": "1P0S", "@chemicalID": "CGU", "@type": "L-peptide linking", "@molecularWeight": "191.139", "chemicalName": "GAMMA-CARBOXY-GLUTAMIC ACID", "formula": "C6 H9 N O6", "InChI": "InChI=1S/C6H9NO6/c7-3(6(12)13)1-2(4(8)9)5(10)11/h2-3H,1,7H2,(H,8,9)(H,10,11)(H,12,13)/t3-/m0/s1", "InChIKey": "UHBYWPGGCSDKFX-VKHMYHEASA-N", "smiles": "C(C(C(=O)O)C(=O)O)[C@@H](C(=O)O)N"}, {"@structureId": "1P0S", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}, {"@structureId": "1P0S", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 3, "name_ligs": ["CGU", "MG", "NA"], "seq": "", "chain_id": "H", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1v3x": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1fax", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR DX-9065"}, {"@pdbId": "1xka", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A"}], "structureId": "1V3X", "title": "Factor Xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine", "pubmedId": "15456260", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2183", "deposition_date": "2003-11-07", "release_date": "2004-11-07", "last_modification_date": "2011-07-13", "structure_authors": "Suzuki, M.", "citation_authors": "Haginoya, N., Kobayashi, S., Komoriya, S., Yoshino, T., Suzuki, M., Shimada, T., Watanabe, K., Hirokawa, Y., Furugori, T., Nagahara, T.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1v3x", "bioAssemblies": "1", "release_date": "Sun Nov 07 00:00:00 PST 2004", "resolution": "2.20"}, "ligs": [{"@structureId": "1V3X", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1V3X", "@chemicalID": "D76", "@type": "non-polymer", "@molecularWeight": "534.051", "chemicalName": "(2R)-4-[(6-CHLORO-2-NAPHTHYL)SULFONYL]-1-[(5-METHYL-4,5,6,7-TETRAHYDRO[1,3]THIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]PIPERAZINE-2-CARBOXAMIDE", "formula": "C23 H24 Cl N5 O4 S2", "InChI": "InChI=1S/C23H24ClN5O4S2/c1-27-7-6-18-20(13-27)34-22(26-18)23(31)29-9-8-28(12-19(29)21(25)30)35(32,33)17-5-3-14-10-16(24)4-2-15(14)11-17/h2-5,10-11,19H,6-9,12-13H2,1H3,(H2,25,30)/t19-/m1/s1", "InChIKey": "OVHHNKPYYVQCLN-LJQANCHMSA-N", "smiles": "C[N@@]1CCc2c(sc(n2)C(=O)N3CC[N@](C[C@@H]3C(=O)N)S(=O)(=O)c4ccc5cc(ccc5c4)Cl)C1"}], "num_ligs": 2, "name_ligs": ["CA", "D76"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "1wu1": {"describe_pdb": {"relatedPDB": {"@pdbId": "1V3X", "@details": "The same protein complexed with structurally related inhibitor"}, "structureId": "1WU1", "title": "Factor Xa in complex with the inhibitor 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl) pyrimidin-2-yl]carbonyl]piperazine", "pubmedId": "15911309", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.30", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "328", "nr_atoms": "2190", "deposition_date": "2004-11-29", "release_date": "2005-11-29", "last_modification_date": "2012-06-20", "structure_authors": "Suzuki, M.", "citation_authors": "Komoriya, S., Haginoya, N., Kobayashi, S., Nagata, T., Mochizuki, A., Suzuki, M., Yoshino, T., Horino, H., Nagahara, T., Suzuki, M., Isobe, Y., Furugoori, T.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "1wu1", "bioAssemblies": "1", "release_date": "Tue Nov 29 00:00:00 PST 2005", "resolution": "2.30"}, "ligs": [{"@structureId": "1WU1", "@chemicalID": "BHD", "@type": "L-peptide linking", "@molecularWeight": "149.102", "chemicalName": "(3S)-3-hydroxy-L-aspartic acid", "formula": "C4 H7 N O5", "InChI": "InChI=1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/t1-,2-/m0/s1", "InChIKey": "YYLQUHNPNCGKJQ-LWMBPPNESA-N", "smiles": "[C@H]([C@@H](C(=O)O)O)(C(=O)O)N"}, {"@structureId": "1WU1", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "1WU1", "@chemicalID": "D91", "@type": "non-polymer", "@molecularWeight": "539.049", "chemicalName": "5-CHLORO-2-({3-ISOBUTYL-4-[(5-PYRIDIN-4-YLPYRIMIDIN-2-YL)CARBONYL]PIPERAZIN-1-YL}SULFONYL)-1H-INDOLE", "formula": "C26 H27 Cl N6 O3 S", "InChI": "InChI=1S/C26H27ClN6O3S/c1-17(2)11-22-16-32(37(35,36)24-13-19-12-21(27)3-4-23(19)31-24)9-10-33(22)26(34)25-29-14-20(15-30-25)18-5-7-28-8-6-18/h3-8,12-15,17,22,31H,9-11,16H2,1-2H3/t22-/m1/s1", "InChIKey": "JUUFKVAFKAKWRV-JOCHJYFZSA-N", "smiles": "CC(C)C[C@@H]1C[N@](CCN1C(=O)c2ncc(cn2)c3ccncc3)S(=O)(=O)c4cc5cc(ccc5[nH]4)Cl"}], "num_ligs": 3, "name_ligs": ["BHD", "CA", "D91"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "1xka": {"describe_pdb": {"structureId": "1XKA", "title": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID", "pubmedId": "9618463", "pubmedCentralId": "PMC22577", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.30", "keywords": "BLOOD COAGULATION FACTOR", "nr_entities": "2", "nr_residues": "330", "nr_atoms": "2580", "deposition_date": "1998-03-19", "release_date": "1999-03-23", "last_modification_date": "2012-06-20", "structure_authors": "Kamata, K., Kim, S.H.", "citation_authors": "Kamata, K., Kawamoto, H., Honma, T., Iwama, T., Kim, S.H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "L"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "C"}}], "structureId": "1xka", "bioAssemblies": "1", "release_date": "Tue Mar 23 00:00:00 PST 1999", "resolution": "2.30"}, "ligs": [{"@structureId": "1XKA", "@chemicalID": "4PP", "@type": "non-polymer", "@molecularWeight": "388.462", "chemicalName": "(2S)-(3'-AMIDINO-3-BIPHENYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID", "formula": "C23 H24 N4 O2", "InChIKey": "FJEAIYBDDQAFGU-NRFANRHFSA-N", "InChI": "InChI=1S/C23H24N4O2/c24-22(25)19-7-2-5-17(15-19)16-4-1-6-18(14-16)21(23(28)29)8-3-11-27-20-9-12-26-13-10-20/h1-2,4-7,9-10,12-15,21H,3,8,11H2,(H3,24,25)(H,26,27)(H,28,29)/t21-/m0/s1", "smiles": "c1cc(cc(c1)[C@H](CCCNc2ccncc2)C(=O)O)c3cccc(c3)C(=N)N"}, {"@structureId": "1XKA", "@chemicalID": "BHD", "@type": "L-peptide linking", "@molecularWeight": "149.102", "chemicalName": "(3S)-3-hydroxy-L-aspartic acid", "formula": "C4 H7 N O5", "InChI": "InChI=1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/t1-,2-/m0/s1", "InChIKey": "YYLQUHNPNCGKJQ-LWMBPPNESA-N", "smiles": "[C@H]([C@@H](C(=O)O)O)(C(=O)O)N"}, {"@structureId": "1XKA", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 3, "name_ligs": ["4PP", "BHD", "CA"], "seq": "", "chain_id": "C", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1xkb": {"describe_pdb": {"structureId": "1XKB", "title": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID", "pubmedId": "9618463", "pubmedCentralId": "PMC22577", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.40", "keywords": "BLOOD COAGULATION FACTOR", "nr_entities": "2", "nr_residues": "660", "nr_atoms": "5134", "deposition_date": "1998-03-19", "release_date": "1999-03-23", "last_modification_date": "2012-06-20", "structure_authors": "Kamata, K., Kim, S.H.", "citation_authors": "Kamata, K., Kawamoto, H., Honma, T., Iwama, T., Kim, S.H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": [{"@id": "A"}, {"@id": "B"}]}, {"@id": "2", "@type": "protein", "Chain": [{"@id": "C"}, {"@id": "D"}]}], "structureId": "1xkb", "bioAssemblies": "4", "release_date": "Tue Mar 23 00:00:00 PST 1999", "resolution": "2.40"}, "ligs": [{"@structureId": "1XKB", "@chemicalID": "4PP", "@type": "non-polymer", "@molecularWeight": "388.462", "chemicalName": "(2S)-(3'-AMIDINO-3-BIPHENYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID", "formula": "C23 H24 N4 O2", "InChIKey": "FJEAIYBDDQAFGU-NRFANRHFSA-N", "InChI": "InChI=1S/C23H24N4O2/c24-22(25)19-7-2-5-17(15-19)16-4-1-6-18(14-16)21(23(28)29)8-3-11-27-20-9-12-26-13-10-20/h1-2,4-7,9-10,12-15,21H,3,8,11H2,(H3,24,25)(H,26,27)(H,28,29)/t21-/m0/s1", "smiles": "c1cc(cc(c1)[C@H](CCCNc2ccncc2)C(=O)O)c3cccc(c3)C(=N)N"}, {"@structureId": "1XKB", "@chemicalID": "BHD", "@type": "L-peptide linking", "@molecularWeight": "149.102", "chemicalName": "(3S)-3-hydroxy-L-aspartic acid", "formula": "C4 H7 N O5", "InChI": "InChI=1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/t1-,2-/m0/s1", "InChIKey": "YYLQUHNPNCGKJQ-LWMBPPNESA-N", "smiles": "[C@H]([C@@H](C(=O)O)O)(C(=O)O)N"}, {"@structureId": "1XKB", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 3, "name_ligs": ["4PP", "BHD", "CA"], "seq": "", "chain_id": "C", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "1z6e": {"describe_pdb": {"structureId": "1Z6E", "title": "Factor XA in complex with the inhibitor 1-(3'-amino-1,2-benzisoxazol-5'-yl)-n-(4-(2'-((dimethylamino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (razaxaban; DPC906; BMS-561389)", "pubmedId": "15771420", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.80", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2276", "deposition_date": "2005-03-22", "release_date": "2006-03-28", "last_modification_date": "2011-07-13", "structure_authors": "Alexander, R.S.", "citation_authors": "Quan, M.L., Lam, P.Y.S., Han, Q., Pinto, D.J.P., He, M.Y., Li, R., Ellis, C.D., Clark, C.G., Teleha, C.A., Sun, J.-H., Alexander, R.S., Bai, S., Luettgen, J.M., Knabb, R.M., Wong, P.C., Wexler, R.R.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "1z6e", "bioAssemblies": "1", "release_date": "Tue Mar 28 00:00:00 PST 2006", "resolution": "1.80"}, "ligs": [{"@structureId": "1Z6E", "@chemicalID": "IK8", "@type": "non-polymer", "@molecularWeight": "528.462", "chemicalName": "1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-N-(4-{2-[(DIMETHYLAMINO)METHYL]-1H-IMIDAZOL-1-YL}-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE", "formula": "C24 H20 F4 N8 O2", "InChI": "InChI=1S/C24H20F4N8O2/c1-34(2)12-21-30-7-8-35(21)13-3-5-17(16(25)10-13)31-23(37)18-11-20(24(26,27)28)32-36(18)14-4-6-19-15(9-14)22(29)33-38-19/h3-11H,12H2,1-2H3,(H2,29,33)(H,31,37)", "InChIKey": "OFJRNBWSFXEHSA-UHFFFAOYSA-N", "smiles": "CN(C)Cc1nccn1c2ccc(c(c2)F)NC(=O)c3cc(nn3c4ccc5c(c4)c(no5)N)C(F)(F)F"}], "num_ligs": 1, "name_ligs": ["IK8"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2bmg": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}], "structureId": "2BMG", "title": "Crystal structure of factor Xa in complex with 50", "pubmedId": "15857135", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.70", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "287", "nr_atoms": "2285", "deposition_date": "2005-03-14", "release_date": "2006-03-08", "last_modification_date": "2019-01-30", "structure_authors": "Schreuder, H., Matter, H., Will, D.W., Nazare, M., Laux, V., Wehner, V., Loenze, P., Liesum, A.", "citation_authors": "Matter, H., Will, D.W., Nazare, M., Schreuder, H., Laux, V., Wehner, V., Liesum, A.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2bmg", "bioAssemblies": "1", "release_date": "Wed Mar 08 00:00:00 PST 2006", "resolution": "2.70"}, "ligs": [{"@structureId": "2BMG", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2BMG", "@chemicalID": "I1H", "@type": "non-polymer", "@molecularWeight": "514.443", "chemicalName": "3-[2-(2,4-DICHLOROPHENYL)ETHOXY]-4-METHOXY-N-[(1-PYRIDIN-4-YLPIPERIDIN-4-YL)METHYL]BENZAMIDE", "formula": "C27 H29 Cl2 N3 O3", "InChI": "InChI=1S/C27H29Cl2N3O3/c1-34-25-5-3-21(16-26(25)35-15-10-20-2-4-22(28)17-24(20)29)27(33)31-18-19-8-13-32(14-9-19)23-6-11-30-12-7-23/h2-7,11-12,16-17,19H,8-10,13-15,18H2,1H3,(H,31,33)", "InChIKey": "UVSAHJWEJXWVGO-UHFFFAOYSA-N", "smiles": "COc1ccc(cc1OCCc2ccc(cc2Cl)Cl)C(=O)NCC3CCN(CC3)c4ccncc4"}], "num_ligs": 2, "name_ligs": ["CA", "I1H"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2boh": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL] -6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}], "structureId": "2BOH", "title": "Crystal structure of factor Xa in complex with compound \"1\"", "pubmedId": "15999990", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE/INHIBITOR", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2283", "deposition_date": "2005-04-11", "release_date": "2006-04-05", "last_modification_date": "2019-01-30", "structure_authors": "Nazare, M., Will, D.W., Matter, H., Schreuder, H., Ritter, K., Urmann, M., Essrich, M., Bauer, A., Wagner, M., Czech, J., Laux, V., Wehner, V.", "citation_authors": "Nazare, M., Will, D.W., Matter, H., Schreuder, H., Ritter, K., Urmann, M., Essrich, M., Bauer, A., Wagner, M., Czech, J., Lorenz, M., Laux, V., Wehner, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2boh", "bioAssemblies": "1", "release_date": "Wed Apr 05 00:00:00 PDT 2006", "resolution": "2.20"}, "ligs": [{"@structureId": "2BOH", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2BOH", "@chemicalID": "IIA", "@type": "non-polymer", "@molecularWeight": "483.025", "chemicalName": "1-{[5-(5-CHLORO-2-THIENYL)ISOXAZOL-3-YL]METHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE", "formula": "C25 H27 Cl N4 O2 S", "InChI": "InChI=1S/C25H27ClN4O2S/c1-16(2)29-11-9-18(10-12-29)27-25(31)21-13-17-5-3-4-6-20(17)30(21)15-19-14-22(32-28-19)23-7-8-24(26)33-23/h3-8,13-14,16,18H,9-12,15H2,1-2H3,(H,27,31)", "InChIKey": "MMGXOGPDBICRQF-UHFFFAOYSA-N", "smiles": "CC(C)N1CCC(CC1)NC(=O)c2cc3ccccc3n2Cc4cc(on4)c5ccc(s5)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "IIA"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2bok": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}], "structureId": "2BOK", "title": "Factor Xa - cation", "pubmedId": "15952226", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.64", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2145", "deposition_date": "2005-04-12", "release_date": "2005-06-16", "last_modification_date": "2017-07-05", "structure_authors": "Morgenthaler, M., Schaerer, K., Paulini, R., Obst-Sander, U., Banner, D.W., Schlatter, D., Benz, J., Stihle, M., Diederich, F.", "citation_authors": "Scharer, K., Morgenthaler, M., Paulini, R., Obst-Sander, U., Banner, D.W., Schlatter, D., Benz, J., Stihle, M., Diederich, F.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2bok", "bioAssemblies": "1", "release_date": "Thu Jun 16 00:00:00 PDT 2005", "resolution": "1.64"}, "ligs": [{"@structureId": "2BOK", "@chemicalID": "784", "@type": "non-polymer", "@molecularWeight": "398.522", "chemicalName": "[AMINO (4-{(3AS,4R,8AS,8BR)-1,3-DIOXO-2- [3-(TRIMETHYLAMMONIO) PROPYL]DECAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL}PHENYL) METHYLENE]AMMONIUM", "formula": "C22 H32 N5 O2 1", "InChI": "InChI=1S/C22H32N5O2/c1-27(2,3)13-5-12-26-21(28)17-16-6-4-11-25(16)19(18(17)22(26)29)14-7-9-15(10-8-14)20(23)24/h7-10,16-19H,4-6,11-13H2,1-3H3,(H3,23,24)/q+1/t16-,17-,18-,19-/m0/s1", "InChIKey": "JCLUABDCGDTVPA-VJANTYMQSA-N", "smiles": "C[N+](C)(C)CCCN1C(=O)[C@H]2[C@@H]3CCC[N@@]3[C@H]([C@H]2C1=O)c4ccc(cc4)C(=N)N"}, {"@structureId": "2BOK", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 2, "name_ligs": ["784", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG-----------AVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 45.49180327868852, "gaps": {"num_gaps": 3, "gap_lengths": [235, 12, 22], "gap_list": [[1, 235], [290, 301], [467, 488]], "gap_window": [[1, 236], [289, 302], [466, 488]]}}, "2bq6": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}], "structureId": "2BQ6", "title": "Crystal structure of factor Xa in complex with 21", "pubmedId": "15999990", "expMethod": "X-RAY DIFFRACTION", "resolution": "3.00", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "301", "nr_atoms": "2277", "deposition_date": "2005-04-27", "release_date": "2006-04-26", "last_modification_date": "2019-01-30", "structure_authors": "Nazare, M., Will, D.W., Matter, H., Schreuder, H., Ritter, K., Urmann, M., Essrich, M., Bauer, A., Wagner, M., Czech, J., Laux, V., Wehner, V.", "citation_authors": "Nazare, M., Will, D.W., Matter, H., Schreuder, H., Ritter, K., Urmann, M., Essrich, M., Bauer, A., Wagner, M., Czech, J., Lorenz, M., Laux, V., Wehner, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2bq6", "bioAssemblies": "1", "release_date": "Wed Apr 26 00:00:00 PDT 2006", "resolution": "3.00"}, "ligs": [{"@structureId": "2BQ6", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2BQ6", "@chemicalID": "IIB", "@type": "non-polymer", "@molecularWeight": "522.062", "chemicalName": "1-{[5-(5-CHLORO-2-THIENYL)ISOXAZOL-3-YL]METHYL}-3-CYANO-N-(1-ISOPROPYLPIPERIDIN-4-YL)-7-METHYL-1H-INDOLE-2-CARBOXAMIDE", "formula": "C27 H28 Cl N5 O2 S", "InChI": "InChI=1S/C27H28ClN5O2S/c1-16(2)32-11-9-18(10-12-32)30-27(34)26-21(14-29)20-6-4-5-17(3)25(20)33(26)15-19-13-22(35-31-19)23-7-8-24(28)36-23/h4-8,13,16,18H,9-12,15H2,1-3H3,(H,30,34)", "InChIKey": "MCLVKEPZVPUETD-UHFFFAOYSA-N", "smiles": "Cc1cccc2c1n(c(c2C#N)C(=O)NC3CCN(CC3)C(C)C)Cc4cc(on4)c5ccc(s5)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "IIB"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2bq7": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 45"}], "structureId": "2BQ7", "title": "Crystal structure of factor Xa in complex with 43", "pubmedId": "15999990", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "301", "nr_atoms": "2271", "deposition_date": "2005-04-27", "release_date": "2006-04-26", "last_modification_date": "2019-01-30", "structure_authors": "Nazare, M., Will, D.W., Matter, H., Schreuder, H., Ritter, K., Urmann, M., Essrich, M., Bauer, A., Wagner, M., Czech, J., Laux, V., Wehner, V.", "citation_authors": "Nazare, M., Will, D.W., Matter, H., Schreuder, H., Ritter, K., Urmann, M., Essrich, M., Bauer, A., Wagner, M., Czech, J., Lorenz, M., Laux, V., Wehner, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2bq7", "bioAssemblies": "1", "release_date": "Wed Apr 26 00:00:00 PDT 2006", "resolution": "2.20"}, "ligs": [{"@structureId": "2BQ7", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2BQ7", "@chemicalID": "IID", "@type": "non-polymer", "@molecularWeight": "405.533", "chemicalName": "N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE", "formula": "C25 H31 N3 O2", "InChIKey": "GIPCBGDQVGKMPO-UHFFFAOYSA-N", "InChI": "InChI=1S/C25H31N3O2/c1-18(2)27-13-11-21(12-14-27)26-25(29)24-16-20-8-4-5-10-23(20)28(24)17-19-7-6-9-22(15-19)30-3/h4-10,15-16,18,21H,11-14,17H2,1-3H3,(H,26,29)", "smiles": "CC(C)N1CCC(CC1)NC(=O)c2cc3ccccc3n2Cc4cccc(c4)OC"}], "num_ligs": 2, "name_ligs": ["CA", "IID"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2bqw": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}], "structureId": "2BQW", "title": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45", "pubmedId": "15999990", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.95", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "301", "nr_atoms": "2273", "deposition_date": "2005-04-28", "release_date": "2006-04-26", "last_modification_date": "2019-02-06", "structure_authors": "Nazare, M., Will, D.W., Matter, H., Schreuder, H., Ritter, K., Urmann, M., Essrich, M., Bauer, A., Wagner, M., Czech, J., Laux, V., Wehner, V.", "citation_authors": "Nazare, M., Will, D.W., Matter, H., Schreuder, H., Ritter, K., Urmann, M., Essrich, M., Bauer, A., Wagner, M., Czech, J., Lorenz, M., Laux, V., Wehner, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2bqw", "bioAssemblies": "1", "release_date": "Wed Apr 26 00:00:00 PDT 2006", "resolution": "2.95"}, "ligs": [{"@structureId": "2BQW", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2BQW", "@chemicalID": "IIE", "@type": "non-polymer", "@molecularWeight": "452.976", "chemicalName": "1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE", "formula": "C25 H29 Cl N4 O2", "InChIKey": "BDLMBQRBNPDCSS-UHFFFAOYSA-N", "InChI": "InChI=1S/C25H29ClN4O2/c1-17(2)29-13-11-21(12-14-29)28-25(32)23-15-18-5-3-4-6-22(18)30(23)16-24(31)27-20-9-7-19(26)8-10-20/h3-10,15,17,21H,11-14,16H2,1-2H3,(H,27,31)(H,28,32)", "smiles": "CC(C)N1CCC(CC1)NC(=O)c2cc3ccccc3n2CC(=O)Nc4ccc(cc4)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "IIE"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2cji": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}], "structureId": "2CJI", "title": "Crystal structure of a Human Factor Xa inhibitor complex", "pubmedId": "16697194", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2180", "deposition_date": "2006-04-03", "release_date": "2006-05-17", "last_modification_date": "2011-07-13", "structure_authors": "Watson, N.S., Campbell, M., Chan, C., Convery, M.A., Hamblin, J.N., Kelly, H.A., King, N.P., Mason, A.M., Mitchell, C., Patel, V.K., Senger, S., Shah, G.P., Weston, H.E., Whitworth, C., Young, R.J.", "citation_authors": "Watson, N.S., Brown, D., Campbell, M., Chan, C., Chaudry, L., Convery, M.A., Fenwick, R., Hamblin, J.N., Haslam, C., Kelly, H.A., King, N.P., Kurtis, C.L., Leach, A.R., Manchee, G.R., Mason, A.M., Mitchell, C., Patel, C., Patel, V.K., Senger, S., Shah, G.P., Weston, H.E., Whitworth, C., Young, R.J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2cji", "bioAssemblies": "1", "release_date": "Wed May 17 00:00:00 PDT 2006", "resolution": "2.10"}, "ligs": [{"@structureId": "2CJI", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2CJI", "@chemicalID": "GSK", "@type": "non-polymer", "@molecularWeight": "465.95", "chemicalName": "6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE", "formula": "C21 H24 Cl N3 O5 S", "InChI": "InChI=1S/C21H24ClN3O5S/c1-14(20(26)24-8-10-30-11-9-24)25-7-6-19(21(25)27)23-31(28,29)18-5-3-15-12-17(22)4-2-16(15)13-18/h2-5,12-14,19,23H,6-11H2,1H3/t14-,19-/m0/s1", "InChIKey": "ICLOZQFWTRAYPX-LIRRHRJNSA-N", "smiles": "C[C@@H](C(=O)N1CCOCC1)N2CC[C@@H](C2=O)NS(=O)(=O)c3ccc4cc(ccc4c3)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "GSK"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2d1j": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1V3X", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED COMPOUND"}, {"@pdbId": "1WU1", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED COMPOUND"}], "structureId": "2D1J", "title": "Factor Xa in complex with the inhibitor 2-[[4-[(5-chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbonyl]thieno[3,2-b]pyridine n-oxide", "pubmedId": "15911309", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "287", "nr_atoms": "2182", "deposition_date": "2005-08-24", "release_date": "2006-08-24", "last_modification_date": "2011-07-13", "structure_authors": "Suzuki, M.", "citation_authors": "Komoriya, S., Haginoya, N., Kobayashi, S., Nagata, T., Mochizuki, A., Suzuki, M., Yoshino, T., Horino, H., Nagahara, T., Suzuki, M., Isobe, Y., Furugoori, T.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2d1j", "bioAssemblies": "1", "release_date": "Thu Aug 24 00:00:00 PDT 2006", "resolution": "2.20"}, "ligs": [{"@structureId": "2D1J", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2D1J", "@chemicalID": "D01", "@type": "non-polymer", "@molecularWeight": "476.956", "chemicalName": "2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE", "formula": "C20 H17 Cl N4 O4 S2", "InChI": "InChI=1S/C20H17ClN4O4S2/c21-14-3-4-15-13(10-14)11-19(22-15)31(28,29)24-8-6-23(7-9-24)20(26)18-12-16-17(30-18)2-1-5-25(16)27/h1-5,10-12,22H,6-9H2", "InChIKey": "DHDQMXPAANQKDC-UHFFFAOYSA-N", "smiles": "c1cc2c(cc(s2)C(=O)N3CCN(CC3)S(=O)(=O)c4cc5cc(ccc5[nH]4)Cl)[n+](c1)[O-]"}], "num_ligs": 2, "name_ligs": ["CA", "D01"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2ei6": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1v3x", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "1wu1", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "2d1j", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "2EI7", "@details": ""}, {"@pdbId": "2EI8", "@details": ""}], "structureId": "2EI6", "title": "FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-cis-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine", "pubmedId": "17555959", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.30", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "287", "nr_atoms": "2174", "deposition_date": "2007-03-12", "release_date": "2008-03-18", "last_modification_date": "2011-07-13", "structure_authors": "Suzuki, M.", "citation_authors": "Nagata, T., Yoshino, T., Haginoya, N., Yoshikawa, K., Isobe, Y., Furugohri, T., Kanno, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2ei6", "bioAssemblies": "1", "release_date": "Tue Mar 18 00:00:00 PDT 2008", "resolution": "2.30"}, "ligs": [{"@structureId": "2EI6", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2EI6", "@chemicalID": "D92", "@type": "non-polymer", "@molecularWeight": "472.003", "chemicalName": "N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE", "formula": "C23 H26 Cl N5 O2 S", "InChIKey": "ARPFWVKYXJZULB-DLBZAZTESA-N", "InChI": "InChI=1S/C23H26ClN5O2S/c1-29-9-8-18-20(12-29)32-23(28-18)22(31)27-17-5-3-2-4-16(17)26-21(30)19-11-13-10-14(24)6-7-15(13)25-19/h6-7,10-11,16-17,25H,2-5,8-9,12H2,1H3,(H,26,30)(H,27,31)/t16-,17+/m0/s1", "smiles": "C[N@@]1CCc2c(sc(n2)C(=O)N[C@@H]3CCCC[C@@H]3NC(=O)c4cc5cc(ccc5[nH]4)Cl)C1"}], "num_ligs": 2, "name_ligs": ["CA", "D92"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2ei7": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1v3x", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "1wu1", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "2d1j", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "2EI6", "@details": ""}, {"@pdbId": "2EI8", "@details": ""}], "structureId": "2EI7", "title": "FACTOR XA IN COMPLEX WITH THE INHIBITOR trans-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.30", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "287", "nr_atoms": "2182", "deposition_date": "2007-03-12", "release_date": "2008-03-18", "last_modification_date": "2018-01-24", "structure_authors": "Suzuki, M.", "citation_authors": "Nagata, T., Yoshino, T., Haginoya, N., Yoshikawa, K., Isobe, Y., Furugohri, T., Kanno, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2ei7", "bioAssemblies": "1", "release_date": "Tue Mar 18 00:00:00 PDT 2008", "resolution": "2.30"}, "ligs": [{"@structureId": "2EI7", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2EI7", "@chemicalID": "D93", "@type": "non-polymer", "@molecularWeight": "472.003", "chemicalName": "N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE", "formula": "C23 H26 Cl N5 O2 S", "InChIKey": "ARPFWVKYXJZULB-IAGOWNOFSA-N", "InChI": "InChI=1S/C23H26ClN5O2S/c1-29-9-8-18-20(12-29)32-23(28-18)22(31)27-17-5-3-2-4-16(17)26-21(30)19-11-13-10-14(24)6-7-15(13)25-19/h6-7,10-11,16-17,25H,2-5,8-9,12H2,1H3,(H,26,30)(H,27,31)/t16-,17-/m1/s1", "smiles": "C[N@@]1CCc2c(sc(n2)C(=O)N[C@@H]3CCCC[C@H]3NC(=O)c4cc5cc(ccc5[nH]4)Cl)C1"}], "num_ligs": 2, "name_ligs": ["CA", "D93"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2ei8": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1v3x", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "1wu1", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "2d1j", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "2EI6", "@details": ""}, {"@pdbId": "2EI7", "@details": ""}], "structureId": "2EI8", "title": "FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-chloroindol-2-yl)carbonyl]-4-(N,N-dimethylcarbamoyl)-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "287", "nr_atoms": "2207", "deposition_date": "2007-03-12", "release_date": "2008-03-18", "last_modification_date": "2011-07-13", "structure_authors": "Suzuki, M.", "citation_authors": "Nagata, T., Yoshino, T., Haginoya, N., Yoshikawa, K., Nagamochi, M., Kobayashi, S., Komoriya, S., Yokomizo, A., Muto, R., Yamaguchi, K., Osanai, K., Suzuki, M., Kanno, H.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2ei8", "bioAssemblies": "1", "release_date": "Tue Mar 18 00:00:00 PDT 2008", "resolution": "2.10"}, "ligs": [{"@structureId": "2EI8", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2EI8", "@chemicalID": "DT8", "@type": "non-polymer", "@molecularWeight": "543.081", "chemicalName": "N-((1R,2S,5S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)-5-(DIMETHYLCARBAMOYL)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE", "formula": "C26 H31 Cl N6 O3 S", "InChI": "InChI=1S/C26H31ClN6O3S/c1-32(2)26(36)14-4-6-18(29-23(34)21-12-15-10-16(27)5-7-17(15)28-21)20(11-14)30-24(35)25-31-19-8-9-33(3)13-22(19)37-25/h5,7,10,12,14,18,20,28H,4,6,8-9,11,13H2,1-3H3,(H,29,34)(H,30,35)/t14-,18-,20+/m0/s1", "InChIKey": "SZBHQQIIGORYND-ADLFWFRXSA-N", "smiles": "C[N@@]1CCc2c(sc(n2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)c4cc5cc(ccc5[nH]4)Cl)C(=O)N(C)C)C1"}], "num_ligs": 2, "name_ligs": ["CA", "DT8"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2fzz": {"describe_pdb": {"structureId": "2FZZ", "title": "Factor Xa in complex with the inhibitor 1-(3-amino-1,2-benzisoxazol-5-yl)-6-(2'-(((3r)-3-hydroxy-1-pyrrolidinyl)methyl)-4-biphenylyl)-3-(trifluoromethyl)-1,4,5,6-tetrahydro-7h-pyrazolo[3,4-c]pyridin-7-one", "pubmedId": "16730984", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2281", "deposition_date": "2006-02-10", "release_date": "2006-06-27", "last_modification_date": "2011-07-13", "structure_authors": "Alexander, R.S.", "citation_authors": "Pinto, D.J., Orwat, M.J., Quan, M.L., Han, Q., Galemmo, R.A., Amparo, E., Wells, B., Ellis, C., He, M.Y., Alexander, R.S., Rossi, K.A., Smallwood, A., Wong, P.C., Luettgen, J.M., Rendina, A.R., Knabb, R.M., Mersinger, L., Kettner, C., Bai, S., He, K., Wexler, R.R., Lam, P.Y.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2fzz", "bioAssemblies": "1", "release_date": "Tue Jun 27 00:00:00 PDT 2006", "resolution": "2.20"}, "ligs": [{"@structureId": "2FZZ", "@chemicalID": "5QC", "@type": "non-polymer", "@molecularWeight": "588.58", "chemicalName": "1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2'-{[(3R)-3-HYDROXYPYRROLIDIN-1-YL]METHYL}BIPHENYL-4-YL)-3-(TRIFLUOROMETHYL)-1,4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE", "formula": "C31 H27 F3 N6 O3", "InChIKey": "DFRIQJHMGZBFOM-JOCHJYFZSA-N", "InChI": "InChI=1S/C31H27F3N6O3/c32-31(33,34)28-24-12-14-39(30(42)27(24)40(36-28)21-9-10-26-25(15-21)29(35)37-43-26)20-7-5-18(6-8-20)23-4-2-1-3-19(23)16-38-13-11-22(41)17-38/h1-10,15,22,41H,11-14,16-17H2,(H2,35,37)/t22-/m1/s1", "smiles": "c1ccc(c(c1)C[N@@]2CC[C@H](C2)O)c3ccc(cc3)N4CCc5c(n(nc5C(F)(F)F)c6ccc7c(c6)c(no7)N)C4=O"}], "num_ligs": 1, "name_ligs": ["5QC"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2g00": {"describe_pdb": {"structureId": "2G00", "title": "Factor Xa in complex with the inhibitor 3-(6-(2'-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-1-yl)benzamide", "pubmedId": "16963264", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2277", "deposition_date": "2006-02-10", "release_date": "2006-10-03", "last_modification_date": "2017-10-18", "structure_authors": "Alexander, R.S.", "citation_authors": "Pinto, D.J., Galemmo, R.A., Quan, M.L., Orwat, M.J., Clark, C., Li, R., Wells, B., Woerner, F., Alexander, R.S., Rossi, K.A., Smallwood, A., Wong, P.C., Luettgen, J.M., Rendina, A.R., Knabb, R.M., He, K., Wexler, R.R., Lam, P.Y.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2g00", "bioAssemblies": "1", "release_date": "Tue Oct 03 00:00:00 PDT 2006", "resolution": "2.10"}, "ligs": [{"@structureId": "2G00", "@chemicalID": "4QC", "@type": "non-polymer", "@molecularWeight": "533.544", "chemicalName": "3-[6-{2'-[(DIMETHYLAMINO)METHYL]BIPHENYL-4-YL}-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1-YL]BENZAMIDE", "formula": "C29 H26 F3 N5 O2", "InChIKey": "PKGPGSWPKRHPKB-UHFFFAOYSA-N", "InChI": "InChI=1S/C29H26F3N5O2/c1-35(2)17-20-6-3-4-9-23(20)18-10-12-21(13-11-18)36-15-14-24-25(28(36)39)37(34-26(24)29(30,31)32)22-8-5-7-19(16-22)27(33)38/h3-13,16H,14-15,17H2,1-2H3,(H2,33,38)", "smiles": "CN(C)Cc1ccccc1c2ccc(cc2)N3CCc4c(n(nc4C(F)(F)F)c5cccc(c5)C(=O)N)C3=O"}], "num_ligs": 1, "name_ligs": ["4QC"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2gd4": {"describe_pdb": {"structureId": "2GD4", "title": "Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex", "pubmedId": "16619025", "pubmedCentralId": "PMC1456925", "expMethod": "X-RAY DIFFRACTION", "resolution": "3.30", "keywords": "HYDROLASE", "nr_entities": "3", "nr_residues": "1484", "nr_atoms": "11102", "deposition_date": "2006-03-15", "release_date": "2006-05-09", "last_modification_date": "2017-07-12", "structure_authors": "Johnson, D.J., Li, W., Adams, T.E., Huntington, J.A.", "citation_authors": "Johnson, D.J., Li, W., Adams, T.E., Huntington, J.A.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": [{"@id": "A"}, {"@id": "L"}]}, {"@id": "2", "@type": "protein", "Chain": [{"@id": "B"}, {"@id": "H"}]}, {"@id": "3", "@type": "protein", "Chain": [{"@id": "C"}, {"@id": "I"}]}], "structureId": "2gd4", "bioAssemblies": "2", "release_date": "Tue May 09 00:00:00 PDT 2006", "resolution": "3.30"}, "ligs": [{"@structureId": "2GD4", "@chemicalID": "BMA", "@type": "D-saccharide", "@molecularWeight": "180.156", "chemicalName": "BETA-D-MANNOSE", "formula": "C6 H12 O6", "InChI": "InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6-/m1/s1", "InChIKey": "WQZGKKKJIJFFOK-RWOPYEJCSA-N", "smiles": "C([C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)O)O)O)O)O"}, {"@structureId": "2GD4", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2GD4", "@chemicalID": "MAN", "@type": "D-saccharide", "@molecularWeight": "180.156", "chemicalName": "ALPHA-D-MANNOSE", "formula": "C6 H12 O6", "InChI": "InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6+/m1/s1", "InChIKey": "WQZGKKKJIJFFOK-PQMKYFCFSA-N", "smiles": "C([C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)O)O)O)O)O"}, {"@structureId": "2GD4", "@chemicalID": "NAG", "@type": "D-saccharide", "@molecularWeight": "221.208", "chemicalName": "N-ACETYL-D-GLUCOSAMINE", "formula": "C8 H15 N O6", "InChI": "InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1", "InChIKey": "OVRNDRQMDRJTHS-FMDGEEDCSA-N", "smiles": "CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O)CO)O)O"}, {"@structureId": "2GD4", "@chemicalID": "NTO", "@type": "saccharide", "@molecularWeight": "1508.26", "chemicalName": "TRISULFOAMINO HEPARIN PENTASACCHARIDE", "formula": "C31 H53 N3 O49 S8", "InChI": "InChI=1S/C31H53N3O49S8/c1-69-27-9(33-85(48,49)50)13(37)17(6(74-27)3-71-88(57,58)59)76-31-22(83-91(66,67)68)16(40)21(24(81-31)26(43)44)79-29-10(34-86(51,52)53)19(82-90(63,64)65)18(7(75-29)4-72-89(60,61)62)77-30-15(39)14(38)20(23(80-30)25(41)42)78-28-8(32-84(45,46)47)12(36)11(35)5(73-28)2-70-87(54,55)56/h5-24,27-40H,2-4H2,1H3,(H,41,42)(H,43,44)(H,45,46,47)(H,48,49,50)(H,51,52,53)(H,54,55,56)(H,57,58,59)(H,60,61,62)(H,63,64,65)(H,66,67,68)/t5-,6-,7-,8-,9-,10-,11-,12-,13-,14-,15-,16+,17-,18-,19-,20+,21+,22-,23+,24-,27+,28-,29-,30-,31-/m1/s1", "InChIKey": "KANJSNBRCNMZMV-ABRZTLGGSA-N", "smiles": "CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O"}], "num_ligs": 5, "name_ligs": ["BMA", "CA", "MAN", "NAG", "NTO"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLP---------------K", "covertura": 48.97540983606557, "gaps": {"num_gaps": 2, "gap_lengths": [235, 16], "gap_list": [[1, 235], [473, 488]], "gap_window": [[1, 236], [472, 488]]}}, "2h9e": {"describe_pdb": {"structureId": "2H9E", "title": "Crystal Structure of FXa/selectide/NAPC2 ternary complex", "pubmedId": "17173931", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE/HYDROLASE INHIBITOR", "nr_entities": "4", "nr_residues": "471", "nr_atoms": "2686", "deposition_date": "2006-06-09", "release_date": "2007-02-13", "last_modification_date": "2017-10-18", "structure_authors": "Murakami, M.T., Geiger, G., Tulinsky, A., Arni, R.K.", "citation_authors": "Murakami, M.T., Rios-Steiner, J., Weaver, S.E., Tulinsky, A., Geiger, J.H., Arni, R.K.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "H"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}, {"@id": "3", "@type": "protein", "Chain": {"@id": "C"}}, {"@id": "4", "@type": "protein", "Chain": {"@id": "S"}}], "structureId": "2h9e", "bioAssemblies": "1", "release_date": "Tue Feb 13 00:00:00 PST 2007", "resolution": "2.20"}, "ligs": [{"@structureId": "2H9E", "@chemicalID": "ACT", "@type": "non-polymer", "@molecularWeight": "59.044", "chemicalName": "ACETATE ION", "formula": "C2 H3 O2 -1", "InChIKey": "QTBSBXVTEAMEQO-UHFFFAOYSA-M", "InChI": "InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1", "smiles": "CC(=O)[O-]"}, {"@structureId": "2H9E", "@chemicalID": "DTY", "@type": "D-peptide linking", "@molecularWeight": "181.189", "chemicalName": "D-TYROSINE", "formula": "C9 H11 N O3", "InChI": "InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m1/s1", "InChIKey": "OUYCCCASQSFEME-MRVPVSSYSA-N", "smiles": "c1cc(ccc1C[C@H](C(=O)O)N)O"}, {"@structureId": "2H9E", "@chemicalID": "LPD", "@type": "L-peptide linking", "@molecularWeight": "114.146", "chemicalName": "L-PROLINAMIDE", "formula": "C5 H10 N2 O", "InChI": "InChI=1S/C5H10N2O/c6-5(8)4-2-1-3-7-4/h4,7H,1-3H2,(H2,6,8)/t4-/m0/s1", "InChIKey": "VLJNHYLEOZPXFW-BYPYZUCNSA-N", "smiles": "C1C[C@H](NC1)C(=O)N"}, {"@structureId": "2H9E", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}, {"@structureId": "2H9E", "@chemicalID": "PO4", "@type": "non-polymer", "@molecularWeight": "94.971", "chemicalName": "PHOSPHATE ION", "formula": "O4 P -3", "InChI": "InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3", "InChIKey": "NBIIXXVUZAFLBC-UHFFFAOYSA-K", "smiles": "[O-]P(=O)([O-])[O-]"}], "num_ligs": 5, "name_ligs": ["ACT", "DTY", "LPD", "NA", "PO4"], "seq": "", "chain_id": "H", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2j2u": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}], "structureId": "2J2U", "title": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX", "pubmedId": "16982192", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.90", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2225", "deposition_date": "2006-08-17", "release_date": "2006-09-27", "last_modification_date": "2011-07-13", "structure_authors": "Senger, S., Convery, M.A., Chan, C., Watson, N.S.", "citation_authors": "Senger, S., Convery, M.A., Chan, C., Watson, N.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2j2u", "bioAssemblies": "1", "release_date": "Wed Sep 27 00:00:00 PDT 2006", "resolution": "1.90"}, "ligs": [{"@structureId": "2J2U", "@chemicalID": "GSQ", "@type": "non-polymer", "@molecularWeight": "454.928", "chemicalName": "5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-SULFONAMIDE", "formula": "C19 H23 Cl N4 O5 S", "InChI": "InChI=1S/C19H23ClN4O5S/c1-12(18(25)23-6-8-29-9-7-23)24-5-4-16(19(24)26)22-30(27,28)17-11-13-10-14(20)2-3-15(13)21-17/h2-3,10-12,16,21-22H,4-9H2,1H3/t12-,16-/m0/s1", "InChIKey": "BHNMMFGOJRIAEZ-LRDDRELGSA-N", "smiles": "C[C@@H](C(=O)N1CCOCC1)N2CC[C@@H](C2=O)NS(=O)(=O)c3cc4cc(ccc4[nH]3)Cl"}], "num_ligs": 1, "name_ligs": ["GSQ"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQ----EAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 46.92622950819672, "gaps": {"num_gaps": 3, "gap_lengths": [235, 5, 22], "gap_list": [[1, 235], [296, 300], [467, 488]], "gap_window": [[1, 236], [295, 301], [466, 488]]}}, "2j34": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}], "structureId": "2J34", "title": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX", "pubmedId": "16982192", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.01", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2261", "deposition_date": "2006-08-18", "release_date": "2006-09-27", "last_modification_date": "2011-07-13", "structure_authors": "Senger, S., Convery, M.A., Chan, C., Watson, N.S.", "citation_authors": "Senger, S., Convery, M.A., Chan, C., Watson, N.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2j34", "bioAssemblies": "1", "release_date": "Wed Sep 27 00:00:00 PDT 2006", "resolution": "2.01"}, "ligs": [{"@structureId": "2J34", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2J34", "@chemicalID": "GS6", "@type": "non-polymer", "@molecularWeight": "471.978", "chemicalName": "6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE", "formula": "C19 H22 Cl N3 O5 S2", "InChIKey": "PHLKBODTBJLXRD-WFASDCNBSA-N", "InChI": "InChI=1S/C19H22ClN3O5S2/c1-12(18(24)22-6-8-28-9-7-22)23-5-4-15(19(23)25)21-30(26,27)17-10-13-2-3-14(20)11-16(13)29-17/h2-3,10-12,15,21H,4-9H2,1H3/t12-,15-/m0/s1", "smiles": "C[C@@H](C(=O)N1CCOCC1)N2CC[C@@H](C2=O)NS(=O)(=O)c3cc4ccc(cc4s3)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "GS6"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2j38": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}], "structureId": "2J38", "title": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX", "pubmedId": "16982192", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2252", "deposition_date": "2006-08-18", "release_date": "2006-09-27", "last_modification_date": "2011-07-13", "structure_authors": "Senger, S., Convery, M.A., Chan, C., Watson, N.S.", "citation_authors": "Senger, S., Convery, M.A., Chan, C., Watson, N.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2j38", "bioAssemblies": "1", "release_date": "Wed Sep 27 00:00:00 PDT 2006", "resolution": "2.10"}, "ligs": [{"@structureId": "2J38", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2J38", "@chemicalID": "GS5", "@type": "non-polymer", "@molecularWeight": "471.978", "chemicalName": "5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE", "formula": "C19 H22 Cl N3 O5 S2", "InChI": "InChI=1S/C19H22ClN3O5S2/c1-12(18(24)22-6-8-28-9-7-22)23-5-4-15(19(23)25)21-30(26,27)17-11-13-10-14(20)2-3-16(13)29-17/h2-3,10-12,15,21H,4-9H2,1H3/t12-,15-/m0/s1", "InChIKey": "LTJNKFUIOOJXNJ-WFASDCNBSA-N", "smiles": "C[C@@H](C(=O)N1CCOCC1)N2CC[C@@H](C2=O)NS(=O)(=O)c3cc4cc(ccc4s3)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "GS5"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2j4i": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}], "structureId": "2J4I", "title": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX", "pubmedId": "16982190", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.80", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2250", "deposition_date": "2006-08-31", "release_date": "2006-09-27", "last_modification_date": "2011-07-13", "structure_authors": "Young, R.J., Campbell, M., Borthwick, A.D., Brown, D., Chan, C., Convery, M.A., Crowe, M.C., Dayal, S., Diallo, H., Kelly, H.A., Paul King, N., Kleanthous, S., Kurtis, C.L., Mason, A.M., Mordaunt, J.E., Patel, C., Pateman, A.J., Senger, S., Shah, G.P., Smith, P.W., Watson, N.S., Weston, H.E., Zhou, P.", "citation_authors": "Young, R.J., Campbell, M., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Chan, C., Convery, M.A., Crowe, M.C., Dayal, S., Diallo, H., Kelly, H.A., Paul King, N., Kleanthous, S., Mason, A.M., Mordaunt, J.E., Patel, C., Pateman, A.J., Senger, S., Shah, G.P., Smith, P.W., Watson, N.S., Weston, H.E., Zhou, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2j4i", "bioAssemblies": "1", "release_date": "Wed Sep 27 00:00:00 PDT 2006", "resolution": "1.80"}, "ligs": [{"@structureId": "2J4I", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2J4I", "@chemicalID": "GSJ", "@type": "non-polymer", "@molecularWeight": "559.098", "chemicalName": "1-PYRROLIDINEACETAMIDE, 3-[[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]AMINO]-ALPHA-METHYL-N-(1-METHYLETHYL)-N-[2-[(METHYLSULFONYL)AMINO]ETHYL]-2-OXO-, (ALPHAS,3S)-", "formula": "C23 H31 Cl N4 O6 S2", "InChIKey": "MTIPCPPIOZUMIV-KKSFZXQISA-N", "InChI": "InChI=1S/C23H31ClN4O6S2/c1-15(2)27(12-10-25-35(4,31)32)22(29)16(3)28-11-9-21(23(28)30)26-36(33,34)20-8-6-17-13-19(24)7-5-18(17)14-20/h5-8,13-16,21,25-26H,9-12H2,1-4H3/t16-,21-/m0/s1", "smiles": "CC(C)N(CCNS(=O)(=O)C)C(=O)[C@H](C)N1CC[C@@H](C1=O)NS(=O)(=O)c2ccc3cc(ccc3c2)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "GSJ"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQE--GEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.540983606557376, "gaps": {"num_gaps": 3, "gap_lengths": [235, 3, 21], "gap_list": [[1, 235], [297, 299], [469, 489]], "gap_window": [[1, 236], [296, 300], [468, 489]]}}, "2j94": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}], "structureId": "2J94", "title": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX", "pubmedId": "17338508", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2258", "deposition_date": "2006-11-02", "release_date": "2007-03-20", "last_modification_date": "2011-07-13", "structure_authors": "Chan, C., Borthwick, A.D., Brown, D., Campbell, M., Chaudry, L., Chung, C.W., Convery, M.A., Hamblin, J.N., Johnstone, L., Kelly, H.A., Kleanthous, S., Burns-Kurtis, C.L., Patikis, A., Patel, C., Pateman, A.J., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Weston, H.E., Whitworth, C., Young, R.J., Zhou, P.", "citation_authors": "Chan, C., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chaudry, L., Chung, C.W., Convery, M.A., Hamblin, J.N., Johnstone, L., Kelly, H.A., Kleanthous, S., Patikis, A., Patel, C., Pateman, A.J., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Weston, H.E., Whitworth, C., Young, R.J., Zhou, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2j94", "bioAssemblies": "1", "release_date": "Tue Mar 20 00:00:00 PDT 2007", "resolution": "2.10"}, "ligs": [{"@structureId": "2J94", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2J94", "@chemicalID": "G15", "@type": "non-polymer", "@molecularWeight": "488.969", "chemicalName": "5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE", "formula": "C17 H21 Cl N6 O5 S2", "InChIKey": "FKCQUVAGEOSYRU-QWRGUYRKSA-N", "InChI": "InChI=1S/C17H21ClN6O5S2/c1-10(15(25)23-6-8-29-9-7-23)24-5-4-11(16(24)26)22-31(27,28)17-19-14(20-21-17)12-2-3-13(18)30-12/h2-3,10-11,22H,4-9H2,1H3,(H,19,20,21)/t10-,11-/m0/s1", "smiles": "C[C@@H](C(=O)N1CCOCC1)N2CC[C@@H](C2=O)NS(=O)(=O)c3nc([nH]n3)c4ccc(s4)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "G15"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2j95": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}], "structureId": "2J95", "title": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX", "pubmedId": "17338508", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.01", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2262", "deposition_date": "2006-11-02", "release_date": "2007-03-20", "last_modification_date": "2011-07-13", "structure_authors": "Chan, C., Borthwick, A.D., Brown, D., Campbell, M., Chaudry, L., Chung, C.W., Convery, M.A., Hamblin, J.N., Johnstone, L., Kelly, H.A., Kleanthous, S., Burns-Kurtis, C.L., Patikis, A., Patel, C., Pateman, A.J., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Weston, H.E., Whitworth, C., Young, R.J., Zhou, P.", "citation_authors": "Chan, C., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chaudry, L., Chung, C.W., Convery, M.A., Hamblin, J.N., Johnstone, L., Kelly, H.A., Kleanthous, S., Patikis, A., Patel, C., Pateman, A.J., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Weston, H.E., Whitworth, C., Young, R.J., Zhou, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2j95", "bioAssemblies": "1", "release_date": "Tue Mar 20 00:00:00 PDT 2007", "resolution": "2.01"}, "ligs": [{"@structureId": "2J95", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2J95", "@chemicalID": "GSX", "@type": "non-polymer", "@molecularWeight": "504.043", "chemicalName": "5'-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-2,2'-BITHIOPHENE-5-SULFONAMIDE", "formula": "C19 H22 Cl N3 O5 S3", "InChI": "InChI=1S/C19H22ClN3O5S3/c1-12(18(24)22-8-10-28-11-9-22)23-7-6-13(19(23)25)21-31(26,27)17-5-3-15(30-17)14-2-4-16(20)29-14/h2-5,12-13,21H,6-11H2,1H3/t12-,13-/m0/s1", "InChIKey": "NAHOZYBRUMVDSR-STQMWFEESA-N", "smiles": "C[C@@H](C(=O)N1CCOCC1)N2CC[C@@H](C2=O)NS(=O)(=O)c3ccc(s3)c4ccc(s4)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "GSX"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2jkh": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}], "structureId": "2JKH", "title": "Factor Xa - cation inhibitor complex", "pubmedId": "19101972", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.25", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2382", "deposition_date": "2008-08-28", "release_date": "2009-01-13", "last_modification_date": "2019-10-30", "structure_authors": "Salonen, L.M., Bucher, C., Banner, D.W., Benz, J., Haap, W., Mary, J.L., Schweizer, W.B., Seiler, P., Kuster, O., Diederich, F.", "citation_authors": "Salonen, L.M., Bucher, C., Banner, D.W., Haap, W., Mary, J.L., Benz, J., Kuster, O., Seiler, P., Schweizer, W.B., Diederich, F.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2jkh", "bioAssemblies": "3", "release_date": "Tue Jan 13 00:00:00 PST 2009", "resolution": "1.25"}, "ligs": [{"@structureId": "2JKH", "@chemicalID": "BI7", "@type": "non-polymer", "@molecularWeight": "464.001", "chemicalName": "3-[(3~{a}~{S},4~{R},8~{a}~{S},8~{b}~{R})-4-[5-(5-chloranylthiophen-2-yl)-1,2-oxazol-3-yl]-1,3-bis(oxidanylidene)-4,6,7,8,8~{a},8~{b}-hexahydro-3~{a}~{H}-pyrrolo[3,4-a]pyrrolizin-2-yl]propyl-trimethyl-azanium", "formula": "C22 H28 Cl N4 O3 S 1", "InChIKey": "IMQAZTOPHVBANA-DSYPUSFNSA-N", "InChI": "InChI=1S/C22H28ClN4O3S/c1-27(2,3)11-5-10-26-21(28)18-14-6-4-9-25(14)20(19(18)22(26)29)13-12-15(30-24-13)16-7-8-17(23)31-16/h7-8,12,14,18-20H,4-6,9-11H2,1-3H3/q+1/t14-,18-,19-,20-/m0/s1", "smiles": "C[N+](C)(C)CCCN1C(=O)[C@H]2[C@@H]3CCCN3[C@H]([C@H]2C1=O)c4cc(on4)c5ccc(s5)Cl"}, {"@structureId": "2JKH", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2JKH", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 3, "name_ligs": ["BI7", "CA", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2p16": {"describe_pdb": {"structureId": "2P16", "title": "Factor Xa in Complex with the Inhibitor APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE", "pubmedId": "17914785", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.30", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2273", "deposition_date": "2007-03-02", "release_date": "2007-10-16", "last_modification_date": "2011-07-13", "structure_authors": "Alexander, R.", "citation_authors": "Pinto, D.J., Orwat, M.J., Koch, S., Rossi, K.A., Alexander, R.S., Smallwood, A., Wong, P.C., Rendina, A.R., Luettgen, J.M., Knabb, R.M., He, K., Xin, B., Wexler, R.R., Lam, P.Y.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2p16", "bioAssemblies": "1", "release_date": "Tue Oct 16 00:00:00 PDT 2007", "resolution": "2.30"}, "ligs": [{"@structureId": "2P16", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2P16", "@chemicalID": "GG2", "@type": "non-polymer", "@molecularWeight": "459.497", "chemicalName": "1-(4-METHOXYPHENYL)-7-OXO-6-[4-(2-OXOPIPERIDIN-1-YL)PHENYL]-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINE-3-CARBOXAMIDE", "formula": "C25 H25 N5 O4", "InChIKey": "QNZCBYKSOIHPEH-UHFFFAOYSA-N", "InChI": "InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)", "smiles": "COc1ccc(cc1)n2c3c(c(n2)C(=O)N)CCN(C3=O)c4ccc(cc4)N5CCCCC5=O"}], "num_ligs": 2, "name_ligs": ["CA", "GG2"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2p3f": {"describe_pdb": {"structureId": "2P3F", "title": "Crystal structure of the factor Xa/NAP5 complex", "pubmedId": "17588602", "expMethod": "X-RAY DIFFRACTION", "resolution": "3.10", "keywords": "HYDROLASE", "nr_entities": "3", "nr_residues": "367", "nr_atoms": "2824", "deposition_date": "2007-03-08", "release_date": "2007-11-06", "last_modification_date": "2011-07-13", "structure_authors": "Rios-Steiner, J.L., Murakami, M.T., Tulinsky, A., Arni, R.K.", "citation_authors": "Rios-Steiner, J.L., Murakami, M.T., Tulinsky, A., Arni, R.K.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "H"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}, {"@id": "3", "@type": "protein", "Chain": {"@id": "N"}}], "structureId": "2p3f", "bioAssemblies": "1", "release_date": "Tue Nov 06 00:00:00 PST 2007", "resolution": "3.10"}, "ligs": [{"@structureId": "2P3F", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 1, "name_ligs": ["NA"], "seq": "", "chain_id": "H", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR-------------------", "covertura": 48.15573770491803, "gaps": {"num_gaps": 2, "gap_lengths": [235, 20], "gap_list": [[1, 235], [470, 489]], "gap_window": [[1, 236], [469, 489]]}}, "2p3t": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1EZQ", "@details": "Factor XA complexed to RPR128515"}, {"@pdbId": "1F0R", "@details": "Factor XA complexed to RPR208815"}, {"@pdbId": "1F0S", "@details": "Factor XA complexed to RPR208707"}, {"@pdbId": "1FJS", "@details": "Factor XA complexed to ZK807834"}, {"@pdbId": "1MQ5", "@details": "Crystal structure of 3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2-thiophenecarboxamide complexed with human factor XA"}, {"@pdbId": "1MQ6", "@details": "Crystal structure of 3-chloro-n-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide complexed with human factor XA"}, {"@pdbId": "2P3U", "@details": "PDB CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED WITH 3-CHLORO-N-(4-CHLORO-2-{[(5-CHLOROPYRIDIN-2-YL)AMINO]CARBONYL}-6-METHOXYPHENYL)-4-[(1-METHYL-1H-IMIDAZOL-2-YL)METHYL]THIOPHENE-2-CARBOXAMIDE {PFIZER 320663}"}], "structureId": "2P3T", "title": "Crystal structure of human factor XA complexed with 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide", "pubmedId": "17536795", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.92", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2261", "deposition_date": "2007-03-09", "release_date": "2008-01-22", "last_modification_date": "2011-07-13", "structure_authors": "Adler, M., Whitlow, M.", "citation_authors": "Ye, B., Arnaiz, D.O., Chou, Y.L., Griedel, B.D., Karanjawala, R., Lee, W., Morrissey, M.M., Sacchi, K.L., Sakata, S.T., Shaw, K.J., Wu, S.C., Zhao, Z., Adler, M., Cheeseman, S., Dole, W.P., Ewing, J., Fitch, R., Lentz, D., Liang, A., Light, D., Morser, J., Post, J., Rumennik, G., Subramanyam, B., Sullivan, M.E., Vergona, R., Walters, J., Wang, Y.X., White, K.A., Whitlow, M., Kochanny, M.J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2p3t", "bioAssemblies": "1", "release_date": "Tue Jan 22 00:00:00 PST 2008", "resolution": "1.92"}, "ligs": [{"@structureId": "2P3T", "@chemicalID": "993", "@type": "non-polymer", "@molecularWeight": "565.859", "chemicalName": "3-CHLORO-4-(2-METHYLAMINO-IMIDAZOL-1-YLMETHYL)-THIOPHENE-2-CARBOXYLIC ACID [4-CHLORO-2-(5-CHLORO-PYRIDIN-2-YLCARBAMOYL)-6-METHOXY-PHENYL]-AMIDE", "formula": "C23 H19 Cl3 N6 O3 S", "InChIKey": "LLHSZBPXQIOQJJ-UHFFFAOYSA-N", "InChI": "InChI=1S/C23H19Cl3N6O3S/c1-27-23-28-5-6-32(23)10-12-11-36-20(18(12)26)22(34)31-19-15(7-14(25)8-16(19)35-2)21(33)30-17-4-3-13(24)9-29-17/h3-9,11H,10H2,1-2H3,(H,27,28)(H,31,34)(H,29,30,33)", "smiles": "CNc1nccn1Cc2csc(c2Cl)C(=O)Nc3c(cc(cc3OC)Cl)C(=O)Nc4ccc(cn4)Cl"}, {"@structureId": "2P3T", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2P3T", "@chemicalID": "CL", "@type": "non-polymer", "@molecularWeight": "35.453", "chemicalName": "CHLORIDE ION", "formula": "Cl -1", "InChI": "InChI=1S/ClH/h1H/p-1", "InChIKey": "VEXZGXHMUGYJMC-UHFFFAOYSA-M", "smiles": "[Cl-]"}], "num_ligs": 3, "name_ligs": ["993", "CA", "CL"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQE--GEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.33606557377049, "gaps": {"num_gaps": 3, "gap_lengths": [235, 3, 22], "gap_list": [[1, 235], [297, 299], [467, 488]], "gap_window": [[1, 236], [296, 300], [466, 488]]}}, "2p3u": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1EZQ", "@details": "Factor XA complexed to RPR128515"}, {"@pdbId": "1F0R", "@details": "Factor XA complexed to RPR208815"}, {"@pdbId": "1F0S", "@details": "Factor XA complexed to RPR208707"}, {"@pdbId": "1FJS", "@details": "Factor XA complexed to ZK807834"}, {"@pdbId": "1MQ5", "@details": "Crystal structure of 3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2-thiophenecarboxamide complexed with human factor XA"}, {"@pdbId": "1MQ6", "@details": "Crystal structure of 3-chloro-n-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide complexed with human factor XA"}, {"@pdbId": "2p3t", "@details": "Crystal structure of human factor XA complexed with 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide"}], "structureId": "2P3U", "title": "Crystal structure of human factor XA complexed with 3-chloro-N-(4-chloro-2-{[(5-chloropyridin-2-yl)amino]carbonyl}-6-methoxyphenyl)-4-[(1-methyl-1H-imidazol-2-yl)methyl]thiophene-2-carboxamide {Pfizer 320663}", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.62", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2257", "deposition_date": "2007-03-09", "release_date": "2007-09-11", "last_modification_date": "2011-07-13", "structure_authors": "Adler, M., Whitlow, M.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2p3u", "bioAssemblies": "1", "release_date": "Tue Sep 11 00:00:00 PDT 2007", "resolution": "1.62"}, "ligs": [{"@structureId": "2P3U", "@chemicalID": "663", "@type": "non-polymer", "@molecularWeight": "550.845", "chemicalName": "3-CHLORO-N-(4-CHLORO-2-{[(5-CHLOROPYRIDIN-2-YL)AMINO]CARBONYL}-6-METHOXYPHENYL)-4-[(1-METHYL-1H-IMIDAZOL-2-YL)METHYL]THIOPHENE-2-CARBOXAMIDE", "formula": "C23 H18 Cl3 N5 O3 S", "InChIKey": "WBFPCLIRIGEEBD-UHFFFAOYSA-N", "InChI": "InChI=1S/C23H18Cl3N5O3S/c1-31-6-5-27-18(31)7-12-11-35-21(19(12)26)23(33)30-20-15(8-14(25)9-16(20)34-2)22(32)29-17-4-3-13(24)10-28-17/h3-6,8-11H,7H2,1-2H3,(H,30,33)(H,28,29,32)", "smiles": "Cn1ccnc1Cc2csc(c2Cl)C(=O)Nc3c(cc(cc3OC)Cl)C(=O)Nc4ccc(cn4)Cl"}, {"@structureId": "2P3U", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["663", "CA"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2p93": {"describe_pdb": {"relatedPDB": [{"@pdbId": "2P94", "@details": ""}, {"@pdbId": "2P95", "@details": ""}], "structureId": "2P93", "title": "Factor xa in complex with the inhibitor 5-chloro-N-(2-(4-(2-oxopyridin-1(2H)-yl)benzamido)ethyl)thiophene-2-carboxamide", "pubmedId": "17588746", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.90", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2265", "deposition_date": "2007-03-23", "release_date": "2007-07-24", "last_modification_date": "2017-10-18", "structure_authors": "Chang, C.-H.", "citation_authors": "Qiao, J.X., Chang, C.-H., Cheney, D.L., Morin, P.E., Wang, G.Z., King, S.R., Wang, T.C., Rendina, A.R., Luettgen, J.M., Knabb, R.M., Wexler, R.R., Lam, P.Y.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2p93", "bioAssemblies": "1", "release_date": "Tue Jul 24 00:00:00 PDT 2007", "resolution": "1.90"}, "ligs": [{"@structureId": "2P93", "@chemicalID": "ME1", "@type": "non-polymer", "@molecularWeight": "401.867", "chemicalName": "5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE", "formula": "C19 H16 Cl N3 O3 S", "InChI": "InChI=1S/C19H16ClN3O3S/c20-16-9-8-15(27-16)19(26)22-11-10-21-18(25)13-4-6-14(7-5-13)23-12-2-1-3-17(23)24/h1-9,12H,10-11H2,(H,21,25)(H,22,26)", "InChIKey": "UCKHUNHXYMAFQM-UHFFFAOYSA-N", "smiles": "c1cc(ccc1C(=O)NCCNC(=O)c2ccc(s2)Cl)N3C=CC=CC3=O"}], "num_ligs": 1, "name_ligs": ["ME1"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2p94": {"describe_pdb": {"relatedPDB": [{"@pdbId": "2P93", "@details": ""}, {"@pdbId": "2P95", "@details": ""}], "structureId": "2P94", "title": "Factor xa in complex with the inhibitor 3-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)cyclohexyl)-1H-indole-6-carboxamide", "pubmedId": "17588746", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.80", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2273", "deposition_date": "2007-03-23", "release_date": "2007-07-24", "last_modification_date": "2011-07-13", "structure_authors": "Chang, C.-H.", "citation_authors": "Qiao, J.X., Chang, C.-H., Cheney, D.L., Morin, P.E., Wang, G.Z., King, S.R., Wang, T.C., Rendina, A.R., Luettgen, J.M., Knabb, R.M., Wexler, R.R., Lam, P.Y.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2p94", "bioAssemblies": "1", "release_date": "Tue Jul 24 00:00:00 PDT 2007", "resolution": "1.80"}, "ligs": [{"@structureId": "2P94", "@chemicalID": "ME4", "@type": "non-polymer", "@molecularWeight": "488.965", "chemicalName": "3-CHLORO-N-((1R,2S) -2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)CYCLOHEXYL)-1H-INDOLE-6-CARBOXAMIDE", "formula": "C27 H25 Cl N4 O3", "InChIKey": "PMRPPULYFDNTHJ-XZOQPEGZSA-N", "InChI": "InChI=1S/C27H25ClN4O3/c28-21-16-29-24-15-18(10-13-20(21)24)27(35)31-23-6-2-1-5-22(23)30-26(34)17-8-11-19(12-9-17)32-14-4-3-7-25(32)33/h3-4,7-16,22-23,29H,1-2,5-6H2,(H,30,34)(H,31,35)/t22-,23+/m0/s1", "smiles": "c1cc(ccc1C(=O)N[C@H]2CCCC[C@H]2NC(=O)c3ccc4c(c3)[nH]cc4Cl)N5C=CC=CC5=O"}], "num_ligs": 1, "name_ligs": ["ME4"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2p95": {"describe_pdb": {"relatedPDB": [{"@pdbId": "2P93", "@details": ""}, {"@pdbId": "2P94", "@details": ""}], "structureId": "2P95", "title": "Factor xa in complex with the inhibitor 5-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-YL)benzamido) cyclopentyl)thiophene-2-carboxamide", "pubmedId": "17588746", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2268", "deposition_date": "2007-03-23", "release_date": "2007-07-24", "last_modification_date": "2017-10-18", "structure_authors": "Chang, C.-H.", "citation_authors": "Qiao, J.X., Chang, C.-H., Cheney, D.L., Morin, P.E., Wang, G.Z., King, S.R., Wang, T.C., Rendina, A.R., Luettgen, J.M., Knabb, R.M., Wexler, R.R., Lam, P.Y.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2p95", "bioAssemblies": "1", "release_date": "Tue Jul 24 00:00:00 PDT 2007", "resolution": "2.20"}, "ligs": [{"@structureId": "2P95", "@chemicalID": "ME5", "@type": "non-polymer", "@molecularWeight": "441.931", "chemicalName": "5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE", "formula": "C22 H20 Cl N3 O3 S", "InChI": "InChI=1S/C22H20ClN3O3S/c23-19-12-11-18(30-19)22(29)25-17-5-3-4-16(17)24-21(28)14-7-9-15(10-8-14)26-13-2-1-6-20(26)27/h1-2,6-13,16-17H,3-5H2,(H,24,28)(H,25,29)/t16-,17+/m0/s1", "InChIKey": "QCPYHSAHOYXXQK-DLBZAZTESA-N", "smiles": "c1cc(ccc1C(=O)N[C@H]2CCC[C@H]2NC(=O)c3ccc(s3)Cl)N4C=CC=CC4=O"}], "num_ligs": 1, "name_ligs": ["ME5"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2phb": {"describe_pdb": {"structureId": "2PHB", "title": "An Orally Efficacious Factor Xa Inhibitor", "pubmedId": "17683371", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.30", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2264", "deposition_date": "2007-04-10", "release_date": "2008-03-25", "last_modification_date": "2017-10-18", "structure_authors": "Zhang, E., Kohrt, J.T., Bigge, C.F., Finzel, B.C.", "citation_authors": "Kohrt, J.T., Bigge, C.F., Bryant, J.W., Casimiro-Garcia, A., Chi, L., Cody, W.L., Dahring, T., Dudley, D.A., Filipski, K.J., Haarer, S., Heemstra, R., Janiczek, N., Narasimhan, L., McClanahan, T., Peterson, J.T., Sahasrabudhe, V., Schaum, R., Van Huis, C.A., Welch, K.M., Zhang, E., Leadley, R.J., Edmunds, J.J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2phb", "bioAssemblies": "1", "release_date": "Tue Mar 25 00:00:00 PDT 2008", "resolution": "2.30"}, "ligs": [{"@structureId": "2PHB", "@chemicalID": "230", "@type": "non-polymer", "@molecularWeight": "484.907", "chemicalName": "(2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE", "formula": "C24 H22 Cl F N4 O4", "InChIKey": "QQBKAVAGLMGMHI-WIYYLYMNSA-N", "InChI": "InChI=1S/C24H22ClFN4O4/c1-34-18-13-21(30(14-18)24(33)27-16-7-5-15(25)6-8-16)23(32)28-20-10-9-17(12-19(20)26)29-11-3-2-4-22(29)31/h2-12,18,21H,13-14H2,1H3,(H,27,33)(H,28,32)/t18-,21-/m1/s1", "smiles": "CO[C@@H]1C[C@@H](N(C1)C(=O)Nc2ccc(cc2)Cl)C(=O)Nc3ccc(cc3F)N4C=CC=CC4=O"}, {"@structureId": "2PHB", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["230", "CA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2pr3": {"describe_pdb": {"relatedPDB": [{"@pdbId": "2G0M", "@details": ""}, {"@pdbId": "2G21", "@details": ""}, {"@pdbId": "2PHB", "@details": ""}], "structureId": "2PR3", "title": "Factor XA inhibitor", "pubmedId": "17581239", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.50", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2260", "deposition_date": "2007-05-03", "release_date": "2007-08-14", "last_modification_date": "2017-10-18", "structure_authors": "Zhang, E., Kohrt, J.T., Bigge, C.F., Finzel, B.C.", "citation_authors": "Van Huis, C.A., Bigge, C.F., Casimiro-Garcia, A., Cody, W.L., Dudley, D.A., Filipski, K.J., Heemstra, R.J., Kohrt, J.T., Narasimhan, L.S., Schaum, R.P., Zhang, E., Bryant, J.W., Haarer, S., Janiczek, N., Leadley, R.J., McClanahan, T., Thomas Peterson, J., Welch, K.M., Edmunds, J.J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2pr3", "bioAssemblies": "1", "release_date": "Tue Aug 14 00:00:00 PDT 2007", "resolution": "1.50"}, "ligs": [{"@structureId": "2PR3", "@chemicalID": "237", "@type": "non-polymer", "@molecularWeight": "546.01", "chemicalName": "(2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[3-FLUORO-2'-(METHYLSULFONYL)BIPHENYL-4-YL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE", "formula": "C26 H25 Cl F N3 O5 S", "InChI": "InChI=1S/C26H25ClFN3O5S/c1-36-19-14-23(31(15-19)26(33)29-18-10-8-17(27)9-11-18)25(32)30-22-12-7-16(13-21(22)28)20-5-3-4-6-24(20)37(2,34)35/h3-13,19,23H,14-15H2,1-2H3,(H,29,33)(H,30,32)/t19-,23-/m1/s1", "InChIKey": "QBTQRXKLWHEJQY-AUSIDOKSSA-N", "smiles": "CO[C@@H]1C[C@@H](N(C1)C(=O)Nc2ccc(cc2)Cl)C(=O)Nc3ccc(cc3F)c4ccccc4S(=O)(=O)C"}, {"@structureId": "2PR3", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["237", "CA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2q1j": {"describe_pdb": {"structureId": "2Q1J", "title": "The discovery of glycine and related amino acid-based factor xa inhibitors", "pubmedId": "16529937", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.90", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2268", "deposition_date": "2007-05-24", "release_date": "2007-08-14", "last_modification_date": "2011-07-13", "structure_authors": "Kohrt, J.T., Filipski, K.J., Cody, W.L., Bigge, C.F., Zhang, E., Finzel, B.C.", "citation_authors": "Kohrt, J.T., Filipski, K.J., Cody, W.L., Bigge, C.F., La, F., Welch, K., Dahring, T., Bryant, J.W., Leonard, D., Bolton, G., Narasimhan, L., Zhang, E., Peterson, J.T., Haarer, S., Sahasrabudhe, V., Janiczek, N., Desiraju, S., Hena, M., Fiakpui, C., Saraswat, N., Sharma, R., Sun, S., Maiti, S.N., Leadley, R., Edmunds, J.J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2q1j", "bioAssemblies": "1", "release_date": "Tue Aug 14 00:00:00 PDT 2007", "resolution": "1.90"}, "ligs": [{"@structureId": "2Q1J", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2Q1J", "@chemicalID": "FXI", "@type": "non-polymer", "@molecularWeight": "558.064", "chemicalName": "1-(butyl{[(4-chlorophenyl)amino]carbonyl}amino)-N-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]cyclopropanecarboxamide", "formula": "C28 H29 Cl F N3 O4 S", "InChI": "InChI=1S/C28H29ClFN3O4S/c1-3-4-17-33(27(35)31-21-12-10-20(29)11-13-21)28(15-16-28)26(34)32-24-14-9-19(18-23(24)30)22-7-5-6-8-25(22)38(2,36)37/h5-14,18H,3-4,15-17H2,1-2H3,(H,31,35)(H,32,34)", "InChIKey": "YZDZQPIVASXYKY-UHFFFAOYSA-N", "smiles": "CCCCN(C(=O)Nc1ccc(cc1)Cl)C2(CC2)C(=O)Nc3ccc(cc3F)c4ccccc4S(=O)(=O)C"}], "num_ligs": 2, "name_ligs": ["CA", "FXI"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2ra0": {"describe_pdb": {"structureId": "2RA0", "title": "X-ray Structure of FXa in complex with 7-fluoroindazole", "pubmedId": "18159923", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.30", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2267", "deposition_date": "2007-09-14", "release_date": "2008-01-29", "last_modification_date": "2011-07-13", "structure_authors": "Abad, M.C.", "citation_authors": "Lee, Y.K., Parks, D.J., Lu, T., Thieu, T.V., Markotan, T., Pan, W., McComsey, D.F., Milkiewicz, K.L., Crysler, C.S., Ninan, N., Abad, M.C., Giardino, E.C., Maryanoff, B.E., Damiano, B.P., Player, M.R.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2ra0", "bioAssemblies": "1", "release_date": "Tue Jan 29 00:00:00 PST 2008", "resolution": "2.30"}, "ligs": [{"@structureId": "2RA0", "@chemicalID": "JNJ", "@type": "non-polymer", "@molecularWeight": "528.513", "chemicalName": "1-(3-amino-1,2-benzisoxazol-5-yl)-6-(4-{2-[(dimethylamino)methyl]-1H-imidazol-1-yl}-2-fluorophenyl)-7-fluoro-1H-indazole-3-carboxamide", "formula": "C27 H22 F2 N8 O2", "InChIKey": "MGUDDBRJHXFTEY-UHFFFAOYSA-N", "InChI": "InChI=1S/C27H22F2N8O2/c1-35(2)13-22-32-9-10-36(22)14-3-5-16(20(28)12-14)17-6-7-18-24(27(31)38)33-37(25(18)23(17)29)15-4-8-21-19(11-15)26(30)34-39-21/h3-12H,13H2,1-2H3,(H2,30,34)(H2,31,38)", "smiles": "CN(C)Cc1nccn1c2ccc(c(c2)F)c3ccc4c(c3F)n(nc4C(=O)N)c5ccc6c(c5)c(no6)N"}], "num_ligs": 1, "name_ligs": ["JNJ"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2uwl": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}], "structureId": "2UWL", "title": "Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa", "pubmedId": "17420122", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.90", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2257", "deposition_date": "2007-03-22", "release_date": "2007-04-24", "last_modification_date": "2011-07-13", "structure_authors": "Young, R.J., Brown, D., Burns-Kurtis, C.L., Chan, C., Convery, M.A., Hubbard, J.A., Kelly, H.A., Pateman, A.J., Patikis, A., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Zhou, P.", "citation_authors": "Young, R.J., Brown, D., Burns-Kurtis, C.L., Chan, C., Convery, M.A., Hubbard, J.A., Kelly, H.A., Pateman, A.J., Patikis, A., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Zhou, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2uwl", "bioAssemblies": "1", "release_date": "Tue Apr 24 00:00:00 PDT 2007", "resolution": "1.90"}, "ligs": [{"@structureId": "2UWL", "@chemicalID": "895", "@type": "non-polymer", "@molecularWeight": "447.957", "chemicalName": "2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE", "formula": "C17 H22 Cl N3 O5 S2", "InChI": "InChI=1S/C17H22ClN3O5S2/c1-12(16(22)20-7-9-26-10-8-20)21-6-4-14(17(21)23)19-28(24,25)11-5-13-2-3-15(18)27-13/h2-3,5,11-12,14,19H,4,6-10H2,1H3/b11-5+/t12-,14-/m0/s1", "InChIKey": "ACEFOQMQINFMRW-DYCFVMESSA-N", "smiles": "C[C@@H](C(=O)N1CCOCC1)N2CC[C@@H](C2=O)NS(=O)(=O)\\C=C\\c3ccc(s3)Cl"}], "num_ligs": 1, "name_ligs": ["895"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2uwo": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}], "structureId": "2UWO", "title": "Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa", "pubmedId": "17420122", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.75", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2243", "deposition_date": "2007-03-22", "release_date": "2007-05-08", "last_modification_date": "2011-07-13", "structure_authors": "Young, R.J., Brown, D., Burns-Kurtis, C.L., Chan, C., Convery, M.A., Hubbard, J.A., Kelly, H.A., Pateman, A.J., Patikis, A., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Zhou, P.", "citation_authors": "Young, R.J., Brown, D., Burns-Kurtis, C.L., Chan, C., Convery, M.A., Hubbard, J.A., Kelly, H.A., Pateman, A.J., Patikis, A., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Zhou, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2uwo", "bioAssemblies": "1", "release_date": "Tue May 08 00:00:00 PDT 2007", "resolution": "1.75"}, "ligs": [{"@structureId": "2UWO", "@chemicalID": "701", "@type": "non-polymer", "@molecularWeight": "461.983", "chemicalName": "(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE", "formula": "C18 H24 Cl N3 O5 S2", "InChIKey": "YMJHMJLNQLVUAV-GHYUOPHCSA-N", "InChI": "InChI=1S/C18H24ClN3O5S2/c1-12(15-3-4-16(19)28-15)11-29(25,26)20-14-5-6-22(18(14)24)13(2)17(23)21-7-9-27-10-8-21/h3-4,11,13-14,20H,5-10H2,1-2H3/b12-11+/t13-,14-/m0/s1", "smiles": "C[C@@H](C(=O)N1CCOCC1)N2CC[C@@H](C2=O)NS(=O)(=O)\\C=C(/C)\\c3ccc(s3)Cl"}], "num_ligs": 1, "name_ligs": ["701"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQE--GEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.540983606557376, "gaps": {"num_gaps": 3, "gap_lengths": [235, 3, 21], "gap_list": [[1, 235], [297, 299], [469, 489]], "gap_window": [[1, 236], [296, 300], [468, 489]]}}, "2uwp": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1FXY", "@details": "COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG- CHLOROMETHYLKETONE"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}], "structureId": "2UWP", "title": "Factor Xa inhibitor complex", "pubmedId": "17420122", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.75", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2257", "deposition_date": "2007-03-22", "release_date": "2007-05-08", "last_modification_date": "2011-07-13", "structure_authors": "Young, R.J., Brown, D., Burns-Kurtis, C.L., Chan, C., Convery, M.A., Hubbard, J.A., Kelly, H.A., Pateman, A.J., Patikis, A., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Zhou, P., Thorpe, J.H.", "citation_authors": "Young, R.J., Brown, D., Burns-Kurtis, C.L., Chan, C., Convery, M.A., Hubbard, J.A., Kelly, H.A., Pateman, A.J., Patikis, A., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Zhou, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2uwp", "bioAssemblies": "1", "release_date": "Tue May 08 00:00:00 PDT 2007", "resolution": "1.75"}, "ligs": [{"@structureId": "2UWP", "@chemicalID": "894", "@type": "non-polymer", "@molecularWeight": "449.973", "chemicalName": "2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE", "formula": "C17 H24 Cl N3 O5 S2", "InChIKey": "IAUZEBLXCOCAFL-JSGCOSHPSA-N", "InChI": "InChI=1S/C17H24ClN3O5S2/c1-12(16(22)20-7-9-26-10-8-20)21-6-4-14(17(21)23)19-28(24,25)11-5-13-2-3-15(18)27-13/h2-3,12,14,19H,4-11H2,1H3/t12-,14-/m0/s1", "smiles": "C[C@@H](C(=O)N1CCOCC1)N2CC[C@@H](C2=O)NS(=O)(=O)CCc3ccc(s3)Cl"}, {"@structureId": "2UWP", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2UWP", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}], "num_ligs": 3, "name_ligs": ["894", "CA", "MG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2vh0": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}], "structureId": "2VH0", "title": "Structure and property based design of factor Xa inhibitors:biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs", "pubmedId": "18053714", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.70", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2286", "deposition_date": "2007-11-16", "release_date": "2008-11-25", "last_modification_date": "2019-05-08", "structure_authors": "Young, R.J., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chan, C., Charbaut, M., Convery, M.A., Diallo, H., Hortense, E., Irving, W.R., Kelly, H.A., King, N.P., Kleanthous, S., Mason, A.M., Pateman, A.J., Patikis, A., Pinto, I.L., Pollard, D.R., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Weston, H.E., Zhou, P.", "citation_authors": "Young, R.J., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chan, C., Charbaut, M., Convery, M.A., Diallo, H., Hortense, E., Irving, W.R., Kelly, H.A., King, N.P., Kleanthous, S., Mason, A.M., Pateman, A.J., Patikis, A.N., Pinto, I.L., Pollard, D.R., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Weston, H.E., Zhou, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2vh0", "bioAssemblies": "1", "release_date": "Tue Nov 25 00:00:00 PST 2008", "resolution": "1.70"}, "ligs": [{"@structureId": "2VH0", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2VH0", "@chemicalID": "GSI", "@type": "non-polymer", "@molecularWeight": "526.047", "chemicalName": "2-(5-chlorothiophen-2-yl)-N-[(3S)-1-(4-{2-[(dimethylamino)methyl]-1H-imidazol-1-yl}-2-fluorophenyl)-2-oxopyrrolidin-3-yl]ethanesulfonamide", "formula": "C22 H25 Cl F N5 O3 S2", "InChI": "InChI=1S/C22H25ClFN5O3S2/c1-27(2)14-21-25-9-11-28(21)15-3-5-19(17(24)13-15)29-10-7-18(22(29)30)26-34(31,32)12-8-16-4-6-20(23)33-16/h3-6,9,11,13,18,26H,7-8,10,12,14H2,1-2H3/t18-/m0/s1", "InChIKey": "JENHCPNBBPPGMN-SFHVURJKSA-N", "smiles": "CN(C)Cc1nccn1c2ccc(c(c2)F)N3CC[C@@H](C3=O)NS(=O)(=O)CCc4ccc(s4)Cl"}, {"@structureId": "2VH0", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}], "num_ligs": 3, "name_ligs": ["CA", "GSI", "MG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2vh6": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}], "structureId": "2VH6", "title": "Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs", "pubmedId": "18054228", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.95", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2262", "deposition_date": "2007-11-19", "release_date": "2008-12-16", "last_modification_date": "2019-05-08", "structure_authors": "Young, R.J., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chan, C., Charbaut, M., Chung, C.W., Convery, M.A., Kelly, H.A., King, N.P., Kleanthous, S., Mason, A.M., Pateman, A.J., Patikis, A.N., Pinto, I.L., Pollard, D.R., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Weston, H.E.", "citation_authors": "Young, R.J., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chan, C., Charbaut, M., Chung, C.W., Convery, M.A., Kelly, H.A., Paul King, N., Kleanthous, S., Mason, A.M., Pateman, A.J., Patikis, A.N., Pinto, I.L., Pollard, D.R., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Weston, H.E.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2vh6", "bioAssemblies": "1", "release_date": "Tue Dec 16 00:00:00 PST 2008", "resolution": "1.95"}, "ligs": [{"@structureId": "2VH6", "@chemicalID": "GSV", "@type": "non-polymer", "@molecularWeight": "557.078", "chemicalName": "2-(5-chlorothiophen-2-yl)-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]-2-oxopyrrolidin-3-yl}ethanesulfonamide", "formula": "C23 H22 Cl F N2 O5 S3", "InChI": "InChI=1S/C23H22ClFN2O5S3/c1-34(29,30)21-5-3-2-4-17(21)15-6-8-20(18(25)14-15)27-12-10-19(23(27)28)26-35(31,32)13-11-16-7-9-22(24)33-16/h2-9,14,19,26H,10-13H2,1H3/t19-/m0/s1", "InChIKey": "MRKBPFVJGAHTFU-IBGZPJMESA-N", "smiles": "CS(=O)(=O)c1ccccc1c2ccc(c(c2)F)N3CC[C@@H](C3=O)NS(=O)(=O)CCc4ccc(s4)Cl"}], "num_ligs": 1, "name_ligs": ["GSV"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQE--GEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.540983606557376, "gaps": {"num_gaps": 3, "gap_lengths": [235, 3, 21], "gap_list": [[1, 235], [297, 299], [469, 489]], "gap_window": [[1, 236], [296, 300], [468, 489]]}}, "2vvc": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXED WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}], "structureId": "2VVC", "title": "Aminopyrrolidine Factor Xa inhibitor", "pubmedId": "19200624", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.95", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "592", "nr_atoms": "4512", "deposition_date": "2008-06-05", "release_date": "2009-07-07", "last_modification_date": "2017-06-28", "structure_authors": "Groebke-Zbinden, K., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Unger, R., Haap, W.", "citation_authors": "Zbinden, K.G., Anselm, L., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Thomi, S., Unger, R., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": [{"@id": "A"}, {"@id": "B"}]}, {"@id": "2", "@type": "protein", "Chain": [{"@id": "K"}, {"@id": "L"}]}], "structureId": "2vvc", "bioAssemblies": "6", "release_date": "Tue Jul 07 00:00:00 PDT 2009", "resolution": "1.95"}, "ligs": [{"@structureId": "2VVC", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2VVC", "@chemicalID": "LZF", "@type": "non-polymer", "@molecularWeight": "504.962", "chemicalName": "5-chloro-N-[(3S,4S)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-4-methoxypyrrolidin-3-yl]thiophene-2-carboxamide", "formula": "C23 H22 Cl F N4 O4 S", "InChI": "InChI=1S/C23H22ClFN4O4S/c1-33-18-12-28(11-17(18)27-23(32)19-7-8-20(24)34-19)13-21(30)26-16-6-5-14(10-15(16)25)29-9-3-2-4-22(29)31/h2-10,17-18H,11-13H2,1H3,(H,26,30)(H,27,32)/t17-,18-/m0/s1", "InChIKey": "BOCLXHFYRGMFSC-ROUUACIJSA-N", "smiles": "CO[C@H]1C[N@](C[C@@H]1NC(=O)c2ccc(s2)Cl)CC(=O)Nc3ccc(cc3F)N4C=CC=CC4=O"}, {"@structureId": "2VVC", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 3, "name_ligs": ["CA", "LZF", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2vvu": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}], "structureId": "2VVU", "title": "Aminopyrrolidine Factor Xa inhibitor", "pubmedId": "19200624", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.30", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2267", "deposition_date": "2008-06-11", "release_date": "2009-07-07", "last_modification_date": "2011-07-13", "structure_authors": "Groebke-Zbinden, K., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Unger, R., Haap, W.", "citation_authors": "Zbinden, K.G., Anselm, L., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Thomi, S., Unger, R., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2vvu", "bioAssemblies": "3", "release_date": "Tue Jul 07 00:00:00 PDT 2009", "resolution": "2.30"}, "ligs": [{"@structureId": "2VVU", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2VVU", "@chemicalID": "H22", "@type": "non-polymer", "@molecularWeight": "474.936", "chemicalName": "5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide", "formula": "C22 H20 Cl F N4 O3 S", "InChIKey": "IYGIXVNAMZPBDK-CQSZACIVSA-N", "InChI": "InChI=1S/C22H20ClFN4O3S/c23-19-7-6-18(32-19)22(31)25-14-8-10-27(12-14)13-20(29)26-17-5-4-15(11-16(17)24)28-9-2-1-3-21(28)30/h1-7,9,11,14H,8,10,12-13H2,(H,25,31)(H,26,29)/t14-/m1/s1", "smiles": "c1cc(c(cc1N2C=CC=CC2=O)F)NC(=O)C[N@@]3CC[C@H](C3)NC(=O)c4ccc(s4)Cl"}, {"@structureId": "2VVU", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 3, "name_ligs": ["CA", "H22", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2vvv": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}], "structureId": "2VVV", "title": "Aminopyrrolidine-related triazole Factor Xa inhibitor", "pubmedId": "19200624", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.73", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2293", "deposition_date": "2008-06-12", "release_date": "2009-07-07", "last_modification_date": "2017-06-28", "structure_authors": "Groebke-Zbinden, K., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Unger, R., Haap, W.", "citation_authors": "Zbinden, K.G., Anselm, L., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Thomi, S., Unger, R., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2vvv", "bioAssemblies": "3", "release_date": "Tue Jul 07 00:00:00 PDT 2009", "resolution": "1.73"}, "ligs": [{"@structureId": "2VVV", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2VVV", "@chemicalID": "H21", "@type": "non-polymer", "@molecularWeight": "472.88", "chemicalName": "5-chloro-N-[1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-1H-1,2,4-triazol-3-yl]thiophene-2-carboxamide", "formula": "C20 H14 Cl F N6 O3 S", "InChIKey": "KAUVVMPQUJSRIS-UHFFFAOYSA-N", "InChI": "InChI=1S/C20H14ClFN6O3S/c21-16-7-6-15(32-16)19(31)25-20-23-11-27(26-20)10-17(29)24-14-5-4-12(9-13(14)22)28-8-2-1-3-18(28)30/h1-9,11H,10H2,(H,24,29)(H,25,26,31)", "smiles": "c1cc(c(cc1N2C=CC=CC2=O)F)NC(=O)Cn3cnc(n3)NC(=O)c4ccc(s4)Cl"}, {"@structureId": "2VVV", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 3, "name_ligs": ["CA", "H21", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2vwl": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}], "structureId": "2VWL", "title": "Aminopyrrolidine Factor Xa inhibitor", "pubmedId": "19200624", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.80", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2229", "deposition_date": "2008-06-26", "release_date": "2009-07-07", "last_modification_date": "2011-07-13", "structure_authors": "Groebke-Zbinden, K., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Unger, R., Haap, W.", "citation_authors": "Zbinden, K.G., Anselm, L., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Thomi, S., Unger, R., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2vwl", "bioAssemblies": "3", "release_date": "Tue Jul 07 00:00:00 PDT 2009", "resolution": "1.80"}, "ligs": [{"@structureId": "2VWL", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2VWL", "@chemicalID": "CL", "@type": "non-polymer", "@molecularWeight": "35.453", "chemicalName": "CHLORIDE ION", "formula": "Cl -1", "InChI": "InChI=1S/ClH/h1H/p-1", "InChIKey": "VEXZGXHMUGYJMC-UHFFFAOYSA-M", "smiles": "[Cl-]"}, {"@structureId": "2VWL", "@chemicalID": "LZH", "@type": "non-polymer", "@molecularWeight": "504.962", "chemicalName": "5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3R,5S)-1-{[2-FLUORO-4-(2-OXO-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-5-HYDROXYMETHYL-PYRROLIDIN-3-YL)-AMIDE", "formula": "C23 H22 Cl F N4 O4 S", "InChI": "InChI=1S/C23H22ClFN4O4S/c24-20-7-6-19(34-20)23(33)26-14-9-16(13-30)28(11-14)12-21(31)27-18-5-4-15(10-17(18)25)29-8-2-1-3-22(29)32/h1-8,10,14,16,30H,9,11-13H2,(H,26,33)(H,27,31)/t14-,16+/m1/s1", "InChIKey": "FMLMGXAAZAZCMG-ZBFHGGJFSA-N", "smiles": "c1cc(c(cc1N2C=CC=CC2=O)F)NC(=O)C[N@]3C[C@@H](C[C@H]3CO)NC(=O)c4ccc(s4)Cl"}, {"@structureId": "2VWL", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 4, "name_ligs": ["CA", "CL", "LZH", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2vwm": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}], "structureId": "2VWM", "title": "Aminopyrrolidine Factor Xa inhibitor", "pubmedId": "19200624", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.96", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "592", "nr_atoms": "4538", "deposition_date": "2008-06-26", "release_date": "2009-07-07", "last_modification_date": "2017-06-28", "structure_authors": "Groebke-Zbinden, K., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Unger, R., Haap, W.", "citation_authors": "Zbinden, K.G., Anselm, L., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Thomi, S., Unger, R., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": [{"@id": "A"}, {"@id": "B"}]}, {"@id": "2", "@type": "protein", "Chain": [{"@id": "K"}, {"@id": "L"}]}], "structureId": "2vwm", "bioAssemblies": "6", "release_date": "Tue Jul 07 00:00:00 PDT 2009", "resolution": "1.96"}, "ligs": [{"@structureId": "2VWM", "@chemicalID": "LZI", "@type": "non-polymer", "@molecularWeight": "572.051", "chemicalName": "(4R)-4-{[(5-chlorothiophen-2-yl)carbonyl]amino}-N-(cyclopropylmethyl)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-L-prolinamide", "formula": "C27 H27 Cl F N5 O4 S", "InChIKey": "LRFNMAKOTZSBFP-UTKZUKDTSA-N", "InChI": "InChI=1S/C27H27ClFN5O4S/c28-23-9-8-22(39-23)27(38)31-17-11-21(26(37)30-13-16-4-5-16)33(14-17)15-24(35)32-20-7-6-18(12-19(20)29)34-10-2-1-3-25(34)36/h1-3,6-10,12,16-17,21H,4-5,11,13-15H2,(H,30,37)(H,31,38)(H,32,35)/t17-,21+/m1/s1", "smiles": "c1cc(c(cc1N2C=CC=CC2=O)F)NC(=O)C[N@]3C[C@@H](C[C@H]3C(=O)NCC4CC4)NC(=O)c5ccc(s5)Cl"}, {"@structureId": "2VWM", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 2, "name_ligs": ["LZI", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQE-GGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.540983606557376, "gaps": {"num_gaps": 3, "gap_lengths": [235, 2, 22], "gap_list": [[1, 235], [297, 298], [467, 488]], "gap_window": [[1, 236], [296, 299], [466, 488]]}}, "2vwn": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}], "structureId": "2VWN", "title": "Aminopyrrolidine Factor Xa inhibitor", "pubmedId": "19200624", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.61", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2283", "deposition_date": "2008-06-26", "release_date": "2009-07-07", "last_modification_date": "2011-07-13", "structure_authors": "Groebke-Zbinden, K., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Unger, R., Haap, W.", "citation_authors": "Zbinden, K.G., Anselm, L., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Thomi, S., Unger, R., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2vwn", "bioAssemblies": "3", "release_date": "Tue Jul 07 00:00:00 PDT 2009", "resolution": "1.61"}, "ligs": [{"@structureId": "2VWN", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2VWN", "@chemicalID": "CL", "@type": "non-polymer", "@molecularWeight": "35.453", "chemicalName": "CHLORIDE ION", "formula": "Cl -1", "InChI": "InChI=1S/ClH/h1H/p-1", "InChIKey": "VEXZGXHMUGYJMC-UHFFFAOYSA-M", "smiles": "[Cl-]"}, {"@structureId": "2VWN", "@chemicalID": "H25", "@type": "non-polymer", "@molecularWeight": "490.935", "chemicalName": "5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide", "formula": "C22 H20 Cl F N4 O4 S", "InChI": "InChI=1S/C22H20ClFN4O4S/c23-19-7-6-18(33-19)22(32)26-16-10-27(11-17(16)29)12-20(30)25-15-5-4-13(9-14(15)24)28-8-2-1-3-21(28)31/h1-9,16-17,29H,10-12H2,(H,25,30)(H,26,32)/t16-,17-/m0/s1", "InChIKey": "ARAVOODWJJJNBY-IRXDYDNUSA-N", "smiles": "c1cc(c(cc1N2C=CC=CC2=O)F)NC(=O)C[N@]3C[C@@H]([C@H](C3)O)NC(=O)c4ccc(s4)Cl"}, {"@structureId": "2VWN", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 4, "name_ligs": ["CA", "CL", "H25", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2vwo": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}], "structureId": "2VWO", "title": "Aminopyrrolidine Factor Xa inhibitor", "pubmedId": "19200624", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.60", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2246", "deposition_date": "2008-06-26", "release_date": "2009-07-07", "last_modification_date": "2011-07-13", "structure_authors": "Groebke-Zbinden, K., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Unger, R., Haap, W.", "citation_authors": "Zbinden, K.G., Anselm, L., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Thomi, S., Unger, R., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2vwo", "bioAssemblies": "3", "release_date": "Tue Jul 07 00:00:00 PDT 2009", "resolution": "1.60"}, "ligs": [{"@structureId": "2VWO", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2VWO", "@chemicalID": "CL", "@type": "non-polymer", "@molecularWeight": "35.453", "chemicalName": "CHLORIDE ION", "formula": "Cl -1", "InChI": "InChI=1S/ClH/h1H/p-1", "InChIKey": "VEXZGXHMUGYJMC-UHFFFAOYSA-M", "smiles": "[Cl-]"}, {"@structureId": "2VWO", "@chemicalID": "LZG", "@type": "non-polymer", "@molecularWeight": "492.926", "chemicalName": "5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE", "formula": "C22 H19 Cl F2 N4 O3 S", "InChI": "InChI=1S/C22H19ClF2N4O3S/c23-19-7-6-18(33-19)22(32)27-17-11-28(10-15(17)25)12-20(30)26-16-5-4-13(9-14(16)24)29-8-2-1-3-21(29)31/h1-9,15,17H,10-12H2,(H,26,30)(H,27,32)/t15-,17-/m0/s1", "InChIKey": "SXIYSYYSKHUTQQ-RDJZCZTQSA-N", "smiles": "c1cc(c(cc1N2C=CC=CC2=O)F)NC(=O)C[N@]3C[C@@H]([C@H](C3)F)NC(=O)c4ccc(s4)Cl"}, {"@structureId": "2VWO", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 4, "name_ligs": ["CA", "CL", "LZG", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2w26": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}], "structureId": "2W26", "title": "Factor Xa in complex with BAY59-7939", "pubmedId": "16161994", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.08", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2226", "deposition_date": "2008-10-24", "release_date": "2008-11-11", "last_modification_date": "2017-03-22", "structure_authors": "Roehrig, S., Straub, A., Pohlmann, J., Lampe, T., Pernerstorfer, J., Schlemmer, K., Reinemer, P., Perzborn, E., Schaefer, M.", "citation_authors": "Roehrig, S., Straub, A., Pohlmann, J., Lampe, T., Pernerstorfer, J., Schlemmer, K., Reinemer, P., Perzborn, E.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2w26", "bioAssemblies": "1", "release_date": "Tue Nov 11 00:00:00 PST 2008", "resolution": "2.08"}, "ligs": [{"@structureId": "2W26", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2W26", "@chemicalID": "RIV", "@type": "non-polymer", "@molecularWeight": "435.881", "chemicalName": "5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide", "formula": "C19 H18 Cl N3 O5 S", "InChIKey": "KGFYHTZWPPHNLQ-AWEZNQCLSA-N", "InChI": "InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1", "smiles": "c1cc(ccc1N2CCOCC2=O)N3C[C@@H](OC3=O)CNC(=O)c4ccc(s4)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "RIV"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2w3i": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}], "structureId": "2W3I", "title": "Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 2", "pubmedId": "19231206", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.90", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2266", "deposition_date": "2008-11-12", "release_date": "2009-04-07", "last_modification_date": "2011-07-13", "structure_authors": "Zhang, E., Mochalkin, I., Casimiro-Garcia, A., Van Huis, C.A.", "citation_authors": "Van Huis, C.A., Casimiro-Garcia, A., Bigge, C.F., Cody, W.L., Dudley, D.A., Filipski, K.J., Heemstra, R.J., Kohrt, J.T., Leadley, R.J.J., Narasimhan, L.S., Mcclanahan, T., Mochalkin, I., Pamment, M., Peterson, J.T., Sahasrabudhe, V., Schaum, R.P., Edmunds, J.J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2w3i", "bioAssemblies": "1", "release_date": "Tue Apr 07 00:00:00 PDT 2009", "resolution": "1.90"}, "ligs": [{"@structureId": "2W3I", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2W3I", "@chemicalID": "L1C", "@type": "non-polymer", "@molecularWeight": "565.955", "chemicalName": "(2R,4S)-N^1^-(4-chlorophenyl)-4-(2,4-difluorophenyl)-4-hydroxy-N^2^-(2-oxo-2H-1,3'-bipyridin-6'-yl)pyrrolidine-1,2-dicarboxamide", "formula": "C28 H22 Cl F2 N5 O4", "InChIKey": "BGECSWGTDIXGJY-QDPGVEIFSA-N", "InChI": "InChI=1S/C28H22ClF2N5O4/c29-17-4-7-19(8-5-17)33-27(39)36-16-28(40,21-10-6-18(30)13-22(21)31)14-23(36)26(38)34-24-11-9-20(15-32-24)35-12-2-1-3-25(35)37/h1-13,15,23,40H,14,16H2,(H,33,39)(H,32,34,38)/t23-,28-/m1/s1", "smiles": "c1cc(ccc1NC(=O)N2C[C@](C[C@@H]2C(=O)Nc3ccc(cn3)N4C=CC=CC4=O)(c5ccc(cc5F)F)O)Cl"}], "num_ligs": 2, "name_ligs": ["CA", "L1C"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2w3k": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}], "structureId": "2W3K", "title": "Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 1", "pubmedId": "19231206", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.05", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2265", "deposition_date": "2008-11-12", "release_date": "2009-04-07", "last_modification_date": "2011-09-28", "structure_authors": "Zhang, E., Mochalkin, I., Casimiro-Garcia, A., Van Huis, C.A.", "citation_authors": "Van Huis, C.A., Casimiro-Garcia, A., Bigge, C.F., Cody, W.L., Dudley, D.A., Filipski, K.J., Heemstra, R.J., Kohrt, J.T., Leadley, R.J.J., Narasimhan, L.S., Mcclanahan, T., Mochalkin, I., Pamment, M., Peterson, J.T., Sahasrabudhe, V., Schaum, R.P., Edmunds, J.J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2w3k", "bioAssemblies": "1", "release_date": "Tue Apr 07 00:00:00 PDT 2009", "resolution": "2.05"}, "ligs": [{"@structureId": "2W3K", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2W3K", "@chemicalID": "L1D", "@type": "non-polymer", "@molecularWeight": "546.977", "chemicalName": "(2R,4S)-N^1^-(4-chlorophenyl)-N^2^-[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]-4-hydroxy-4-phenylpyrrolidine-1,2-dicarboxamide", "formula": "C29 H24 Cl F N4 O4", "InChIKey": "ZFOBYPBSJINJKI-VAVYLYDRSA-N", "InChI": "InChI=1S/C29H24ClFN4O4/c30-20-9-11-21(12-10-20)32-28(38)35-18-29(39,19-6-2-1-3-7-19)17-25(35)27(37)33-24-14-13-22(16-23(24)31)34-15-5-4-8-26(34)36/h1-16,25,39H,17-18H2,(H,32,38)(H,33,37)/t25-,29-/m1/s1", "smiles": "c1ccc(cc1)[C@]2(C[C@@H](N(C2)C(=O)Nc3ccc(cc3)Cl)C(=O)Nc4ccc(cc4F)N5C=CC=CC5=O)O"}], "num_ligs": 2, "name_ligs": ["CA", "L1D"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2wyg": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}], "structureId": "2WYG", "title": "Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs", "pubmedId": "20006499", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.88", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2229", "deposition_date": "2009-11-16", "release_date": "2010-12-01", "last_modification_date": "2019-10-16", "structure_authors": "Kleanthous, S., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chaudry, L., Chan, C., Clarte, M., Convery, M.A., Harling, J.D., Hortense, E., Irving, W.R., Irvine, S., Pateman, A.J., Patikis, A., Pinto, I.L., Pollard, D.R., Roethka, T.J., Senger, S., Shah, G.P., Stelman, G.J., Toomey, J.R., Watson, N.S., Whittaker, C., Zhou, P., Young, R.J.", "citation_authors": "Kleanthous, S., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chaudry, L., Chan, C., Clarte, M., Convery, M.A., Harling, J.D., Hortense, E., Irving, W.R., Irvine, S., Pateman, A.J., Patikis, A., Pinto, I.L., Pollard, D.R., Roethka, T.J., Senger, S., Shah, G.P., Stelman, G.J., Toomey, J.R., Watson, N.S., Whittaker, C., Zhou, P., Young, R.J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2wyg", "bioAssemblies": "1", "release_date": "Wed Dec 01 00:00:00 PST 2010", "resolution": "1.88"}, "ligs": [{"@structureId": "2WYG", "@chemicalID": "461", "@type": "non-polymer", "@molecularWeight": "471.996", "chemicalName": "(E)-2-(5-CHLOROTHIOPHEN-2-YL)-N-[(3S)-1-{4-[(1R)-1-(DIMETHYLAMINO)ETHYL]-2-FLUOROPHENYL}-2-OXOPYRROLIDIN-3-YL]ETHENESULFONAMIDE", "formula": "C20 H23 Cl F N3 O3 S2", "InChI": "InChI=1S/C20H23ClFN3O3S2/c1-13(24(2)3)14-4-6-18(16(22)12-14)25-10-8-17(20(25)26)23-30(27,28)11-9-15-5-7-19(21)29-15/h4-7,9,11-13,17,23H,8,10H2,1-3H3/b11-9+/t13-,17+/m1/s1", "InChIKey": "AFDHTIFDRFSZDA-IUJLQVPDSA-N", "smiles": "C[C@H](c1ccc(c(c1)F)N2CC[C@@H](C2=O)NS(=O)(=O)\\C=C\\c3ccc(s3)Cl)N(C)C"}], "num_ligs": 1, "name_ligs": ["461"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNT------EAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 46.72131147540984, "gaps": {"num_gaps": 3, "gap_lengths": [235, 7, 21], "gap_list": [[1, 235], [294, 300], [469, 489]], "gap_window": [[1, 236], [293, 301], [468, 489]]}}, "2wyj": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}], "structureId": "2WYJ", "title": "Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs", "pubmedId": "20006499", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.38", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2241", "deposition_date": "2009-11-16", "release_date": "2010-12-01", "last_modification_date": "2019-05-29", "structure_authors": "Kleanthous, S., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chaudry, L., Chan, C., Clarte, M., Convery, M.A., Harling, J.D., Hortense, E., Irving, W.R., Irvine, S., Pateman, A.J., Patikis, A., Pinto, I.L., Pollard, D.R., Roethka, T.J., Senger, S., Shah, G.P., Stelman, G.J., Toomey, J.R., Watson, N.S., Whittaker, C., Zhou, P., Young, R.J.", "citation_authors": "Kleanthous, S., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chaudry, L., Chan, C., Clarte, M., Convery, M.A., Harling, J.D., Hortense, E., Irving, W.R., Irvine, S., Pateman, A.J., Patikis, A., Pinto, I.L., Pollard, D.R., Roethka, T.J., Senger, S., Shah, G.P., Stelman, G.J., Toomey, J.R., Watson, N.S., Whittaker, C., Zhou, P., Young, R.J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2wyj", "bioAssemblies": "1", "release_date": "Wed Dec 01 00:00:00 PST 2010", "resolution": "2.38"}, "ligs": [{"@structureId": "2WYJ", "@chemicalID": "898", "@type": "non-polymer", "@molecularWeight": "471.996", "chemicalName": "(E)-2-(5-CHLOROTHIOPHEN-2-YL)-N-[(3S)-1-{4-[(1S)-1-(DIMETHYLAMINO)ETHYL]-2-FLUOROPHENYL}-2-OXOPYRROLIDIN-3-YL]ETHENESULFONAMIDE", "formula": "C20 H23 Cl F N3 O3 S2", "InChI": "InChI=1S/C20H23ClFN3O3S2/c1-13(24(2)3)14-4-6-18(16(22)12-14)25-10-8-17(20(25)26)23-30(27,28)11-9-15-5-7-19(21)29-15/h4-7,9,11-13,17,23H,8,10H2,1-3H3/b11-9+/t13-,17-/m0/s1", "InChIKey": "AFDHTIFDRFSZDA-WZMLOTFKSA-N", "smiles": "C[C@@H](c1ccc(c(c1)F)N2CC[C@@H](C2=O)NS(=O)(=O)\\C=C\\c3ccc(s3)Cl)N(C)C"}], "num_ligs": 1, "name_ligs": ["898"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQE---EAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.13114754098361, "gaps": {"num_gaps": 3, "gap_lengths": [235, 4, 22], "gap_list": [[1, 235], [297, 300], [467, 488]], "gap_window": [[1, 236], [296, 301], [466, 488]]}}, "2xbv": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)- 3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2- PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5- DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3, 5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6, 7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2- CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL- 2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2- BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'- ((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3- (TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C] PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}], "structureId": "2XBV", "title": "Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor", "pubmedId": "20650636", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.66", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2198", "deposition_date": "2010-04-15", "release_date": "2010-08-04", "last_modification_date": "2011-07-13", "structure_authors": "Banner, D.W., Benz, J., Schlatter, D., Anselm, L., Haap, W.", "citation_authors": "Anselm, L., Banner, D.W., Benz, J., Groebke Zbinden, K., Himber, J., Hilpert, H., Huber, W., Kuhn, B., Mary, J.L., Otteneder, M.B., Panday, N., Ricklin, F., Stahl, M., Thomi, S., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2xbv", "bioAssemblies": "1", "release_date": "Wed Aug 04 00:00:00 PDT 2010", "resolution": "1.66"}, "ligs": [{"@structureId": "2XBV", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2XBV", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}, {"@structureId": "2XBV", "@chemicalID": "XBV", "@type": "non-polymer", "@molecularWeight": "519.903", "chemicalName": "(3R,4R)-1-(2,2-DIFLUORO-ETHYL)-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(5-CHLORO-PYRIDIN-2-YL)-AMIDE]-4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE}", "formula": "C24 H21 Cl F3 N5 O3", "InChIKey": "DVMCMTVFXINJGW-IRXDYDNUSA-N", "InChI": "InChI=1S/C24H21ClF3N5O3/c25-14-4-7-21(29-10-14)31-24(36)17-12-32(13-20(27)28)11-16(17)23(35)30-19-6-5-15(9-18(19)26)33-8-2-1-3-22(33)34/h1-10,16-17,20H,11-13H2,(H,30,35)(H,29,31,36)/t16-,17-/m0/s1", "smiles": "c1cc(c(cc1N2C=CC=CC2=O)F)NC(=O)[C@H]3C[N@](C[C@@H]3C(=O)Nc4ccc(cn4)Cl)CC(F)F"}], "num_ligs": 3, "name_ligs": ["CA", "NA", "XBV"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2xbw": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)- 3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2- PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5- DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3, 5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6, 7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2- CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL- 2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2- BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'- ((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3- (TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C] PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}], "structureId": "2XBW", "title": "Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor", "pubmedId": "20650636", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.72", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2259", "deposition_date": "2010-04-15", "release_date": "2010-08-04", "last_modification_date": "2017-06-28", "structure_authors": "Banner, D.W., Benz, J., Schlatter, D., Thomi, S., Haap, W.", "citation_authors": "Anselm, L., Banner, D.W., Benz, J., Groebke Zbinden, K., Himber, J., Hilpert, H., Huber, W., Kuhn, B., Mary, J.L., Otteneder, M.B., Panday, N., Ricklin, F., Stahl, M., Thomi, S., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2xbw", "bioAssemblies": "1", "release_date": "Wed Aug 04 00:00:00 PDT 2010", "resolution": "1.72"}, "ligs": [{"@structureId": "2XBW", "@chemicalID": "455", "@type": "non-polymer", "@molecularWeight": "533.96", "chemicalName": "(3R,4R)-1-SULFAMOYL-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(4-CHLORO-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE}", "formula": "C23 H21 Cl F N5 O5 S", "InChIKey": "GYWPDZGVFZEVMA-ROUUACIJSA-N", "InChI": "InChI=1S/C23H21ClFN5O5S/c24-14-4-6-15(7-5-14)27-22(32)17-12-29(36(26,34)35)13-18(17)23(33)28-20-9-8-16(11-19(20)25)30-10-2-1-3-21(30)31/h1-11,17-18H,12-13H2,(H,27,32)(H,28,33)(H2,26,34,35)/t17-,18-/m0/s1", "smiles": "c1cc(ccc1NC(=O)[C@H]2C[N@@](C[C@@H]2C(=O)Nc3ccc(cc3F)N4C=CC=CC4=O)S(=O)(=O)N)Cl"}, {"@structureId": "2XBW", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2XBW", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 3, "name_ligs": ["455", "CA", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2xbx": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)- 3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2- PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5- DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3, 5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6, 7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2- CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL- 2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2- BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'- ((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3- (TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C] PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}], "structureId": "2XBX", "title": "Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor", "pubmedId": "20650636", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.85", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2208", "deposition_date": "2010-04-15", "release_date": "2010-08-04", "last_modification_date": "2017-06-28", "structure_authors": "Banner, D.W., Benz, J., Schlatter, D., Haap, W.", "citation_authors": "Anselm, L., Banner, D.W., Benz, J., Groebke Zbinden, K., Himber, J., Hilpert, H., Huber, W., Kuhn, B., Mary, J.L., Otteneder, M.B., Panday, N., Ricklin, F., Stahl, M., Thomi, S., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2xbx", "bioAssemblies": "1", "release_date": "Wed Aug 04 00:00:00 PDT 2010", "resolution": "1.85"}, "ligs": [{"@structureId": "2XBX", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2XBX", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}, {"@structureId": "2XBX", "@chemicalID": "RR8", "@type": "non-polymer", "@molecularWeight": "532.972", "chemicalName": "(3R,4R)-1-METHANESULFONYL-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(4-CHLORO-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE}", "formula": "C24 H22 Cl F N4 O5 S", "InChI": "InChI=1S/C24H22ClFN4O5S/c1-36(34,35)29-13-18(23(32)27-16-7-5-15(25)6-8-16)19(14-29)24(33)28-21-10-9-17(12-20(21)26)30-11-3-2-4-22(30)31/h2-12,18-19H,13-14H2,1H3,(H,27,32)(H,28,33)/t18-,19-/m0/s1", "InChIKey": "CUZHVTKMXOGVKA-OALUTQOASA-N", "smiles": "CS(=O)(=O)[N@]1C[C@@H]([C@H](C1)C(=O)Nc2ccc(cc2F)N3C=CC=CC3=O)C(=O)Nc4ccc(cc4)Cl"}], "num_ligs": 3, "name_ligs": ["CA", "NA", "RR8"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2xby": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)- 3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2- PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5- DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3, 5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6, 7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2- CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL- 2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2- BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'- ((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3- (TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C] PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}], "structureId": "2XBY", "title": "Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor", "pubmedId": "20650636", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.02", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2198", "deposition_date": "2010-04-15", "release_date": "2010-08-04", "last_modification_date": "2017-06-28", "structure_authors": "Banner, D.W., Benz, J., Schlatter, D., Thomi, S., Haap, W.", "citation_authors": "Anselm, L., Banner, D.W., Benz, J., Groebke Zbinden, K., Himber, J., Hilpert, H., Huber, W., Kuhn, B., Mary, J.L., Otteneder, M.B., Panday, N., Ricklin, F., Stahl, M., Thomi, S., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2xby", "bioAssemblies": "1", "release_date": "Wed Aug 04 00:00:00 PDT 2010", "resolution": "2.02"}, "ligs": [{"@structureId": "2XBY", "@chemicalID": "63C", "@type": "non-polymer", "@molecularWeight": "525.959", "chemicalName": "(3R,4R)-1-METHYLCARBAMOYLMETHYL-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(4-CHLORO-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE}", "formula": "C26 H25 Cl F N5 O4", "InChI": "InChI=1S/C26H25ClFN5O4/c1-29-23(34)15-32-13-19(25(36)30-17-7-5-16(27)6-8-17)20(14-32)26(37)31-22-10-9-18(12-21(22)28)33-11-3-2-4-24(33)35/h2-12,19-20H,13-15H2,1H3,(H,29,34)(H,30,36)(H,31,37)/t19-,20-/m0/s1", "InChIKey": "DXHIEYAKKGEXDY-PMACEKPBSA-N", "smiles": "CNC(=O)CN1C[C@@H]([C@H](C1)C(=O)Nc2ccc(cc2F)N3C=CC=CC3=O)C(=O)Nc4ccc(cc4)Cl"}, {"@structureId": "2XBY", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2XBY", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 3, "name_ligs": ["63C", "CA", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2xc0": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)- 3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2- PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5- DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3, 5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6, 7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2- CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL- 2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2- BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'- ((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3- (TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C] PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}], "structureId": "2XC0", "title": "Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor", "pubmedId": "20650636", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.05", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2210", "deposition_date": "2010-04-15", "release_date": "2010-08-04", "last_modification_date": "2011-07-13", "structure_authors": "Banner, D.W., Benz, J., Schlatter, D., Anselm, L., Haap, W.", "citation_authors": "Anselm, L., Banner, D.W., Benz, J., Groebke Zbinden, K., Himber, J., Hilpert, H., Huber, W., Kuhn, B., Mary, J.L., Otteneder, M.B., Panday, N., Ricklin, F., Stahl, M., Thomi, S., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2xc0", "bioAssemblies": "1", "release_date": "Wed Aug 04 00:00:00 PDT 2010", "resolution": "2.05"}, "ligs": [{"@structureId": "2XC0", "@chemicalID": "8NC", "@type": "non-polymer", "@molecularWeight": "546.543", "chemicalName": "(3R,4R)-1-METHANESULFONYL-PYRROLIDINE-3,4--DICARBOXYLIC ACID 3-[(3-FLUORO-4-METHOXY-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE}", "formula": "C25 H24 F2 N4 O6 S", "InChI": "InChI=1S/C25H24F2N4O6S/c1-37-22-9-6-15(11-20(22)27)28-24(33)17-13-30(38(2,35)36)14-18(17)25(34)29-21-8-7-16(12-19(21)26)31-10-4-3-5-23(31)32/h3-12,17-18H,13-14H2,1-2H3,(H,28,33)(H,29,34)/t17-,18-/m0/s1", "InChIKey": "JORQWQCWRYRBEL-ROUUACIJSA-N", "smiles": "COc1ccc(cc1F)NC(=O)[C@H]2C[N@@](C[C@@H]2C(=O)Nc3ccc(cc3F)N4C=CC=CC4=O)S(=O)(=O)C"}, {"@structureId": "2XC0", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2XC0", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 3, "name_ligs": ["8NC", "CA", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2xc4": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)- 3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2- PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5- DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3, 5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6, 7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2- CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL- 2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2- BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'- ((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3- (TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C] PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}], "structureId": "2XC4", "title": "Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor", "pubmedId": "20650636", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.67", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2296", "deposition_date": "2010-04-16", "release_date": "2010-08-04", "last_modification_date": "2017-06-28", "structure_authors": "Banner, D.W., Benz, J., Schlatter, D., Thomi, S., Haap, W.", "citation_authors": "Anselm, L., Banner, D.W., Benz, J., Groebke Zbinden, K., Himber, J., Hilpert, H., Huber, W., Kuhn, B., Mary, J.L., Otteneder, M.B., Panday, N., Ricklin, F., Stahl, M., Thomi, S., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2xc4", "bioAssemblies": "1", "release_date": "Wed Aug 04 00:00:00 PDT 2010", "resolution": "1.67"}, "ligs": [{"@structureId": "2XC4", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2XC4", "@chemicalID": "IVK", "@type": "non-polymer", "@molecularWeight": "536.906", "chemicalName": "(3R,4R)-N-(4-CHLOROPHENYL)-N'-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-1-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-3,4-DICARBOXAMIDE", "formula": "C25 H21 Cl F4 N4 O3", "InChI": "InChI=1S/C25H21ClF4N4O3/c26-15-4-6-16(7-5-15)31-23(36)18-12-33(14-25(28,29)30)13-19(18)24(37)32-21-9-8-17(11-20(21)27)34-10-2-1-3-22(34)35/h1-11,18-19H,12-14H2,(H,31,36)(H,32,37)/t18-,19-/m0/s1", "InChIKey": "TYMJFUUUNPEDQB-OALUTQOASA-N", "smiles": "c1cc(ccc1NC(=O)[C@H]2C[N@@](C[C@@H]2C(=O)Nc3ccc(cc3F)N4C=CC=CC4=O)CC(F)(F)F)Cl"}, {"@structureId": "2XC4", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 3, "name_ligs": ["CA", "IVK", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2xc5": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)- 3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2- PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5- DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3, 5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6, 7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2- CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL- 2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2- BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'- ((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3- (TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C] PYRIDIN-1- YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3 ,4-DICARBOXYLIC ACID INHIBITOR"}], "structureId": "2XC5", "title": "Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor", "pubmedId": "20650636", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.70", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "296", "nr_atoms": "2209", "deposition_date": "2010-04-16", "release_date": "2010-08-04", "last_modification_date": "2011-07-13", "structure_authors": "Banner, D.W., Benz, J., Schlatter, D., Anselm, L., Haap, W.", "citation_authors": "Anselm, L., Banner, D.W., Benz, J., Groebke Zbinden, K., Himber, J., Hilpert, H., Huber, W., Kuhn, B., Mary, J.L., Otteneder, M.B., Panday, N., Ricklin, F., Stahl, M., Thomi, S., Haap, W.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2xc5", "bioAssemblies": "1", "release_date": "Wed Aug 04 00:00:00 PDT 2010", "resolution": "1.70"}, "ligs": [{"@structureId": "2XC5", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2XC5", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}, {"@structureId": "2XC5", "@chemicalID": "OYJ", "@type": "non-polymer", "@molecularWeight": "550.962", "chemicalName": "(3R,4R)-1-METHANESULFONYL-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(4-CHLORO-3-FLUORO-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE}", "formula": "C24 H21 Cl F2 N4 O5 S", "InChI": "InChI=1S/C24H21ClF2N4O5S/c1-37(35,36)30-12-16(23(33)28-14-5-7-18(25)19(26)10-14)17(13-30)24(34)29-21-8-6-15(11-20(21)27)31-9-3-2-4-22(31)32/h2-11,16-17H,12-13H2,1H3,(H,28,33)(H,29,34)/t16-,17-/m0/s1", "InChIKey": "XRNMSDIWHHURFN-IRXDYDNUSA-N", "smiles": "CS(=O)(=O)[N@]1C[C@@H]([C@H](C1)C(=O)Nc2ccc(cc2F)N3C=CC=CC3=O)C(=O)Nc4ccc(c(c4)F)Cl"}], "num_ligs": 3, "name_ligs": ["CA", "NA", "OYJ"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2y5f": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031 )COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3-ADAMANTAN-1-YL -UREIDO)-3-(3-CARBAMIMIDOYL-PHENYL)-N-PHENETHYL- PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5- CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4 -[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N- IMINO-13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL )PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL -4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL) PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5- CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-( PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO- 1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1- PYRROLIDINYL)METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1, 4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-(( DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4 -C]PYRIDIN-1-YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2Y5G", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5H", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}], "structureId": "2Y5F", "title": "FACTOR XA - CATION INHIBITOR COMPLEX", "pubmedId": "22162109", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.29", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "288", "nr_atoms": "2383", "deposition_date": "2011-01-13", "release_date": "2011-12-28", "last_modification_date": "2012-01-18", "structure_authors": "Banner, D.W., Salonen, L.M., Holland, M.C., Haap, W., Benz, J., Diederich, F.", "citation_authors": "Salonen, L.M., Holland, M.C., Kaib, P.S., Haap, W., Benz, J., Mary, J.L., Kuster, O., Schweizer, W.B., Banner, D.W., Diederich, F.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2y5f", "bioAssemblies": "1", "release_date": "Wed Dec 28 00:00:00 PST 2011", "resolution": "1.29"}, "ligs": [{"@structureId": "2Y5F", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}, {"@structureId": "2Y5F", "@chemicalID": "XWG", "@type": "non-polymer", "@molecularWeight": "520.064", "chemicalName": "(3AS,4R,5S,8AS,8BR)-4-[5-(5-CHLOROTHIOPHEN-2-YL)-1,2-OXAZOL-3-YL]-2-[3-[1-(2-HYDROXYETHYL)PYRROLIDIN-1-IUM-1-YL]PROPYL]-4,6,7,8,8A,8B-HEXAHYDRO-3AH-PYRROLO[3,4-A]PYRROLIZINE-1,3-DIONE", "formula": "C25 H32 Cl N4 O4 S 1", "InChIKey": "NGWQPUFWVMNLQW-ZMVGRULKSA-N", "InChI": "InChI=1S/C25H32ClN4O4S/c26-20-7-6-19(35-20)18-15-16(27-34-18)23-22-21(17-5-3-8-28(17)23)24(32)29(25(22)33)9-4-12-30(13-14-31)10-1-2-11-30/h6-7,15,17,21-23,31H,1-5,8-14H2/q+1/t17-,21-,22-,23-/m0/s1", "smiles": "c1cc(sc1c2cc(no2)[C@H]3[C@@H]4[C@H]([C@H]5[N@@]3CCC5)C(=O)N(C4=O)CCC[N+]6(CCCC6)CCO)Cl"}], "num_ligs": 2, "name_ligs": ["NA", "XWG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2y5g": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031 )COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3-ADAMANTAN-1-YL -UREIDO)-3-(3-CARBAMIMIDOYL-PHENYL)-N-PHENETHYL- PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5- CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4 -[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N- IMINO-13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL )PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL -4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL) PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5- CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-( PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO- 1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1- PYRROLIDINYL)METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1, 4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-(( DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4 -C]PYRIDIN-1-YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2Y5F", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5H", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}], "structureId": "2Y5G", "title": "FACTOR XA - CATION INHIBITOR COMPLEX", "pubmedId": "22162109", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.29", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "288", "nr_atoms": "2385", "deposition_date": "2011-01-13", "release_date": "2011-12-28", "last_modification_date": "2012-01-18", "structure_authors": "Banner, D.W., Salonen, L.M., Holland, M.C., Haap, W., Benz, J., Diederich, F.", "citation_authors": "Salonen, L.M., Holland, M.C., Kaib, P.S., Haap, W., Benz, J., Mary, J.L., Kuster, O., Schweizer, W.B., Banner, D.W., Diederich, F.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2y5g", "bioAssemblies": "1", "release_date": "Wed Dec 28 00:00:00 PST 2011", "resolution": "1.29"}, "ligs": [{"@structureId": "2Y5G", "@chemicalID": "FJD", "@type": "non-polymer", "@molecularWeight": "464.001", "chemicalName": "3-[(3AS,4R,5S,8AS,8BR)-4-[5-(5-CHLOROTHIOPHEN-2-YL)-1,3-OXAZOL-2-YL]-1,3-DIOXO-4,6,7,8,8A,8B-HEXAHYDRO-3AH-PYRROLO[3,4-A]PYRROLIZIN-2-YL]PROPYL-TRIMETHYL-AZANIUM", "formula": "C22 H28 Cl N4 O3 S 1", "InChIKey": "AYOZEWNCAPQIAE-ZQEOTTOMSA-N", "InChI": "InChI=1S/C22H28ClN4O3S/c1-27(2,3)11-5-10-26-21(28)17-13-6-4-9-25(13)19(18(17)22(26)29)20-24-12-14(30-20)15-7-8-16(23)31-15/h7-8,12-13,17-19H,4-6,9-11H2,1-3H3/q+1/t13-,17-,18-,19+/m0/s1", "smiles": "C[N+](C)(C)CCCN1C(=O)[C@H]2[C@@H]3CCC[N@@]3[C@H]([C@H]2C1=O)c4ncc(o4)c5ccc(s5)Cl"}, {"@structureId": "2Y5G", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 2, "name_ligs": ["FJD", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2y5h": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031 )COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3-ADAMANTAN-1-YL -UREIDO)-3-(3-CARBAMIMIDOYL-PHENYL)-N-PHENETHYL- PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5- CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4 -[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N- IMINO-13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL )PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL -4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL) PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5- CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-( PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO- 1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1- PYRROLIDINYL)METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1, 4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-(( DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4 -C]PYRIDIN-1-YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2Y5F", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5G", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}], "structureId": "2Y5H", "title": "FACTOR XA - CATION INHIBITOR COMPLEX", "pubmedId": "22162109", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.33", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "288", "nr_atoms": "2373", "deposition_date": "2011-01-13", "release_date": "2011-12-28", "last_modification_date": "2012-01-18", "structure_authors": "Banner, D.W., Salonen, L.M., Holland, M.C., Haap, W., Benz, J., Diederich, F.", "citation_authors": "Salonen, L.M., Holland, M.C., Kaib, P.S., Haap, W., Benz, J., Mary, J.L., Kuster, O., Schweizer, W.B., Banner, D.W., Diederich, F.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "2y5h", "bioAssemblies": "1", "release_date": "Wed Dec 28 00:00:00 PST 2011", "resolution": "1.33"}, "ligs": [{"@structureId": "2Y5H", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}, {"@structureId": "2Y5H", "@chemicalID": "Y5H", "@type": "non-polymer", "@molecularWeight": "464.001", "chemicalName": "3-[(3AS,4R,5S,8AS,8BR)-4-[2-(5-CHLOROTHIOPHEN-2-YL)-1,3-OXAZOL-4-YL]-1,3-DIOXO-4,6,7,8,8A,8B-HEXAHYDRO-3AH-PYRROLO[3,4-A]PYRROLIZIN-2-YL]PROPYL-TRIMETHYL-AZANIUM", "formula": "C22 H28 Cl N4 O3 S 1", "InChIKey": "JCNHSXPHCSYYCR-QZHFEQFPSA-N", "InChI": "InChI=1S/C22H28ClN4O3S/c1-27(2,3)11-5-10-26-21(28)17-14-6-4-9-25(14)19(18(17)22(26)29)13-12-30-20(24-13)15-7-8-16(23)31-15/h7-8,12,14,17-19H,4-6,9-11H2,1-3H3/q+1/t14-,17-,18-,19-/m0/s1", "smiles": "C[N+](C)(C)CCCN1C(=O)[C@H]2[C@@H]3CCC[N@@]3[C@H]([C@H]2C1=O)c4coc(n4)c5ccc(s5)Cl"}], "num_ligs": 2, "name_ligs": ["NA", "Y5H"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2y7x": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031 )COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3-ADAMANTAN-1-YL -UREIDO)-3-(3-CARBAMIMIDOYL-PHENYL)-N-PHENETHYL- PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5- CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4 -[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N- IMINO-13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL )PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL -4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL) PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5- CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-( PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO- 1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1- PYRROLIDINYL)METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1, 4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-(( DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4 -C]PYRIDIN-1-YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2Y5F", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5G", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5H", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y7Z", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y80", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y81", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y82", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}], "structureId": "2Y7X", "title": "The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs", "pubmedId": "21349711", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.90", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2263", "deposition_date": "2011-02-02", "release_date": "2011-03-16", "last_modification_date": "2017-06-28", "structure_authors": "Watson, N.S., Adams, C., Belton, D., Brown, D., Burns-Kurtis, C.L., Chaudry, L., Chan, C., Convery, M.A., Davies, D.E., Exall, A.M., Harling, J.D., Irving, W.R., Irvine, S., Kleanthous, S., McLay, I.M., Pateman, A.J., Patikis, A.N., Roethka, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Young, R.J.", "citation_authors": "Watson, N.S., Adams, C., Belton, D., Brown, D., Burns-Kurtis, C.L., Chaudry, L., Chan, C., Convery, M.A., Davies, D.E., Exall, A.M., Harling, J.D., Irvine, S., Irving, W.R., Kleanthous, S., Mclay, I.M., Pateman, A.J., Patikis, A.N., Roethke, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Young, R.J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2y7x", "bioAssemblies": "1", "release_date": "Wed Mar 16 00:00:00 PDT 2011", "resolution": "1.90"}, "ligs": [{"@structureId": "2Y7X", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2Y7X", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}, {"@structureId": "2Y7X", "@chemicalID": "MZA", "@type": "non-polymer", "@molecularWeight": "473.948", "chemicalName": "6-CHLORO-N-[(3S)-1-(5-FLUORO-1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL)-2-OXO-PYRROLIDIN-3-YL]NAPHTHALENE-2-SULFONAMIDE", "formula": "C23 H21 Cl F N3 O3 S", "InChIKey": "BJOZEZZETKKCMQ-FQEVSTJZSA-N", "InChI": "InChI=1S/C23H21ClFN3O3S/c24-17-4-1-15-12-18(5-2-14(15)11-17)32(30,31)27-20-8-10-28(23(20)29)21-6-3-16-13-26-9-7-19(16)22(21)25/h1-6,11-12,20,26-27H,7-10,13H2/t20-/m0/s1", "smiles": "c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)N[C@H]3CCN(C3=O)c4ccc5c(c4F)CCNC5"}], "num_ligs": 3, "name_ligs": ["CA", "MG", "MZA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2y7z": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031 )COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3-ADAMANTAN-1-YL -UREIDO)-3-(3-CARBAMIMIDOYL-PHENYL)-N-PHENETHYL- PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5- CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4 -[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N- IMINO-13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL )PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL -4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL) PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5- CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-( PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO- 1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1- PYRROLIDINYL)METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1, 4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-(( DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4 -C]PYRIDIN-1-YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2Y5F", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5G", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5H", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y7X", "@details": "THE DISCOVERY OF POTENT AND LONG-ACTING ORAL FACTOR XA INHIBITORS WITH TETRAHYDROISOQUINOLINE AND BENZAZEPINE P4 MOTIFS"}, {"@pdbId": "2Y80", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y81", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y82", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}], "structureId": "2Y7Z", "title": "Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs", "pubmedId": "21349710", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.84", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2263", "deposition_date": "2011-02-02", "release_date": "2011-03-16", "last_modification_date": "2019-10-16", "structure_authors": "Young, R.J., Adams, C., Blows, M., Brown, D., Burns-Kurtis, C.L., Chaudry, L., Chan, C., Convery, M.A., Davies, D.E., Exall, A.M., Foster, G., Harling, J.D., Hortense, E., Irving, W.R., Irvine, S., Jackson, S., Kleanthous, S., Pateman, A.J., Patikis, A.N., Roethka, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Watson, N.S.", "citation_authors": "Young, R.J., Adams, C., Blows, M., Brown, D., Burns-Kurtis, C.L., Chan, C., Chaudry, L., Convery, M.A., Davies, D.E., Exall, A.M., Foster, G., Harling, J.D., Hortense, E., Irvine, S., Irving, W.R., Jackson, S., Kleanthous, S., Pateman, A.J., Patikis, A.N., Roethka, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Watson, N.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2y7z", "bioAssemblies": "1", "release_date": "Wed Mar 16 00:00:00 PDT 2011", "resolution": "1.84"}, "ligs": [{"@structureId": "2Y7Z", "@chemicalID": "C0Z", "@type": "non-polymer", "@molecularWeight": "484.01", "chemicalName": "6-CHLORO-N-[(3S)-1-[(1S)-1-DIMETHYLAMINO-2,3-DIHYDRO-1H-INDEN-5-YL]-2-OXO-PYRROLIDIN-3-YL]NAPHTHALENE-2-SULFONAMIDE", "formula": "C25 H26 Cl N3 O3 S", "InChI": "InChI=1S/C25H26ClN3O3S/c1-28(2)24-10-5-18-14-20(7-9-22(18)24)29-12-11-23(25(29)30)27-33(31,32)21-8-4-16-13-19(26)6-3-17(16)15-21/h3-4,6-9,13-15,23-24,27H,5,10-12H2,1-2H3/t23-,24-/m0/s1", "InChIKey": "DBFTVRMJVISJEX-ZEQRLZLVSA-N", "smiles": "CN(C)[C@H]1CCc2c1ccc(c2)N3CC[C@@H](C3=O)NS(=O)(=O)c4ccc5cc(ccc5c4)Cl"}, {"@structureId": "2Y7Z", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2Y7Z", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}], "num_ligs": 3, "name_ligs": ["C0Z", "CA", "MG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2y80": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031 )COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3-ADAMANTAN-1-YL -UREIDO)-3-(3-CARBAMIMIDOYL-PHENYL)-N-PHENETHYL- PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5- CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4 -[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N- IMINO-13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL )PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL -4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL) PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5- CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-( PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO- 1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1- PYRROLIDINYL)METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1, 4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-(( DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4 -C]PYRIDIN-1-YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2Y5F", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5G", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5H", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y7X", "@details": "THE DISCOVERY OF POTENT AND LONG-ACTING ORAL FACTOR XA INHIBITORS WITH TETRAHYDROISOQUINOLINE AND BENZAZEPINE P4 MOTIFS"}, {"@pdbId": "2Y7Z", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y81", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y82", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}], "structureId": "2Y80", "title": "Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs", "pubmedId": "21349710", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.90", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2271", "deposition_date": "2011-02-02", "release_date": "2011-03-16", "last_modification_date": "2019-10-16", "structure_authors": "Young, R.J., Adams, C., Blows, M., Brown, D., Burns-Kurtis, C.L., Chaudry, L., Chan, C., Convery, M.A., Davies, D.E., Exall, A.M., Foster, G., Harling, J.D., Hortense, E., Irving, W.R., Irvine, S., Jackson, S., Kleanthous, S., Pateman, A.J., Patikis, A.N., Roethka, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Watson, N.S.", "citation_authors": "Young, R.J., Adams, C., Blows, M., Brown, D., Burns-Kurtis, C.L., Chan, C., Chaudry, L., Convery, M.A., Davies, D.E., Exall, A.M., Foster, G., Harling, J.D., Hortense, E., Irvine, S., Irving, W.R., Jackson, S., Kleanthous, S., Pateman, A.J., Patikis, A.N., Roethka, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Watson, N.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2y80", "bioAssemblies": "1", "release_date": "Wed Mar 16 00:00:00 PDT 2011", "resolution": "1.90"}, "ligs": [{"@structureId": "2Y80", "@chemicalID": "439", "@type": "non-polymer", "@molecularWeight": "484.01", "chemicalName": "6-CHLORO-N-{(3S)-1-[(1S)-1-(DIMETHYLAMINO)-2,3-DIHYDRO-1H-INDEN-5-YL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE", "formula": "C25 H26 Cl N3 O3 S", "InChIKey": "DBFTVRMJVISJEX-BJKOFHAPSA-N", "InChI": "InChI=1S/C25H26ClN3O3S/c1-28(2)24-10-5-18-14-20(7-9-22(18)24)29-12-11-23(25(29)30)27-33(31,32)21-8-4-16-13-19(26)6-3-17(16)15-21/h3-4,6-9,13-15,23-24,27H,5,10-12H2,1-2H3/t23-,24+/m0/s1", "smiles": "CN(C)[C@@H]1CCc2c1ccc(c2)N3CC[C@@H](C3=O)NS(=O)(=O)c4ccc5cc(ccc5c4)Cl"}, {"@structureId": "2Y80", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2Y80", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}], "num_ligs": 3, "name_ligs": ["439", "CA", "MG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "2y81": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031 )COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3-ADAMANTAN-1-YL -UREIDO)-3-(3-CARBAMIMIDOYL-PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5- CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4 -[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N- IMINO-13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL )PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL -4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL) PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5- CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-( PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO- 1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1- PYRROLIDINYL)METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1, 4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-(( DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4 -C]PYRIDIN-1-YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2Y5F", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5G", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5H", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y7X", "@details": "THE DISCOVERY OF POTENT AND LONG-ACTING ORAL FACTOR XA INHIBITORS WITH TETRAHYDROISOQUINOLINE AND BENZAZEPINE P4 MOTIFS"}], "structureId": "2Y81", "title": "Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs", "pubmedId": "21349710", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.70", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2258", "deposition_date": "2011-02-02", "release_date": "2011-03-16", "last_modification_date": "2019-10-16", "structure_authors": "Young, R.J., Adams, C., Blows, M., Brown, D., Burns-Kurtis, C.L., Chaudry, L., Chan, C., Convery, M.A., Davies, D.E., Exall, A.M., Foster, G., Harling, J.D., Hortense, E., Irving, W.R., Irvine, S., Jackson, S., Kleanthous, S., Pateman, A.J., Patikis, A.N., Roethka, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Watson, N.S.", "citation_authors": "Young, R.J., Adams, C., Blows, M., Brown, D., Burns-Kurtis, C.L., Chan, C., Chaudry, L., Convery, M.A., Davies, D.E., Exall, A.M., Foster, G., Harling, J.D., Hortense, E., Irvine, S., Irving, W.R., Jackson, S., Kleanthous, S., Pateman, A.J., Patikis, A.N., Roethka, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Watson, N.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2y81", "bioAssemblies": "1", "release_date": "Wed Mar 16 00:00:00 PDT 2011", "resolution": "1.70"}, "ligs": [{"@structureId": "2Y81", "@chemicalID": "931", "@type": "non-polymer", "@molecularWeight": "487.974", "chemicalName": "6-CHLORO-N-((3S)-2-OXO-1-{4-[(2R)-2--PYRROLIDINYL] PHENYL}-3-PYRROLIDINYL)-2-NAPHTHALENESULFONAMIDE", "formula": "C24 H23 Cl F N3 O3 S", "InChI": "InChI=1S/C24H23ClFN3O3S/c25-18-6-3-16-13-19(7-4-15(16)12-18)33(31,32)28-22-9-11-29(24(22)30)23-8-5-17(14-20(23)26)21-2-1-10-27-21/h3-8,12-14,21-22,27-28H,1-2,9-11H2/t21-,22+/m1/s1", "InChIKey": "OKMBULRSJZKGQF-YADHBBJMSA-N", "smiles": "c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)N[C@H]3CCN(C3=O)c4ccc(cc4F)[C@H]5CCCN5"}, {"@structureId": "2Y81", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2Y81", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}], "num_ligs": 3, "name_ligs": ["931", "CA", "MG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "2y82": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031 )COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3-ADAMANTAN-1-YL -UREIDO)-3-(3-CARBAMIMIDOYL-PHENYL)-N-PHENETHYL- PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5- CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4 -[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N- IMINO-13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL )PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL -4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL) PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5- CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-( PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO- 1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1- PYRROLIDINYL)METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1, 4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-(( DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4 -C]PYRIDIN-1-YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2Y5F", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5G", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5H", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y7X", "@details": "THE DISCOVERY OF POTENT AND LONG-ACTING ORAL FACTOR XA INHIBITORS WITH TETRAHYDROISOQUINOLINE AND BENZAZEPINE P4 MOTIFS"}, {"@pdbId": "2Y7Z", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y80", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y81", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}], "structureId": "2Y82", "title": "Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs", "pubmedId": "21349710", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2263", "deposition_date": "2011-02-02", "release_date": "2011-03-16", "last_modification_date": "2019-10-16", "structure_authors": "Young, R.J., Adams, C., Blows, M., Brown, D., Burns-Kurtis, C.L., Chaudry, L., Chan, C., Convery, M.A., Davies, D.E., Exall, A.M., Foster, G., Harling, J.D., Hortense, E., Irving, W.R., Irvine, S., Jackson, S., Kleanthous, S., Pateman, A.J., Patikis, A.N., Roethka, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Watson, N.S.", "citation_authors": "Young, R.J., Adams, C., Blows, M., Brown, D., Burns-Kurtis, C.L., Chan, C., Chaudry, L., Convery, M.A., Davies, D.E., Exall, A.M., Foster, G., Harling, J.D., Hortense, E., Irvine, S., Irving, W.R., Jackson, S., Kleanthous, S., Pateman, A.J., Patikis, A.N., Roethka, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Watson, N.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "2y82", "bioAssemblies": "1", "release_date": "Wed Mar 16 00:00:00 PDT 2011", "resolution": "2.20"}, "ligs": [{"@structureId": "2Y82", "@chemicalID": "930", "@type": "non-polymer", "@molecularWeight": "487.974", "chemicalName": "6-CHLORO-N-((3S)-2-OXO-1-{4-[(2S)-2-PYRROLIDINYL]PHENYL}-3-PYRROLIDINYL)-2-NAPHTHALENESULFONAMIDE", "formula": "C24 H23 Cl F N3 O3 S", "InChIKey": "OKMBULRSJZKGQF-VXKWHMMOSA-N", "InChI": "InChI=1S/C24H23ClFN3O3S/c25-18-6-3-16-13-19(7-4-15(16)12-18)33(31,32)28-22-9-11-29(24(22)30)23-8-5-17(14-20(23)26)21-2-1-10-27-21/h3-8,12-14,21-22,27-28H,1-2,9-11H2/t21-,22-/m0/s1", "smiles": "c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)N[C@H]3CCN(C3=O)c4ccc(cc4F)[C@@H]5CCCN5"}, {"@structureId": "2Y82", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "2Y82", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}], "num_ligs": 3, "name_ligs": ["930", "CA", "MG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "3cen": {"describe_pdb": {"structureId": "3CEN", "title": "Factor XA in complex with the inhibitor N-(2-(((5-chloro-2-pyridinyl) amino)sulfonyl)phenyl)-4-(2-oxo-1(2H)-pyridinyl)benzamide", "pubmedId": "18424044", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.60", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2271", "deposition_date": "2008-02-29", "release_date": "2008-05-20", "last_modification_date": "2011-07-13", "structure_authors": "Chang, C.-H.", "citation_authors": "Corte, J.R., Fang, T., Pinto, D.J.P., Han, W., Hu, Z., Jiang, X.-J., Li, Y.-L., Gauuan, J.F., Hadden, M., Orton, D., Rendina, A.R., Luettgen, J.M., Wong, P.C., He, K., Morin, P., Chang, C.-H., Cheney, D.L., Knabb, R.M., Wexler, R.R., Lam, P.Y.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "3cen", "bioAssemblies": "1", "release_date": "Tue May 20 00:00:00 PDT 2008", "resolution": "1.60"}, "ligs": [{"@structureId": "3CEN", "@chemicalID": "FXA", "@type": "non-polymer", "@molecularWeight": "480.923", "chemicalName": "N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE", "formula": "C23 H17 Cl N4 O4 S", "InChI": "InChI=1S/C23H17ClN4O4S/c24-17-10-13-21(25-15-17)27-33(31,32)20-6-2-1-5-19(20)26-23(30)16-8-11-18(12-9-16)28-14-4-3-7-22(28)29/h1-15H,(H,25,27)(H,26,30)", "InChIKey": "MIJGLXFQYBTIFY-UHFFFAOYSA-N", "smiles": "c1ccc(c(c1)NC(=O)c2ccc(cc2)N3C=CC=CC3=O)S(=O)(=O)Nc4ccc(cn4)Cl"}], "num_ligs": 1, "name_ligs": ["FXA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "3cs7": {"describe_pdb": {"structureId": "3CS7", "title": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1H-pyrazolo[3,4-c]pyridin-7(4H)-one", "pubmedId": "18550370", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2276", "deposition_date": "2008-04-09", "release_date": "2008-07-08", "last_modification_date": "2011-07-13", "structure_authors": "Alexander, R.S.", "citation_authors": "Qiao, J.X., Cheney, D.L., Alexander, R.S., Smallwood, A.M., King, S.R., He, K., Rendina, A.R., Luettgen, J.M., Knabb, R.M., Wexler, R.R., Lam, P.Y.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "3cs7", "bioAssemblies": "1", "release_date": "Tue Jul 08 00:00:00 PDT 2008", "resolution": "2.20"}, "ligs": [{"@structureId": "3CS7", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3CS7", "@chemicalID": "LG0", "@type": "non-polymer", "@molecularWeight": "510.551", "chemicalName": "1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1H-pyrazolo[3,4-c]pyridin-7(4H)-one", "formula": "C28 H29 F3 N4 O2", "InChI": "InChI=1S/C28H29F3N4O2/c1-37-22-10-8-21(9-11-22)35-24-23(25(32-35)28(29,30)31)12-17-34(26(24)36)20-6-4-19(5-7-20)27(13-14-27)18-33-15-2-3-16-33/h4-11H,2-3,12-18H2,1H3", "InChIKey": "VNHRSGCBTKUBAX-UHFFFAOYSA-N", "smiles": "COc1ccc(cc1)n2c3c(c(n2)C(F)(F)F)CCN(C3=O)c4ccc(cc4)C5(CC5)CN6CCCC6"}], "num_ligs": 2, "name_ligs": ["CA", "LG0"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "3ens": {"describe_pdb": {"structureId": "3ENS", "title": "Crystal structure of human FXA in complex with methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyano-3-{[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate", "pubmedId": "18998662", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.30", "keywords": "HYDROLASE, BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "664", "nr_atoms": "5128", "deposition_date": "2008-09-25", "release_date": "2008-12-30", "last_modification_date": "2017-10-25", "structure_authors": "Klei, H.E.", "citation_authors": "Shi, Y., Sitkoff, D., Zhang, J., Klei, H.E., Kish, K., Liu, E.C., Hartl, K.S., Seiler, S.M., Chang, M., Huang, C., Youssef, S., Steinbacher, T.E., Schumacher, W.A., Grazier, N., Pudzianowski, A., Apedo, A., Discenza, L., Yanchunas, J., Stein, P.D., Atwal, K.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": [{"@id": "A"}, {"@id": "C"}]}, {"@id": "2", "@type": "protein", "Chain": [{"@id": "B"}, {"@id": "D"}]}], "structureId": "3ens", "bioAssemblies": "2", "release_date": "Tue Dec 30 00:00:00 PST 2008", "resolution": "2.30"}, "ligs": [{"@structureId": "3ENS", "@chemicalID": "ACT", "@type": "non-polymer", "@molecularWeight": "59.044", "chemicalName": "ACETATE ION", "formula": "C2 H3 O2 -1", "InChIKey": "QTBSBXVTEAMEQO-UHFFFAOYSA-M", "InChI": "InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1", "smiles": "CC(=O)[O-]"}, {"@structureId": "3ENS", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3ENS", "@chemicalID": "ENS", "@type": "non-polymer", "@molecularWeight": "512.989", "chemicalName": "methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyano-3-{[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate", "formula": "C25 H29 Cl N6 O4", "InChIKey": "QDGDCWKBZPDHTQ-UZXYXVAJSA-N", "InChI": "InChI=1S/C25H29ClN6O4/c1-36-25(35)17(13-27)23(29-19-9-6-7-16-18(26)14-28-22(16)19)30-20-8-2-3-12-32(24(20)34)15-21(33)31-10-4-5-11-31/h6-7,9,14,20,28-30H,2-5,8,10-12,15H2,1H3/b23-17+/t20-/m0/s1", "smiles": "COC(=O)C(=C(Nc1cccc2c1[nH]cc2Cl)N[C@H]3CCCCN(C3=O)CC(=O)N4CCCC4)C#N"}, {"@structureId": "3ENS", "@chemicalID": "GOL", "@type": "non-polymer", "@molecularWeight": "92.094", "chemicalName": "GLYCEROL", "formula": "C3 H8 O3", "InChIKey": "PEDCQBHIVMGVHV-UHFFFAOYSA-N", "InChI": "InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2", "smiles": "C(C(CO)O)O"}, {"@structureId": "3ENS", "@chemicalID": "MES", "@type": "non-polymer", "@molecularWeight": "195.237", "chemicalName": "2-(N-MORPHOLINO)-ETHANESULFONIC ACID", "formula": "C6 H13 N O4 S", "InChIKey": "SXGZJKUKBWWHRA-UHFFFAOYSA-N", "InChI": "InChI=1S/C6H13NO4S/c8-12(9,10)6-3-7-1-4-11-5-2-7/h1-6H2,(H,8,9,10)", "smiles": "C1COCC[NH+]1CCS(=O)(=O)[O-]"}, {"@structureId": "3ENS", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 6, "name_ligs": ["ACT", "CA", "ENS", "GOL", "MES", "NA"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLP----------------", "covertura": 48.77049180327869, "gaps": {"num_gaps": 2, "gap_lengths": [235, 17], "gap_list": [[1, 235], [473, 489]], "gap_window": [[1, 236], [472, 489]]}}, "3ffg": {"describe_pdb": {"structureId": "3FFG", "title": "Factor XA in complex with the inhibitor (R)-6-(2'-((3- HYDROXYPYRROLIDIN-1-YL)METHYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN- 7(4H)-ONE", "pubmedId": "20100660", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.54", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2288", "deposition_date": "2008-12-03", "release_date": "2009-12-08", "last_modification_date": "2011-07-13", "structure_authors": "Alexander, R.A.", "citation_authors": "Quan, M.L., Pinto, D.J., Rossi, K.A., Sheriff, S., Alexander, R.S., Amparo, E., Kish, K., Knabb, R.M., Luettgen, J.M., Morin, P., Smallwood, A., Woerner, F.J., Wexler, R.R.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "3ffg", "bioAssemblies": "1", "release_date": "Tue Dec 08 00:00:00 PST 2009", "resolution": "1.54"}, "ligs": [{"@structureId": "3FFG", "@chemicalID": "FFG", "@type": "non-polymer", "@molecularWeight": "615.605", "chemicalName": "(R)-6-(2'-((3-hydroxypyrrolidin-1-yl)methyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1h-pyrazolo[3,4-c]pyridin-7(4h)-one", "formula": "C32 H28 F3 N7 O3", "InChIKey": "YBWAYLVOTDFQQI-XMMPIXPASA-N", "InChI": "InChI=1S/C32H28F3N7O3/c33-32(34,35)28-26-13-15-41(30(44)27(26)42(39-28)23-6-3-5-20(16-23)29-36-31(45)38-37-29)22-10-8-19(9-11-22)25-7-2-1-4-21(25)17-40-14-12-24(43)18-40/h1-11,16,24,43H,12-15,17-18H2,(H2,36,37,38,45)/t24-/m1/s1", "smiles": "c1ccc(c(c1)C[N@@]2CC[C@H](C2)O)c3ccc(cc3)N4CCc5c(n(nc5C(F)(F)F)c6cccc(c6)C7=NNC(=O)N7)C4=O"}], "num_ligs": 1, "name_ligs": ["FFG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "3hpt": {"describe_pdb": {"structureId": "3HPT", "title": "Crystal structure of human FxA in complex with (S)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine", "pubmedId": "19541481", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.19", "keywords": "HYDROLASE, BLOOD CLOTTING", "nr_entities": "2", "nr_residues": "664", "nr_atoms": "5129", "deposition_date": "2009-06-04", "release_date": "2009-11-17", "last_modification_date": "2017-11-01", "structure_authors": "Klei, H.E., Ghosh, K., Rushith, A., Kish, K.", "citation_authors": "Shi, Y., Zhang, J., Shi, M., O'Connor, S.P., Bisaha, S.N., Li, C., Sitkoff, D., Pudzianowski, A.T., Chong, S., Klei, H.E., Kish, K., Yanchunas, J., Liu, E.C., Hartl, K.S., Seiler, S.M., Steinbacher, T.E., Schumacher, W.A., Atwal, K.S., Stein, P.D.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": [{"@id": "A"}, {"@id": "C"}]}, {"@id": "2", "@type": "protein", "Chain": [{"@id": "B"}, {"@id": "D"}]}], "structureId": "3hpt", "bioAssemblies": "2", "release_date": "Tue Nov 17 00:00:00 PST 2009", "resolution": "2.19"}, "ligs": [{"@structureId": "3HPT", "@chemicalID": "ACT", "@type": "non-polymer", "@molecularWeight": "59.044", "chemicalName": "ACETATE ION", "formula": "C2 H3 O2 -1", "InChIKey": "QTBSBXVTEAMEQO-UHFFFAOYSA-M", "InChI": "InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1", "smiles": "CC(=O)[O-]"}, {"@structureId": "3HPT", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3HPT", "@chemicalID": "DMS", "@type": "non-polymer", "@molecularWeight": "78.133", "chemicalName": "DIMETHYL SULFOXIDE", "formula": "C2 H6 O S", "InChIKey": "IAZDPXIOMUYVGZ-UHFFFAOYSA-N", "InChI": "InChI=1S/C2H6OS/c1-4(2)3/h1-2H3", "smiles": "CS(=O)C"}, {"@structureId": "3HPT", "@chemicalID": "GOL", "@type": "non-polymer", "@molecularWeight": "92.094", "chemicalName": "GLYCEROL", "formula": "C3 H8 O3", "InChIKey": "PEDCQBHIVMGVHV-UHFFFAOYSA-N", "InChI": "InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2", "smiles": "C(C(CO)O)O"}, {"@structureId": "3HPT", "@chemicalID": "MES", "@type": "non-polymer", "@molecularWeight": "195.237", "chemicalName": "2-(N-MORPHOLINO)-ETHANESULFONIC ACID", "formula": "C6 H13 N O4 S", "InChIKey": "SXGZJKUKBWWHRA-UHFFFAOYSA-N", "InChI": "InChI=1S/C6H13NO4S/c8-12(9,10)6-3-7-1-4-11-5-2-7/h1-6H2,(H,8,9,10)", "smiles": "C1COCC[NH+]1CCS(=O)(=O)[O-]"}, {"@structureId": "3HPT", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}, {"@structureId": "3HPT", "@chemicalID": "YET", "@type": "non-polymer", "@molecularWeight": "436.507", "chemicalName": "1-cyano-2-(2-methyl-1-benzofuran-5-yl)-3-[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]guanidine", "formula": "C23 H28 N6 O3", "InChI": "InChI=1S/C23H28N6O3/c1-16-12-17-13-18(7-8-20(17)32-16)26-23(25-15-24)27-19-6-2-3-11-29(22(19)31)14-21(30)28-9-4-5-10-28/h7-8,12-13,19H,2-6,9-11,14H2,1H3,(H2,25,26,27)/t19-/m0/s1", "InChIKey": "BQUXAJWDRCSKFN-IBGZPJMESA-N", "smiles": "Cc1cc2cc(ccc2o1)/N=C(/NC#N)\\N[C@H]3CCCCN(C3=O)CC(=O)N4CCCC4"}], "num_ligs": 7, "name_ligs": ["ACT", "CA", "DMS", "GOL", "MES", "NA", "YET"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLP----------------", "covertura": 48.77049180327869, "gaps": {"num_gaps": 2, "gap_lengths": [235, 17], "gap_list": [[1, 235], [473, 489]], "gap_window": [[1, 236], [472, 489]]}}, "3iit": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1v3x", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "1wu1", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "2d1j", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "2EI6", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "2EI7", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}, {"@pdbId": "2EI8", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED INHIBITOR"}], "structureId": "3IIT", "title": "Factor XA in complex with a cis-1,2-diaminocyclohexane derivative", "pubmedId": "19900814", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.80", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "287", "nr_atoms": "2206", "deposition_date": "2009-08-03", "release_date": "2010-08-04", "last_modification_date": "2011-07-13", "structure_authors": "Suzuki, M.", "citation_authors": "Yoshikawa, K., Kobayashi, S., Nakamoto, Y., Haginoya, N., Komoriya, S., Yoshino, T., Nagata, T., Mochizuki, A., Watanabe, K., Suzuki, M., Kanno, H., Ohta, T.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "3iit", "bioAssemblies": "1", "release_date": "Wed Aug 04 00:00:00 PDT 2010", "resolution": "1.80"}, "ligs": [{"@structureId": "3IIT", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3IIT", "@chemicalID": "D14", "@type": "non-polymer", "@molecularWeight": "541.065", "chemicalName": "7-chloro-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{[(5-methyl-5,6-dihydro-4H-pyrrolo[3,4-d][1,3]thiazol-2-yl)carbonyl]amino}cyclohexyl]isoquinoline-3-carboxamide", "formula": "C26 H29 Cl N6 O3 S", "InChIKey": "GZCKMZURFJCTJE-ZYSHUDEJSA-N", "InChI": "InChI=1S/C26H29ClN6O3S/c1-32(2)26(36)15-5-7-18(29-23(34)20-9-14-4-6-17(27)8-16(14)11-28-20)19(10-15)30-24(35)25-31-21-12-33(3)13-22(21)37-25/h4,6,8-9,11,15,18-19H,5,7,10,12-13H2,1-3H3,(H,29,34)(H,30,35)/t15-,18-,19+/m0/s1", "smiles": "C[N@@]1Cc2c(sc(n2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)c4cc5ccc(cc5cn4)Cl)C(=O)N(C)C)C1"}], "num_ligs": 2, "name_ligs": ["CA", "D14"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "3k9x": {"describe_pdb": {"relatedPDB": {"@pdbId": "3ECN", "@details": "X-ray crystal structure of human FXA in complex with    (S,E)-METHYL 3-(3-CHLORO-1H-INDOL-7-YLAMINO)-2-CYANO-3-(2-OXO-1-(    2-OXO-2-(PYRROLIDIN-1-YL)ETHYL)AZEPAN-3-YLAMINO)ACRYLATE"}, "structureId": "3K9X", "title": "X-ray crystal structure of human fxa in complex with (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-(2-OXO-2- (PYRROLIDIN-1-YL)ETHYL)AZEPAN-3- YLAMINO)METHYLENE)NICOTINAMIDE", "pubmedId": "19896847", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.90", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "664", "nr_atoms": "5072", "deposition_date": "2009-10-16", "release_date": "2009-12-15", "last_modification_date": "2017-11-01", "structure_authors": "Klei, H.E., Kish, K., Ghosh, K., Rushith, A.", "citation_authors": "Shi, Y., Li, C., O'Connor, S.P., Zhang, J., Shi, M., Bisaha, S.N., Wang, Y., Sitkoff, D., Pudzianowski, A.T., Huang, C., Klei, H.E., Kish, K., Yanchunas, J., Liu, E.C., Hartl, K.S., Seiler, S.M., Steinbacher, T.E., Schumacher, W.A., Atwal, K.S., Stein, P.D.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": [{"@id": "A"}, {"@id": "C"}]}, {"@id": "2", "@type": "protein", "Chain": [{"@id": "B"}, {"@id": "D"}]}], "structureId": "3k9x", "bioAssemblies": "2", "release_date": "Tue Dec 15 00:00:00 PST 2009", "resolution": "1.90"}, "ligs": [{"@structureId": "3K9X", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3K9X", "@chemicalID": "GOL", "@type": "non-polymer", "@molecularWeight": "92.094", "chemicalName": "GLYCEROL", "formula": "C3 H8 O3", "InChIKey": "PEDCQBHIVMGVHV-UHFFFAOYSA-N", "InChI": "InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2", "smiles": "C(C(CO)O)O"}, {"@structureId": "3K9X", "@chemicalID": "MBM", "@type": "non-polymer", "@molecularWeight": "516.591", "chemicalName": "N-{N'-(2-methyl-1-benzofuran-5-yl)-N-[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]carbamimidoyl}pyridine-3-carboxamide", "formula": "C28 H32 N6 O4", "InChI": "InChI=1S/C28H32N6O4/c1-19-15-21-16-22(9-10-24(21)38-19)30-28(32-26(36)20-7-6-11-29-17-20)31-23-8-2-3-14-34(27(23)37)18-25(35)33-12-4-5-13-33/h6-7,9-11,15-17,23H,2-5,8,12-14,18H2,1H3,(H2,30,31,32,36)/t23-/m0/s1", "InChIKey": "GNYXHJVKEWBHAI-QHCPKHFHSA-N", "smiles": "Cc1cc2cc(ccc2o1)/N=C(\\N[C@H]3CCCCN(C3=O)CC(=O)N4CCCC4)/NC(=O)c5cccnc5"}, {"@structureId": "3K9X", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 4, "name_ligs": ["CA", "GOL", "MBM", "NA"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLP----------------", "covertura": 48.77049180327869, "gaps": {"num_gaps": 2, "gap_lengths": [235, 17], "gap_list": [[1, 235], [473, 489]], "gap_window": [[1, 236], [472, 489]]}}, "3kl6": {"describe_pdb": {"structureId": "3KL6", "title": "Discovery of Tetrahydropyrimidin-2(1H)-one derivative TAK-442: A potent, selective and orally active factor Xa inhibitor", "pubmedId": "20355714", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.45", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "298", "nr_atoms": "2254", "deposition_date": "2009-11-06", "release_date": "2009-12-01", "last_modification_date": "2013-04-24", "structure_authors": "Aertgeerts, K.", "citation_authors": "Fujimoto, T., Imaeda, Y., Konishi, N., Hiroe, K., Kawamura, M., Textor, G.P., Aertgeerts, K., Kubo, K.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "3kl6", "bioAssemblies": "1", "release_date": "Tue Dec 01 00:00:00 PST 2009", "resolution": "1.45"}, "ligs": [{"@structureId": "3KL6", "@chemicalID": "443", "@type": "non-polymer", "@molecularWeight": "479.977", "chemicalName": "1-(1-{(2S)-3-[(6-chloronaphthalen-2-yl)sulfonyl]-2-hydroxypropanoyl}piperidin-4-yl)tetrahydropyrimidin-2(1H)-one", "formula": "C22 H26 Cl N3 O5 S", "InChIKey": "GEHAEMCVKDPMKO-HXUWFJFHSA-N", "InChI": "InChI=1S/C22H26ClN3O5S/c23-17-4-2-16-13-19(5-3-15(16)12-17)32(30,31)14-20(27)21(28)25-10-6-18(7-11-25)26-9-1-8-24-22(26)29/h2-5,12-13,18,20,27H,1,6-11,14H2,(H,24,29)/t20-/m1/s1", "smiles": "c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)C[C@H](C(=O)N3CCC(CC3)N4CCCNC4=O)O"}, {"@structureId": "3KL6", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3KL6", "@chemicalID": "EDO", "@type": "non-polymer", "@molecularWeight": "62.068", "chemicalName": "1,2-ETHANEDIOL", "formula": "C2 H6 O2", "InChIKey": "LYCAIKOWRPUZTN-UHFFFAOYSA-N", "InChI": "InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2", "smiles": "C(CO)O"}], "num_ligs": 3, "name_ligs": ["443", "CA", "EDO"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM----------------------", "covertura": 47.540983606557376, "gaps": {"num_gaps": 2, "gap_lengths": [235, 23], "gap_list": [[1, 235], [467, 489]], "gap_window": [[1, 236], [466, 489]]}}, "3kqb": {"describe_pdb": {"relatedPDB": [{"@pdbId": "3KQC", "@details": ""}, {"@pdbId": "3KQD", "@details": ""}, {"@pdbId": "3KQE", "@details": ""}], "structureId": "3KQB", "title": "Factor xa in complex with the inhibitor n-(3-fluoro-2'- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h- 1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-1h- pyrazole-5-carboxamide", "pubmedId": "20100660", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.25", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2260", "deposition_date": "2009-11-17", "release_date": "2010-02-23", "last_modification_date": "2019-07-17", "structure_authors": "Sheriff, S.", "citation_authors": "Quan, M.L., Pinto, D.J., Rossi, K.A., Sheriff, S., Alexander, R.S., Amparo, E., Kish, K., Knabb, R.M., Luettgen, J.M., Morin, P., Smallwood, A., Woerner, F.J., Wexler, R.R.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "3kqb", "bioAssemblies": "1", "release_date": "Tue Feb 23 00:00:00 PST 2010", "resolution": "2.25"}, "ligs": [{"@structureId": "3KQB", "@chemicalID": "LGJ", "@type": "non-polymer", "@molecularWeight": "586.518", "chemicalName": "N-(3-FLUORO-2'-(METHYLSULFONYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE", "formula": "C26 H18 F4 N6 O4 S", "InChIKey": "YIHPFOJBRPDMES-UHFFFAOYSA-N", "InChI": "InChI=1S/C26H18F4N6O4S/c1-41(39,40)21-8-3-2-7-17(21)14-9-10-19(18(27)12-14)31-24(37)20-13-22(26(28,29)30)35-36(20)16-6-4-5-15(11-16)23-32-25(38)34-33-23/h2-13H,1H3,(H,31,37)(H2,32,33,34,38)", "smiles": "CS(=O)(=O)c1ccccc1c2ccc(c(c2)F)NC(=O)c3cc(nn3c4cccc(c4)C5=NNC(=O)N5)C(F)(F)F"}, {"@structureId": "3KQB", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 2, "name_ligs": ["LGJ", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "3kqc": {"describe_pdb": {"relatedPDB": [{"@pdbId": "3KQB", "@details": ""}, {"@pdbId": "3KQD", "@details": ""}, {"@pdbId": "3KQE", "@details": ""}], "structureId": "3KQC", "title": "Factor xa in complex with the inhibitor 6-(2'- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h- 1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-5,6- dihydro-1h-pyrazolo[3,4-c]pyridin-7(4h)-one", "pubmedId": "20100660", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2256", "deposition_date": "2009-11-17", "release_date": "2010-02-23", "last_modification_date": "2019-07-17", "structure_authors": "Sheriff, S.", "citation_authors": "Quan, M.L., Pinto, D.J., Rossi, K.A., Sheriff, S., Alexander, R.S., Amparo, E., Kish, K., Knabb, R.M., Luettgen, J.M., Morin, P., Smallwood, A., Woerner, F.J., Wexler, R.R.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "3kqc", "bioAssemblies": "1", "release_date": "Tue Feb 23 00:00:00 PST 2010", "resolution": "2.20"}, "ligs": [{"@structureId": "3KQC", "@chemicalID": "LGK", "@type": "non-polymer", "@molecularWeight": "594.564", "chemicalName": "6-(2'-(METHYLSULFONYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE", "formula": "C28 H21 F3 N6 O4 S", "InChIKey": "LOIQROHBNJYIKB-UHFFFAOYSA-N", "InChI": "InChI=1S/C28H21F3N6O4S/c1-42(40,41)22-8-3-2-7-20(22)16-9-11-18(12-10-16)36-14-13-21-23(26(36)38)37(35-24(21)28(29,30)31)19-6-4-5-17(15-19)25-32-27(39)34-33-25/h2-12,15H,13-14H2,1H3,(H2,32,33,34,39)", "smiles": "CS(=O)(=O)c1ccccc1c2ccc(cc2)N3CCc4c(n(nc4C(F)(F)F)c5cccc(c5)C6=NNC(=O)N6)C3=O"}, {"@structureId": "3KQC", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 2, "name_ligs": ["LGK", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "3kqd": {"describe_pdb": {"relatedPDB": [{"@pdbId": "3KQB", "@details": ""}, {"@pdbId": "3KQC", "@details": ""}, {"@pdbId": "3KQE", "@details": ""}], "structureId": "3KQD", "title": "Factor xa in complex with the inhibitor 1-(3-(5-oxo-4,5- dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2'-(pyrrolidin-1- ylmethyl)biphenyl-4-yl)-3-(trifluoromethyl)-5,6-dihydro- 1h-pyrazolo[3,4-c]pyridin-7(4h)-one", "pubmedId": "20100660", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.75", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2266", "deposition_date": "2009-11-17", "release_date": "2010-02-23", "last_modification_date": "2019-07-17", "structure_authors": "Sheriff, S.", "citation_authors": "Quan, M.L., Pinto, D.J., Rossi, K.A., Sheriff, S., Alexander, R.S., Amparo, E., Kish, K., Knabb, R.M., Luettgen, J.M., Morin, P., Smallwood, A., Woerner, F.J., Wexler, R.R.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "3kqd", "bioAssemblies": "1", "release_date": "Tue Feb 23 00:00:00 PST 2010", "resolution": "2.75"}, "ligs": [{"@structureId": "3KQD", "@chemicalID": "LGL", "@type": "non-polymer", "@molecularWeight": "599.606", "chemicalName": "1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-6-(2'-(PYRROLIDIN-1-YLMETHYL)BIPHENYL-4-YL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE", "formula": "C32 H28 F3 N7 O2", "InChIKey": "QNPOXJFBWDKXGC-UHFFFAOYSA-N", "InChI": "InChI=1S/C32H28F3N7O2/c33-32(34,35)28-26-14-17-41(23-12-10-20(11-13-23)25-9-2-1-6-22(25)19-40-15-3-4-16-40)30(43)27(26)42(39-28)24-8-5-7-21(18-24)29-36-31(44)38-37-29/h1-2,5-13,18H,3-4,14-17,19H2,(H2,36,37,38,44)", "smiles": "c1ccc(c(c1)CN2CCCC2)c3ccc(cc3)N4CCc5c(n(nc5C(F)(F)F)c6cccc(c6)C7=NNC(=O)N7)C4=O"}, {"@structureId": "3KQD", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 2, "name_ligs": ["LGL", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "3kqe": {"describe_pdb": {"relatedPDB": [{"@pdbId": "3KQB", "@details": ""}, {"@pdbId": "3KQC", "@details": ""}, {"@pdbId": "3KQD", "@details": ""}], "structureId": "3KQE", "title": "Factor xa in complex with the inhibitor 3-methyl-1-(3-(5- oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2'- (pyrrolidin-1-ylmethyl)biphenyl-4-yl)-5,6-dihydro-1h- pyrazolo[3,4-c]pyridin-7(4h)-one", "pubmedId": "20100660", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.35", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2267", "deposition_date": "2009-11-17", "release_date": "2010-02-23", "last_modification_date": "2019-07-17", "structure_authors": "Sheriff, S.", "citation_authors": "Quan, M.L., Pinto, D.J., Rossi, K.A., Sheriff, S., Alexander, R.S., Amparo, E., Kish, K., Knabb, R.M., Luettgen, J.M., Morin, P., Smallwood, A., Woerner, F.J., Wexler, R.R.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "3kqe", "bioAssemblies": "1", "release_date": "Tue Feb 23 00:00:00 PST 2010", "resolution": "2.35"}, "ligs": [{"@structureId": "3KQE", "@chemicalID": "LGM", "@type": "non-polymer", "@molecularWeight": "545.634", "chemicalName": "3-METHYL-1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-6-(2'-(PYRROLIDIN-1-YLMETHYL)BIPHENYL-4-YL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE", "formula": "C32 H31 N7 O2", "InChI": "InChI=1S/C32H31N7O2/c1-21-27-15-18-38(25-13-11-22(12-14-25)28-10-3-2-7-24(28)20-37-16-4-5-17-37)31(40)29(27)39(36-21)26-9-6-8-23(19-26)30-33-32(41)35-34-30/h2-3,6-14,19H,4-5,15-18,20H2,1H3,(H2,33,34,35,41)", "InChIKey": "DBOPERRYUICVTA-UHFFFAOYSA-N", "smiles": "Cc1c2c(n(n1)c3cccc(c3)C4=NNC(=O)N4)C(=O)N(CC2)c5ccc(cc5)c6ccccc6CN7CCCC7"}, {"@structureId": "3KQE", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 2, "name_ligs": ["LGM", "NA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "3liw": {"describe_pdb": {"structureId": "3LIW", "title": "Factor XA in complex with (R)-2-(1-ADAMANTYLCARBAMOYLAMINO)-3-(3-CARBAMIDOYL-PHENYL)-N-PHENETHYL-PROPIONIC ACID AMIDE", "pubmedId": "12437104", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.22", "replaces": "1KYE", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2263", "deposition_date": "2010-01-25", "release_date": "2010-04-07", "last_modification_date": "2011-07-13", "structure_authors": "Mueller, M.M., Sperl, S., Sturzebecher, J., Bode, W., Moroder, L.", "citation_authors": "Mueller, M.M., Sperl, S., Sturzebecher, J., Bode, W., Moroder, L.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "3liw", "bioAssemblies": "1", "release_date": "Wed Apr 07 00:00:00 PDT 2010", "resolution": "2.22"}, "ligs": [{"@structureId": "3LIW", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3LIW", "@chemicalID": "RUP", "@type": "non-polymer", "@molecularWeight": "487.636", "chemicalName": "(R)-2-(3-ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL-PHENYL)-N-PHENETHYL-PROPIONAMIDE", "formula": "C29 H37 N5 O2", "InChI": "InChI=1S/C29H37N5O2/c30-26(31)24-8-4-7-20(14-24)15-25(27(35)32-10-9-19-5-2-1-3-6-19)33-28(36)34-29-16-21-11-22(17-29)13-23(12-21)18-29/h1-8,14,21-23,25H,9-13,15-18H2,(H3,30,31)(H,32,35)(H2,33,34,36)/t21-,22+,23-,25-,29-/m1/s1", "InChIKey": "QYKLXCYULDLMPX-ZEFMGYOLSA-N", "smiles": "c1ccc(cc1)CCNC(=O)[C@@H](Cc2cccc(c2)C(=N)N)NC(=O)NC34CC5CC(C3)CC(C5)C4"}], "num_ligs": 2, "name_ligs": ["CA", "RUP"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "3m36": {"describe_pdb": {"relatedPDB": [{"@pdbId": "3M35", "@details": ""}, {"@pdbId": "3M37", "@details": ""}], "structureId": "3M36", "title": "Factor XA in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423)", "pubmedId": "14640539", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.15", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2276", "deposition_date": "2010-03-08", "release_date": "2010-04-21", "last_modification_date": "2011-07-13", "structure_authors": "Alexander, R.S.", "citation_authors": "Pruitt, J.R., Pinto, D.J.P., Galemmo, R.A.Jr., Alexander, R.S., Rossi, K.A., Wells, B.L., Drummond, S., Bostrom, L.L., Burdick, D., Bruckner, R., Chen, H., Smallwood, A., Wong, P.C., Wright, M.R., Bai, S., Luettgen, J.M., Knabb, R.M., Lam, P.Y.S., Wexler, R.R.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "3m36", "bioAssemblies": "1", "release_date": "Wed Apr 21 00:00:00 PDT 2010", "resolution": "2.15"}, "ligs": [{"@structureId": "3M36", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3M36", "@chemicalID": "M35", "@type": "non-polymer", "@molecularWeight": "532.51", "chemicalName": "1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide", "formula": "C25 H20 F4 N4 O3 S", "InChI": "InChI=1S/C25H20F4N4O3S/c1-37(35,36)22-8-3-2-7-18(22)16-9-10-20(19(26)12-16)31-24(34)21-13-23(25(27,28)29)32-33(21)17-6-4-5-15(11-17)14-30/h2-13H,14,30H2,1H3,(H,31,34)", "InChIKey": "ZLUOAFAJSUPHOG-UHFFFAOYSA-N", "smiles": "CS(=O)(=O)c1ccccc1c2ccc(c(c2)F)NC(=O)c3cc(nn3c4cccc(c4)CN)C(F)(F)F"}], "num_ligs": 2, "name_ligs": ["CA", "M35"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "3m37": {"describe_pdb": {"relatedPDB": [{"@pdbId": "3M35", "@details": ""}, {"@pdbId": "3M36", "@details": ""}], "structureId": "3M37", "title": "Factor XA in complex with the inhibitor 1-[2-(aminomethyl)phenyl]-N-(3-fluoro-2'-sulfamoylbiphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC602)", "pubmedId": "14640539", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.90", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "286", "nr_atoms": "2276", "deposition_date": "2010-03-08", "release_date": "2010-04-21", "last_modification_date": "2011-07-13", "structure_authors": "Alexander, R.S.", "citation_authors": "Pruitt, J.R., Pinto, D.J.P., Galemmo, R.A.Jr., Alexander, R.S., Rossi, K.A., Wells, B.L., Drummond, S., Bostrom, L.L., Burdick, D., Bruckner, R., Chen, H., Smallwood, A., Wong, P.C., Wright, M.R., Bai, S., Luettgen, J.M., Knabb, R.M., Lam, P.Y.S., Wexler, R.R.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}], "structureId": "3m37", "bioAssemblies": "1", "release_date": "Wed Apr 21 00:00:00 PDT 2010", "resolution": "1.90"}, "ligs": [{"@structureId": "3M37", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3M37", "@chemicalID": "M37", "@type": "non-polymer", "@molecularWeight": "533.498", "chemicalName": "1-[2-(aminomethyl)phenyl]-N-(3-fluoro-2'-sulfamoylbiphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide", "formula": "C24 H19 F4 N5 O3 S", "InChI": "InChI=1S/C24H19F4N5O3S/c25-17-11-14(16-6-2-4-8-21(16)37(30,35)36)9-10-18(17)31-23(34)20-12-22(24(26,27)28)32-33(20)19-7-3-1-5-15(19)13-29/h1-12H,13,29H2,(H,31,34)(H2,30,35,36)", "InChIKey": "TYPXEIGMGZWOGB-UHFFFAOYSA-N", "smiles": "c1ccc(c(c1)CN)n2c(cc(n2)C(F)(F)F)C(=O)Nc3ccc(cc3F)c4ccccc4S(=O)(=O)N"}], "num_ligs": 2, "name_ligs": ["CA", "M37"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "3q3k": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1V3X", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED inhibitor"}, {"@pdbId": "1WU1", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED inhibitor"}, {"@pdbId": "2EI6", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED inhibitor"}, {"@pdbId": "2EI7", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED inhibitor"}, {"@pdbId": "2EI8", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED inhibitor"}, {"@pdbId": "3IIT", "@details": "THE SAME PROTEIN COMPLEXED WITH STRUCTURALLY RELATED inhibitor"}], "structureId": "3Q3K", "title": "Factor Xa in complex with a phenylenediamine derivative", "pubmedId": "21345673", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.00", "keywords": "hydrolase/hydrolase inhibitor", "nr_entities": "2", "nr_residues": "287", "nr_atoms": "2169", "deposition_date": "2010-12-22", "release_date": "2011-12-28", "last_modification_date": "2012-06-20", "structure_authors": "Suzuki, M., Imai, E.", "citation_authors": "Yoshikawa, K., Yoshino, T., Yokomizo, Y., Uoto, K., Naito, H., Kawakami, K., Mochizuki, A., Nagata, T., Suzuki, M., Kanno, H., Takemura, M., Ohta, T.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "3q3k", "bioAssemblies": "1", "release_date": "Wed Dec 28 00:00:00 PST 2011", "resolution": "2.00"}, "ligs": [{"@structureId": "3Q3K", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3Q3K", "@chemicalID": "D90", "@type": "non-polymer", "@molecularWeight": "465.955", "chemicalName": "N-(2-{[(5-chloro-1H-indol-2-yl)carbonyl]amino}phenyl)-5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamide", "formula": "C23 H20 Cl N5 O2 S", "InChIKey": "HLZHKMHNSZRIOD-UHFFFAOYSA-N", "InChI": "InChI=1S/C23H20ClN5O2S/c1-29-9-8-18-20(12-29)32-23(28-18)22(31)27-17-5-3-2-4-16(17)26-21(30)19-11-13-10-14(24)6-7-15(13)25-19/h2-7,10-11,25H,8-9,12H2,1H3,(H,26,30)(H,27,31)", "smiles": "C[N@@]1CCc2c(sc(n2)C(=O)Nc3ccccc3NC(=O)c4cc5cc(ccc5[nH]4)Cl)C1"}], "num_ligs": 2, "name_ligs": ["CA", "D90"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "3sw2": {"describe_pdb": {"relatedPDB": [{"@pdbId": "3ENS", "@details": "X-ray crystal structure of human FXA in complex with methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyano-3-{[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate"}, {"@pdbId": "3HPT", "@details": "X-ray crystal structure of human FXA in complex with (S)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine"}, {"@pdbId": "3K9X", "@details": "X-ray crystal structure of human FXA in complex with (S)-N-((2-methylbenzofuran-5-ylamino)(2-oxo-1-(2-oxo-2- (pyrrolidin-1-yl)ethyl)azepan-3-ylamino)methylene)nicotinamide"}], "structureId": "3SW2", "title": "X-ray crystal structure of human FXA in complex with 6-chloro-N-((3S)-2-oxo-1-(2-oxo-2-((5S)-8-oxo-5,6-dihydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2H,4H,8H)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide", "pubmedId": "22041058", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.42", "keywords": "HYDROLASE/HYDROLASE INHIBITOR", "nr_entities": "2", "nr_residues": "332", "nr_atoms": "2200", "deposition_date": "2011-07-13", "release_date": "2011-11-16", "last_modification_date": "2011-12-07", "structure_authors": "Klei, H.E.", "citation_authors": "Shi, Y., O'Connor, S.P., Sitkoff, D., Zhang, J., Shi, M., Bisaha, S.N., Wang, Y., Li, C., Ruan, Z., Michael Lawrence, R., Klei, H.E., Kish, K., Liu, E.C., Seiler, S.M., Schweizer, L., Steinbacher, T.E., Schumacher, W.A., Robl, J.A., Macor, J.E., Atwal, K.S., Stein, P.D.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "3sw2", "bioAssemblies": "1", "release_date": "Wed Nov 16 00:00:00 PST 2011", "resolution": "2.42"}, "ligs": [{"@structureId": "3SW2", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3SW2", "@chemicalID": "FI1", "@type": "non-polymer", "@molecularWeight": "569.072", "chemicalName": "6-chloro-N-((3S)-2-oxo-1-(2-oxo-2-((5S)-8-oxo-5,6-dihydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2H,4H,8H)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide", "formula": "C28 H29 Cl N4 O5 S", "InChIKey": "FLGSVBQCPOVGER-VNZMSGEBSA-N", "InChI": "InChI=1S/C28H29ClN4O5S/c29-22-8-6-20-13-23(9-7-19(20)12-22)39(37,38)30-24-3-2-10-31(28(24)36)17-27(35)32-14-18-11-21(16-32)25-4-1-5-26(34)33(25)15-18/h1,4-9,12-13,18,21,24,30H,2-3,10-11,14-17H2/t18-,21+,24-/m0/s1", "smiles": "c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)N[C@H]3CCCN(C3=O)CC(=O)N4C[C@@H]5C[C@H](C4)C6=CC=CC(=O)N6C5"}, {"@structureId": "3SW2", "@chemicalID": "GOL", "@type": "non-polymer", "@molecularWeight": "92.094", "chemicalName": "GLYCEROL", "formula": "C3 H8 O3", "InChIKey": "PEDCQBHIVMGVHV-UHFFFAOYSA-N", "InChI": "InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2", "smiles": "C(C(CO)O)O"}, {"@structureId": "3SW2", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}], "num_ligs": 4, "name_ligs": ["CA", "FI1", "GOL", "NA"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "3tk5": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1V3X", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "1WU1", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "2D1J", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "2EI6", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "2EI7", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "2EI8", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "3TK6", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}], "structureId": "3TK5", "title": "Factor Xa in complex with D102-4380", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE/HYDROLASE INHIBITOR", "nr_entities": "2", "nr_residues": "287", "nr_atoms": "2216", "deposition_date": "2011-08-25", "release_date": "2012-08-29", "last_modification_date": "2017-11-08", "structure_authors": "Suzuki, M., Mochizuki, A., Nagata, T., Takano, H., Kanno, H., Kishida, M., Ohta, T.", "citation_authors": "Mochizuki, A., Nagata, T., Takano, H., Kanno, H., Kishida, M., Suzuki, M., Ohta, T.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "3tk5", "bioAssemblies": "1", "release_date": "Wed Aug 29 00:00:00 PDT 2012", "resolution": "2.20"}, "ligs": [{"@structureId": "3TK5", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3TK5", "@chemicalID": "D1Q", "@type": "non-polymer", "@molecularWeight": "527.035", "chemicalName": "4-{3-[(4-chlorophenyl)amino]-3-oxopropyl}-3-({[5-(propan-2-yl)-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl]carbonyl}amino)benzoic acid", "formula": "C26 H27 Cl N4 O4 S", "InChIKey": "FQNIFNHOEQFSHE-UHFFFAOYSA-N", "InChI": "InChI=1S/C26H27ClN4O4S/c1-15(2)31-12-11-20-22(14-31)36-25(30-20)24(33)29-21-13-17(26(34)35)4-3-16(21)5-10-23(32)28-19-8-6-18(27)7-9-19/h3-4,6-9,13,15H,5,10-12,14H2,1-2H3,(H,28,32)(H,29,33)(H,34,35)", "smiles": "CC(C)[N@@]1CCc2c(sc(n2)C(=O)Nc3cc(ccc3CCC(=O)Nc4ccc(cc4)Cl)C(=O)O)C1"}], "num_ligs": 2, "name_ligs": ["CA", "D1Q"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "3tk6": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1V3X", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "1WU1", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "2D1J", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "2EI6", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "2EI7", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "2EI8", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}, {"@pdbId": "3TK5", "@details": "THE SAME PROTEIN COMPLEXED WITH RELATED compound"}], "structureId": "3TK6", "title": "factor Xa in complex with D46-5241", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.80", "keywords": "HYDROLASE/HYDROLASE INHIBITOR", "nr_entities": "2", "nr_residues": "287", "nr_atoms": "2222", "deposition_date": "2011-08-25", "release_date": "2012-08-29", "last_modification_date": "2017-11-08", "structure_authors": "Suzuki, M., Mochizuki, A., Nagata, T., Takano, H., Kanno, H., Kishida, M., Ohta, T.", "citation_authors": "Mochizuki, A., Nagata, T., Takano, H., Kanno, H., Kishida, M., Suzuki, M., Ohta, T.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "3tk6", "bioAssemblies": "1", "release_date": "Wed Aug 29 00:00:00 PDT 2012", "resolution": "1.80"}, "ligs": [{"@structureId": "3TK6", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "3TK6", "@chemicalID": "D46", "@type": "non-polymer", "@molecularWeight": "446.973", "chemicalName": "N-[2-({[(5-chlorothiophen-2-yl)carbonyl]amino}methyl)phenyl]-5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamide", "formula": "C20 H19 Cl N4 O2 S2", "InChIKey": "LMUFNFLXBDOGET-UHFFFAOYSA-N", "InChI": "InChI=1S/C20H19ClN4O2S2/c1-25-9-8-14-16(11-25)29-20(24-14)19(27)23-13-5-3-2-4-12(13)10-22-18(26)15-6-7-17(21)28-15/h2-7H,8-11H2,1H3,(H,22,26)(H,23,27)", "smiles": "C[N@@]1CCc2c(sc(n2)C(=O)Nc3ccccc3CNC(=O)c4ccc(s4)Cl)C1"}], "num_ligs": 2, "name_ligs": ["CA", "D46"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.74590163934426, "gaps": {"num_gaps": 2, "gap_lengths": [235, 22], "gap_list": [[1, 235], [467, 488]], "gap_window": [[1, 236], [466, 488]]}}, "4a7i": {"describe_pdb": {"relatedPDB": [{"@pdbId": "1C5M", "@details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"@pdbId": "1EZQ", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"@pdbId": "1F0R", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"@pdbId": "1F0S", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"@pdbId": "1FAX", "@details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1FJS", "@details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031 )COMPLEXED WITH FACTOR XA"}, {"@pdbId": "1G2L", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1G2M", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "1HCG", "@details": "BLOOD COAGULATION FACTOR XA"}, {"@pdbId": "1IOE", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"@pdbId": "1IQE", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"@pdbId": "1IQF", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"@pdbId": "1IQG", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"@pdbId": "1IQH", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"@pdbId": "1IQI", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"@pdbId": "1IQJ", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"@pdbId": "1IQK", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"@pdbId": "1IQL", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}, {"@pdbId": "1IQM", "@details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"@pdbId": "1IQN", "@details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"@pdbId": "1KSN", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"@pdbId": "1KYE", "@details": "FACTOR XA IN COMPLEX WITH (R)-2-(3-ADAMANTAN-1-YL -UREIDO)-3-(3-CARBAMIMIDOYL-PHENYL)-N-PHENETHYL- PROPIONAMIDE"}, {"@pdbId": "1LPG", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"@pdbId": "1LPK", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"@pdbId": "1LPZ", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"@pdbId": "1LQD", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"@pdbId": "1MQ5", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"@pdbId": "1MQ6", "@details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5- CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4 -[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"@pdbId": "1MSX", "@details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N- IMINO-13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL )PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"@pdbId": "1NFU", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"@pdbId": "1NFW", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"@pdbId": "1NFX", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"@pdbId": "1NFY", "@details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"@pdbId": "1NL8", "@details": "THEORETICAL MODEL OF THE TISSUE FACTOR/FACTOR VIIA/ FACTORXA COMPLEX"}, {"@pdbId": "1P0S", "@details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"@pdbId": "1V3X", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL -4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL) PIPERAZINE"}, {"@pdbId": "1WU1", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5- CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-( PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE"}, {"@pdbId": "1XKA", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1XKB", "@details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID"}, {"@pdbId": "1Z6E", "@details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"@pdbId": "2BMG", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"@pdbId": "2BOH", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"@pdbId": "2BOK", "@details": "FACTOR XA - CATION"}, {"@pdbId": "2BQ6", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"@pdbId": "2BQ7", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"@pdbId": "2BQW", "@details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"@pdbId": "2CJI", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2FZZ", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO- 1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1- PYRROLIDINYL)METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1, 4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE"}, {"@pdbId": "2G00", "@details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-(( DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4 -C]PYRIDIN-1-YL)BENZAMIDE"}, {"@pdbId": "2GD4", "@details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- PENTASACCHARIDE COMPLEX"}, {"@pdbId": "2J2U", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J34", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J38", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J4I", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J94", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2J95", "@details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2JKH", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2UWL", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWO", "@details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"@pdbId": "2UWP", "@details": "FACTOR XA INHIBITOR COMPLEX"}, {"@pdbId": "2VH0", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"@pdbId": "2VH6", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"@pdbId": "2VVC", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVU", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VVV", "@details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWL", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWM", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWN", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2VWO", "@details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"@pdbId": "2W26", "@details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"@pdbId": "2W3I", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2"}, {"@pdbId": "2W3K", "@details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1"}, {"@pdbId": "2WYG", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2WYJ", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS"}, {"@pdbId": "2XBV", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBW", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBX", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XBY", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC0", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC4", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2XC5", "@details": "FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID INHIBITOR"}, {"@pdbId": "2Y5F", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5G", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y5H", "@details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"@pdbId": "2Y7X", "@details": "THE DISCOVERY OF POTENT AND LONG-ACTING ORAL FACTOR XA INHIBITORS WITH TETRAHYDROISOQUINOLINE AND BENZAZEPINE P4 MOTIFS"}, {"@pdbId": "2Y7Z", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y80", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y81", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}, {"@pdbId": "2Y82", "@details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS"}], "structureId": "4A7I", "title": "Factor Xa in complex with a potent 2-amino-ethane sulfonamide inhibitor", "pubmedId": "22190348", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.40", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "350", "nr_atoms": "2272", "deposition_date": "2011-11-14", "release_date": "2012-02-01", "last_modification_date": "2012-02-01", "structure_authors": "Nazare, M., Matter, H., Will, D.W., Wagner, M., Urmann, M., Czech, J., Schreuder, H., Bauer, A., Ritter, K., Wehner, V.", "citation_authors": "Nazare, M., Matter, H., Will, D.W., Wagner, M., Urmann, M., Czech, J., Schreuder, H., Bauer, A., Ritter, K., Wehner, V.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "4a7i", "bioAssemblies": "1", "release_date": "Wed Feb 01 00:00:00 PST 2012", "resolution": "2.40"}, "ligs": [{"@structureId": "4A7I", "@chemicalID": "A7I", "@type": "non-polymer", "@molecularWeight": "393.952", "chemicalName": "5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [2-(1--ISOPROPYL-PIPERIDIN-4-YLSULFAMOYL)-ETHYL]-AMIDE", "formula": "C15 H24 Cl N3 O3 S2", "InChI": "InChI=1S/C15H24ClN3O3S2/c1-11(2)19-8-5-12(6-9-19)18-24(21,22)10-7-17-15(20)13-3-4-14(16)23-13/h3-4,11-12,18H,5-10H2,1-2H3,(H,17,20)", "InChIKey": "XIOBNAKYNXSFFO-UHFFFAOYSA-N", "smiles": "CC(C)N1CCC(CC1)NS(=O)(=O)CCNC(=O)c2ccc(s2)Cl"}, {"@structureId": "4A7I", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["A7I", "CA"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "4bti": {"describe_pdb": {"relatedPDB": [{"@pdbId": "4BTT", "@details": "FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 31."}, {"@pdbId": "4BTU", "@details": "FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 57."}], "structureId": "4BTI", "title": "factor Xa in complex with the dual thrombin-FXa inhibitor 58.", "pubmedId": "24175584", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.30", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "700", "nr_atoms": "4584", "deposition_date": "2013-06-18", "release_date": "2013-12-25", "last_modification_date": "2019-05-08", "structure_authors": "Meneyrol, J., Follmann, M., Lassalle, G., Wehner, V., Barre, G., Rousseaux, T., Altenburger, J.M., Petit, F., Bocskei, Z., Stehlin-Gaon, C., Schreuder, H., Alet, N., Herault, J.-P., Millet, L., Dol, F., Hasbrand, C., Schaeffer, P., Sadoun, F., Klieber, S., Briot, C., Bono, F., Herbert, J.-M.", "citation_authors": "Meneyrol, J., Follmann, M., Lassalle, G., Wehner, V., Barre, G., Rousseaux, T., Altenburger, J., Petit, F., Bocskei, Z., Schreuder, H., Alet, N., Herault, J., Millet, L., Dol, F., Florian, P., Schaeffer, P., Sadoun, F., Klieber, S., Briot, C., Bono, F., Herbert, J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": [{"@id": "A"}, {"@id": "E"}]}, {"@id": "2", "@type": "protein", "Chain": [{"@id": "B"}, {"@id": "F"}]}], "structureId": "4bti", "bioAssemblies": "2", "release_date": "Wed Dec 25 00:00:00 PST 2013", "resolution": "2.30"}, "ligs": [{"@structureId": "4BTI", "@chemicalID": "7R9", "@type": "non-polymer", "@molecularWeight": "648.142", "chemicalName": "5-Chloro-thiophene-2-carboxylic acid [(S)-2-[2-difluoromethoxy-3-(2-oxo-piperidin-1-yl)-benzenesulfonylamino]-3-((S)-3-dimethylamino-pyrrolidin-1-yl)-3-oxo-propyl]-amide", "formula": "C26 H32 Cl F2 N5 O6 S2", "InChI": "InChI=1S/C26H32ClF2N5O6S2/c1-32(2)16-11-13-33(15-16)25(37)17(14-30-24(36)19-9-10-21(27)41-19)31-42(38,39)20-7-5-6-18(23(20)40-26(28)29)34-12-4-3-8-22(34)35/h5-7,9-10,16-17,26,31H,3-4,8,11-15H2,1-2H3,(H,30,36)/t16-,17-/m0/s1", "InChIKey": "GMYAFDWQODYJNI-IRXDYDNUSA-N", "smiles": "CN(C)[C@H]1CCN(C1)C(=O)[C@H](CNC(=O)c2ccc(s2)Cl)NS(=O)(=O)c3cccc(c3OC(F)F)N4CCCCC4=O"}, {"@structureId": "4BTI", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["7R9", "CA"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "4btt": {"describe_pdb": {"relatedPDB": [{"@pdbId": "4BTI", "@details": "FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 58."}, {"@pdbId": "4BTU", "@details": "FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 57."}], "structureId": "4BTT", "title": "factor Xa in complex with the dual thrombin-FXa inhibitor 31.", "pubmedId": "24175584", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.59", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "700", "nr_atoms": "4591", "deposition_date": "2013-06-19", "release_date": "2013-12-18", "last_modification_date": "2019-05-08", "structure_authors": "Meneyrol, J., Follmann, M., Lassalle, G., Wehner, V., Barre, G., Rousseaux, T., Altenburger, J.M., Petit, F., Bocskei, Z., Stehlin-Gaon, C., Schreuder, H., Alet, N., Herault, J.-P., Millet, L., Dol, F., Hasbrand, C., Schaeffer, P., Sadoun, F., Klieber, S., Briot, C., Bono, F., Herbert, J.-M.", "citation_authors": "Meneyrol, J., Follmann, M., Lassalle, G., Wehner, V., Barre, G., Rousseaux, T., Altenburger, J., Petit, F., Bocskei, Z., Schreuder, H., Alet, N., Herault, J., Millet, L., Dol, F., Florian, P., Schaeffer, P., Sadoun, F., Klieber, S., Briot, C., Bono, F., Herbert, J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": [{"@id": "A"}, {"@id": "E"}]}, {"@id": "2", "@type": "protein", "Chain": [{"@id": "B"}, {"@id": "F"}]}], "structureId": "4btt", "bioAssemblies": "2", "release_date": "Wed Dec 18 00:00:00 PST 2013", "resolution": "2.59"}, "ligs": [{"@structureId": "4BTT", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "4BTT", "@chemicalID": "VYR", "@type": "non-polymer", "@molecularWeight": "637.167", "chemicalName": "N-[(S)-1-[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-2-(4-methoxy-piperidin-1-yl)-2-oxo-ethyl]-2-ethyl-3-(3-oxo-morpholin-4-yl)-benzenesulfonamide", "formula": "C28 H33 Cl N4 O7 S2", "InChIKey": "VOALXMVXTCHJGT-NRFANRHFSA-N", "InChI": "InChI=1S/C28H33ClN4O7S2/c1-3-20-22(33-13-14-39-17-27(33)34)5-4-6-25(20)42(36,37)31-21(28(35)32-11-9-19(38-2)10-12-32)15-18-16-23(40-30-18)24-7-8-26(29)41-24/h4-8,16,19,21,31H,3,9-15,17H2,1-2H3/t21-/m0/s1", "smiles": "CCc1c(cccc1S(=O)(=O)N[C@@H](Cc2cc(on2)c3ccc(s3)Cl)C(=O)N4CCC(CC4)OC)N5CCOCC5=O"}], "num_ligs": 2, "name_ligs": ["CA", "VYR"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "4btu": {"describe_pdb": {"relatedPDB": [{"@pdbId": "4BTI", "@details": "FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 58."}, {"@pdbId": "4BTT", "@details": "FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 31."}], "structureId": "4BTU", "title": "Factor Xa in complex with the dual thrombin-FXa inhibitor 57.", "pubmedId": "24175584", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.37", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "700", "nr_atoms": "4668", "deposition_date": "2013-06-19", "release_date": "2013-12-18", "last_modification_date": "2019-05-08", "structure_authors": "Meneyrol, J., Follmann, M., Lassalle, G., Wehner, V., Barre, G., Rousseaux, T., Altenburger, J.M., Petit, F., Bocskei, Z., Stehlin-Gaon, C., Schreuder, H., Alet, N., Herault, J.-P., Millet, L., Dol, F., Hasbrand, C., Schaeffer, P., Sadoun, F., Klieber, S., Briot, C., Bono, F., Herbert, J.-M.", "citation_authors": "Meneyrol, J., Follmann, M., Lassalle, G., Wehner, V., Barre, G., Rousseaux, T., Altenburger, J., Petit, F., Bocskei, Z., Schreuder, H., Alet, N., Herault, J., Millet, L., Dol, F., Florian, P., Schaeffer, P., Sadoun, F., Klieber, S., Briot, C., Bono, F., Herbert, J.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": [{"@id": "A"}, {"@id": "E"}]}, {"@id": "2", "@type": "protein", "Chain": [{"@id": "B"}, {"@id": "F"}]}], "structureId": "4btu", "bioAssemblies": "2", "release_date": "Wed Dec 18 00:00:00 PST 2013", "resolution": "2.37"}, "ligs": [{"@structureId": "4BTU", "@chemicalID": "6XS", "@type": "non-polymer", "@molecularWeight": "620.544", "chemicalName": "5-Chloro-thiophene-2-carboxylic acid [(S)-2-[2-chloro-5-fluoro-3-(2-oxo-piperidin-1-yl)-benzenesulfonylamino]-3-(4-methyl-piperazin-1-yl)-3-oxo-propyl]-amide", "formula": "C24 H28 Cl2 F N5 O5 S2", "InChIKey": "PVTLJXXAPWJMAT-INIZCTEOSA-N", "InChI": "InChI=1S/C24H28Cl2FN5O5S2/c1-30-8-10-31(11-9-30)24(35)16(14-28-23(34)18-5-6-20(25)38-18)29-39(36,37)19-13-15(27)12-17(22(19)26)32-7-3-2-4-21(32)33/h5-6,12-13,16,29H,2-4,7-11,14H2,1H3,(H,28,34)/t16-/m0/s1", "smiles": "CN1CCN(CC1)C(=O)[C@H](CNC(=O)c2ccc(s2)Cl)NS(=O)(=O)c3cc(cc(c3Cl)N4CCCCC4=O)F"}, {"@structureId": "4BTU", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["6XS", "CA"], "seq": "", "chain_id": "B", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "4y6d": {"describe_pdb": {"structureId": "4Y6D", "title": "Factor Xa complex with GTC000101", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.55", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2316", "deposition_date": "2015-02-12", "release_date": "2015-09-30", "last_modification_date": "2015-09-30", "structure_authors": "Convery, M.A.", "citation_authors": "Convery, M.A.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "4y6d", "bioAssemblies": "1", "release_date": "Wed Sep 30 00:00:00 PDT 2015", "resolution": "1.55"}, "ligs": [{"@structureId": "4Y6D", "@chemicalID": "48U", "@type": "non-polymer", "@molecularWeight": "471.953", "chemicalName": "4-[(3S)-3-({[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonyl}amino)-2-oxopyrrolidin-1-yl]-3-fluoro-N,N-dimethylbenzamide", "formula": "C19 H19 Cl F N3 O4 S2", "InChI": "InChI=1S/C19H19ClFN3O4S2/c1-23(2)18(25)12-3-5-16(14(21)11-12)24-9-7-15(19(24)26)22-30(27,28)10-8-13-4-6-17(20)29-13/h3-6,8,10-11,15,22H,7,9H2,1-2H3/b10-8+/t15-/m0/s1", "InChIKey": "YVFKLOGRKAMHKF-HQPKTYMTSA-N", "smiles": "CN(C)C(=O)c1ccc(c(c1)F)N2CC[C@@H](C2=O)NS(=O)(=O)/C=C/c3ccc(s3)Cl"}], "num_ligs": 1, "name_ligs": ["48U"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQ----EAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.13114754098361, "gaps": {"num_gaps": 3, "gap_lengths": [235, 5, 21], "gap_list": [[1, 235], [296, 300], [469, 489]], "gap_window": [[1, 236], [295, 301], [468, 489]]}}, "4y71": {"describe_pdb": {"structureId": "4Y71", "title": "Factor Xa complex with GTC000398", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.80", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2312", "deposition_date": "2015-02-13", "release_date": "2015-09-30", "last_modification_date": "2015-09-30", "structure_authors": "Convery, M.A., Young, R.J., Senger, S., Hamblin, J.N., Chan, C., Toomey, J.R., Watson, N.S.", "citation_authors": "Convery, M.A., Young, R.J., Senger, S., Hamblin, J.N., Chan, C., Toomey, J.R., Watson, N.S.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "4y71", "bioAssemblies": "1", "release_date": "Wed Sep 30 00:00:00 PDT 2015", "resolution": "1.80"}, "ligs": [{"@structureId": "4Y71", "@chemicalID": "48W", "@type": "non-polymer", "@molecularWeight": "507.002", "chemicalName": "6-chloro-N-{(3S)-1-[(2S)-1-(4-methyl-5-oxo-1,4-diazepan-1-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide", "formula": "C23 H27 Cl N4 O5 S", "InChI": "InChI=1S/C23H27ClN4O5S/c1-15(22(30)27-9-8-21(29)26(2)11-12-27)28-10-7-20(23(28)31)25-34(32,33)19-6-4-16-13-18(24)5-3-17(16)14-19/h3-6,13-15,20,25H,7-12H2,1-2H3/t15-,20-/m0/s1", "InChIKey": "USQCUKQZXOWUDF-YWZLYKJASA-N", "smiles": "C[C@@H](C(=O)N1CCC(=O)N(CC1)C)N2CC[C@@H](C2=O)NS(=O)(=O)c3ccc4cc(ccc4c3)Cl"}, {"@structureId": "4Y71", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["48W", "CA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "4y76": {"describe_pdb": {"structureId": "4Y76", "title": "Factor Xa complex with GTC000401", "pubmedId": "17338508", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.00", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2272", "deposition_date": "2015-02-13", "release_date": "2015-09-30", "last_modification_date": "2015-09-30", "structure_authors": "Convery, M.A., Young, R.J., Senger, S., Hamblin, J.N., Chan, C., Toomey, J.R., Watson, N.S.", "citation_authors": "Chan, C., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chaudry, L., Chung, C.W., Convery, M.A., Hamblin, J.N., Johnstone, L., Kelly, H.A., Kleanthous, S., Patikis, A., Patel, C., Pateman, A.J., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Weston, H.E., Whitworth, C., Young, R.J., Zhou, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "4y76", "bioAssemblies": "1", "release_date": "Wed Sep 30 00:00:00 PDT 2015", "resolution": "2.00"}, "ligs": [{"@structureId": "4Y76", "@chemicalID": "4O1", "@type": "non-polymer", "@molecularWeight": "550.07", "chemicalName": "N~2~-[(6-chloronaphthalen-2-yl)sulfonyl]-N~2~-{(3S)-1-[(2S)-1-(4-methyl-1,4-diazepan-1-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl}glycinamide", "formula": "C25 H32 Cl N5 O5 S", "InChIKey": "JZNNJFBGWSQFIG-JTSKRJEESA-N", "InChI": "InChI=1S/C25H32ClN5O5S/c1-17(24(33)29-10-3-9-28(2)12-13-29)30-11-8-22(25(30)34)31(16-23(27)32)37(35,36)21-7-5-18-14-20(26)6-4-19(18)15-21/h4-7,14-15,17,22H,3,8-13,16H2,1-2H3,(H2,27,32)/t17-,22-/m0/s1", "smiles": "C[C@@H](C(=O)N1CCCN(CC1)C)N2CC[C@@H](C2=O)N(CC(=O)N)S(=O)(=O)c3ccc4cc(ccc4c3)Cl"}, {"@structureId": "4Y76", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["4O1", "CA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLY--KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.540983606557376, "gaps": {"num_gaps": 3, "gap_lengths": [235, 3, 21], "gap_list": [[1, 235], [280, 282], [469, 489]], "gap_window": [[1, 236], [279, 283], [468, 489]]}}, "4y79": {"describe_pdb": {"structureId": "4Y79", "title": "Factor Xa complex with GTC000406", "pubmedId": "17338508", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.10", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2281", "deposition_date": "2015-02-13", "release_date": "2015-09-30", "last_modification_date": "2015-09-30", "structure_authors": "Convery, M.A., Young, R.J., Senger, S., Hamblin, J.N., Chan, C., Toomey, J.R., Watson, N.S.", "citation_authors": "Chan, C., Borthwick, A.D., Brown, D., Burns-Kurtis, C.L., Campbell, M., Chaudry, L., Chung, C.W., Convery, M.A., Hamblin, J.N., Johnstone, L., Kelly, H.A., Kleanthous, S., Patikis, A., Patel, C., Pateman, A.J., Senger, S., Shah, G.P., Toomey, J.R., Watson, N.S., Weston, H.E., Whitworth, C., Young, R.J., Zhou, P.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "4y79", "bioAssemblies": "1", "release_date": "Wed Sep 30 00:00:00 PDT 2015", "resolution": "2.10"}, "ligs": [{"@structureId": "4Y79", "@chemicalID": "4O6", "@type": "non-polymer", "@molecularWeight": "441.929", "chemicalName": "(E)-2-(4-chlorophenyl)-N-{(3S)-1-[(2S)-1-(morpholin-4-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl}ethenesulfonamide", "formula": "C19 H24 Cl N3 O5 S", "InChI": "InChI=1S/C19H24ClN3O5S/c1-14(18(24)22-9-11-28-12-10-22)23-8-6-17(19(23)25)21-29(26,27)13-7-15-2-4-16(20)5-3-15/h2-5,7,13-14,17,21H,6,8-12H2,1H3/b13-7+/t14-,17-/m0/s1", "InChIKey": "DNCVZNVETAOAJO-PPYZAHLJSA-N", "smiles": "C[C@@H](C(=O)N1CCOCC1)N2CC[C@@H](C2=O)NS(=O)(=O)/C=C/c3ccc(cc3)Cl"}, {"@structureId": "4Y79", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "4Y79", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}], "num_ligs": 3, "name_ligs": ["4O6", "CA", "MG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "4y7a": {"describe_pdb": {"structureId": "4Y7A", "title": "Factor Xa complex with GTC000422", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.99", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2300", "deposition_date": "2015-02-13", "release_date": "2015-09-30", "last_modification_date": "2015-09-30", "structure_authors": "Convery, M.A., Young, R.J., Senger, S., Hamblin, J.N., Chan, C., Toomey, J.R., Watson, N.S.", "citation_authors": "Convery, M.A.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "4y7a", "bioAssemblies": "1", "release_date": "Wed Sep 30 00:00:00 PDT 2015", "resolution": "1.99"}, "ligs": [{"@structureId": "4Y7A", "@chemicalID": "987", "@type": "non-polymer", "@molecularWeight": "478.992", "chemicalName": "N-[(3S)-1-{(2S)-1-[(3S)-3-aminopiperidin-1-yl]-1-oxopropan-2-yl}-2-oxopyrrolidin-3-yl]-6-chloronaphthalene-2-sulfonamide", "formula": "C22 H27 Cl N4 O4 S", "InChIKey": "SWAVCKCAPZVXAE-DCPHZVHLSA-N", "InChI": "InChI=1S/C22H27ClN4O4S/c1-14(21(28)26-9-2-3-18(24)13-26)27-10-8-20(22(27)29)25-32(30,31)19-7-5-15-11-17(23)6-4-16(15)12-19/h4-7,11-12,14,18,20,25H,2-3,8-10,13,24H2,1H3/t14-,18-,20-/m0/s1", "smiles": "C[C@@H](C(=O)N1CCC[C@@H](C1)N)N2CC[C@@H](C2=O)NS(=O)(=O)c3ccc4cc(ccc4c3)Cl"}, {"@structureId": "4Y7A", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "4Y7A", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}], "num_ligs": 3, "name_ligs": ["987", "CA", "MG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "4y7b": {"describe_pdb": {"structureId": "4Y7B", "title": "Factor Xa complex with GTC000441", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.79", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2295", "deposition_date": "2015-02-13", "release_date": "2015-09-30", "last_modification_date": "2015-09-30", "structure_authors": "Convery, M.A., Young, R.J., Senger, S., Hamblin, J.N., Chan, C., Toomey, J.R., Watson, N.S.", "citation_authors": "Convery, M.A.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "4y7b", "bioAssemblies": "1", "release_date": "Wed Sep 30 00:00:00 PDT 2015", "resolution": "1.79"}, "ligs": [{"@structureId": "4Y7B", "@chemicalID": "44I", "@type": "non-polymer", "@molecularWeight": "562.124", "chemicalName": "6-chloro-N-{(3S)-1-[(2S)-1-{(1R,5S)-7-[2-(methylamino)ethyl]-3,7-diazabicyclo[3.3.1]non-3-yl}-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide", "formula": "C27 H36 Cl N5 O4 S", "InChI": "InChI=1S/C27H36ClN5O4S/c1-18(26(34)32-16-19-11-20(17-32)15-31(14-19)10-8-29-2)33-9-7-25(27(33)35)30-38(36,37)24-6-4-21-12-23(28)5-3-22(21)13-24/h3-6,12-13,18-20,25,29-30H,7-11,14-17H2,1-2H3/t18-,19-,20+,25-/m0/s1", "InChIKey": "NSTQUPKYMBYQSS-KSYXXAMZSA-N", "smiles": "C[C@@H](C(=O)N1C[C@@H]2C[C@H](C1)CN(C2)CCNC)N3CC[C@@H](C3=O)NS(=O)(=O)c4ccc5cc(ccc5c4)Cl"}, {"@structureId": "4Y7B", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["44I", "CA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "4zh8": {"describe_pdb": {"structureId": "4ZH8", "title": "Factor Xa complex with GTC000006", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.80", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "387", "nr_atoms": "2270", "deposition_date": "2015-04-24", "release_date": "2016-01-13", "last_modification_date": "2018-04-11", "structure_authors": "Convery, M.A.", "citation_authors": "Convery, M.A.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "4zh8", "bioAssemblies": "1", "release_date": "Wed Jan 13 00:00:00 PST 2016", "resolution": "1.80"}, "ligs": [{"@structureId": "4ZH8", "@chemicalID": "4O4", "@type": "non-polymer", "@molecularWeight": "534.024", "chemicalName": "6-chloro-N-{(3S)-1-[(2S)-1-(morpholin-4-yl)-1-oxopropan-2-yl]-2-oxo-2,3-dihydro-1H-pyrrol-3-yl}-N-(2-oxobutyl)naphthalene-2-sulfonamide", "formula": "C25 H28 Cl N3 O6 S", "InChI": "InChI=1S/C25H28ClN3O6S/c1-3-21(30)16-29(36(33,34)22-7-5-18-14-20(26)6-4-19(18)15-22)23-8-9-28(25(23)32)17(2)24(31)27-10-12-35-13-11-27/h4-9,14-15,17,23H,3,10-13,16H2,1-2H3/t17-,23-/m0/s1", "InChIKey": "MPHFQCQENHLINH-SBUREZEXSA-N", "smiles": "CCC(=O)CN([C@H]1C=CN(C1=O)[C@@H](C)C(=O)N2CCOCC2)S(=O)(=O)c3ccc4cc(ccc4c3)Cl"}, {"@structureId": "4ZH8", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["4O4", "CA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "4zha": {"describe_pdb": {"structureId": "4ZHA", "title": "Factor Xa complex with GTC000102", "expMethod": "X-RAY DIFFRACTION", "resolution": "1.86", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "388", "nr_atoms": "2281", "deposition_date": "2015-04-24", "release_date": "2016-01-13", "last_modification_date": "2016-01-13", "structure_authors": "Convery, M.A.", "citation_authors": "Convery, M.A.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "4zha", "bioAssemblies": "1", "release_date": "Wed Jan 13 00:00:00 PST 2016", "resolution": "1.86"}, "ligs": [{"@structureId": "4ZHA", "@chemicalID": "4O5", "@type": "non-polymer", "@molecularWeight": "455.911", "chemicalName": "4-[(3S)-3-({[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonyl}amino)-2-oxo-2,3-dihydro-1H-pyrrol-1-yl]-3-fluoro-N-methylbenzamide", "formula": "C18 H15 Cl F N3 O4 S2", "InChIKey": "AJYGFYXIRNIYPA-KGXGESDWSA-N", "InChI": "InChI=1S/C18H15ClFN3O4S2/c1-21-17(24)11-2-4-15(13(20)10-11)23-8-6-14(18(23)25)22-29(26,27)9-7-12-3-5-16(19)28-12/h2-10,14,22H,1H3,(H,21,24)/b9-7+/t14-/m0/s1", "smiles": "CNC(=O)c1ccc(c(c1)F)N2C=C[C@@H](C2=O)NS(=O)(=O)/C=C/c3ccc(s3)Cl"}, {"@structureId": "4ZHA", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "4ZHA", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}], "num_ligs": 3, "name_ligs": ["4O5", "CA", "MG"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "5k0h": {"describe_pdb": {"structureId": "5K0H", "title": "Human factor Xa in complex with synthetic inhibitor benzylsulfonyl-dSer(Benzyl)-Gly-4-amidinobenzylamide", "pubmedId": "16848746", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.20", "keywords": "HYDROLASE", "nr_entities": "2", "nr_residues": "285", "nr_atoms": "2269", "deposition_date": "2016-05-17", "release_date": "2016-07-06", "last_modification_date": "2016-07-06", "structure_authors": "Steinmetzer, T.", "citation_authors": "Schweinitz, A., Sturzebecher, A., Sturzebecher, U., Schuster, O., Sturzebecher, J., Steinmetzer, T.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "A"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "B"}}], "structureId": "5k0h", "bioAssemblies": "1", "release_date": "Wed Jul 06 00:00:00 PDT 2016", "resolution": "2.20"}, "ligs": [{"@structureId": "5K0H", "@chemicalID": "6PK", "@type": "non-polymer", "@molecularWeight": "537.631", "chemicalName": "O-benzyl-N-(benzylsulfonyl)-D-seryl-N-[(4-carbamimidoylphenyl)methyl]glycinamide", "formula": "C27 H31 N5 O5 S", "InChI": "InChI=1S/C27H31N5O5S/c28-26(29)23-13-11-20(12-14-23)15-30-25(33)16-31-27(34)24(18-37-17-21-7-3-1-4-8-21)32-38(35,36)19-22-9-5-2-6-10-22/h1-14,24,32H,15-19H2,(H3,28,29)(H,30,33)(H,31,34)/t24-/m1/s1", "InChIKey": "RXJPCNAPBKYKMA-XMMPIXPASA-N", "smiles": "[H]/N=C(\\c1ccc(cc1)CNC(=O)CNC(=O)[C@@H](COCc2ccccc2)NS(=O)(=O)Cc3ccccc3)/N"}, {"@structureId": "5K0H", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}], "num_ligs": 2, "name_ligs": ["6PK", "CA"], "seq": "", "chain_id": "A", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT--------------------", "covertura": 47.950819672131146, "gaps": {"num_gaps": 2, "gap_lengths": [235, 21], "gap_list": [[1, 235], [469, 489]], "gap_window": [[1, 236], [468, 489]]}}, "5voe": {"describe_pdb": {"structureId": "5VOE", "title": "DesGla-XaS195A Bound to Aptamer 11F7t", "pubmedId": "29863725", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.00", "keywords": "HYDROLASE/RNA", "nr_entities": "3", "nr_residues": "320", "nr_atoms": "2970", "deposition_date": "2017-05-02", "release_date": "2018-06-20", "last_modification_date": "2019-12-04", "structure_authors": "Gunaratne, R., Kumar, S., Frederiksen, J.W., Stayrook, S., Lohrmann, J.L., Perry, K., Chabata, C.V., Thalji, N.K., Ho, M.D., Arepally, G., Camire, R.M., Krishnaswamy, S.K., Sullenger, B.A.", "citation_authors": "Gunaratne, R., Kumar, S., Frederiksen, J.W., Stayrook, S., Lohrmann, J.L., Perry, K., Bompiani, K.M., Chabata, C.V., Thalji, N.K., Ho, M.D., Arepally, G., Camire, R.M., Krishnaswamy, S., Sullenger, B.A.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "H"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}, {"@id": "3", "@type": "rna", "Chain": {"@id": "A"}}], "structureId": "5voe", "bioAssemblies": "1", "release_date": "Wed Jun 20 00:00:00 PDT 2018", "resolution": "2.00"}, "ligs": [{"@structureId": "5VOE", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "5VOE", "@chemicalID": "CFL", "@type": "DNA linking", "@molecularWeight": "325.188", "chemicalName": "4-amino-1-(2-deoxy-2-fluoro-5-O-phosphono-beta-D-arabinofuranosyl)pyrimidin-2(1H)-one", "formula": "C9 H13 F N3 O7 P", "InChIKey": "KTAATIGPZHTGOP-PXBUCIJWSA-N", "InChI": "InChI=1S/C9H13FN3O7P/c10-6-7(14)4(3-19-21(16,17)18)20-8(6)13-2-1-5(11)12-9(13)15/h1-2,4,6-8,14H,3H2,(H2,11,12,15)(H2,16,17,18)/t4-,6+,7-,8-/m1/s1", "smiles": "C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)F"}, {"@structureId": "5VOE", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}, {"@structureId": "5VOE", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}, {"@structureId": "5VOE", "@chemicalID": "UFT", "@type": "DNA linking", "@molecularWeight": "326.172", "chemicalName": "2'-deoxy-2'-fluorouridine 5'-(dihydrogen phosphate)", "formula": "C9 H12 F N2 O8 P", "InChI": "InChI=1S/C9H12FN2O8P/c10-6-7(14)4(3-19-21(16,17)18)20-8(6)12-2-1-5(13)11-9(12)15/h1-2,4,6-8,14H,3H2,(H,11,13,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1", "InChIKey": "RTGGYPQTXNSBPD-XVFCMESISA-N", "smiles": "C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)F"}], "num_ligs": 5, "name_ligs": ["CA", "CFL", "MG", "NA", "UFT"], "seq": "", "chain_id": "H", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHE--RQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.33606557377049, "gaps": {"num_gaps": 3, "gap_lengths": [235, 3, 22], "gap_list": [[1, 235], [370, 372], [467, 488]], "gap_window": [[1, 236], [369, 373], [466, 488]]}}, "5vof": {"describe_pdb": {"structureId": "5VOF", "title": "DesGla-XaS195A Bound to Aptamer 11F7t and Rivaroxaban", "pubmedId": "29863725", "expMethod": "X-RAY DIFFRACTION", "resolution": "2.25", "keywords": "HYDROLASE/HYDROLASE INHIBITOR/RNA", "nr_entities": "3", "nr_residues": "320", "nr_atoms": "2999", "deposition_date": "2017-05-02", "release_date": "2018-06-13", "last_modification_date": "2019-12-04", "structure_authors": "Krishnaswamy, S., Kumar, S.", "citation_authors": "Gunaratne, R., Kumar, S., Frederiksen, J.W., Stayrook, S., Lohrmann, J.L., Perry, K., Bompiani, K.M., Chabata, C.V., Thalji, N.K., Ho, M.D., Arepally, G., Camire, R.M., Krishnaswamy, S., Sullenger, B.A.", "status": "CURRENT"}, "pdb_info": {"Method": {"@name": "xray"}, "Entity": [{"@id": "1", "@type": "protein", "Chain": {"@id": "H"}}, {"@id": "2", "@type": "protein", "Chain": {"@id": "L"}}, {"@id": "3", "@type": "rna", "Chain": {"@id": "A"}}], "structureId": "5vof", "bioAssemblies": "1", "release_date": "Wed Jun 13 00:00:00 PDT 2018", "resolution": "2.25"}, "ligs": [{"@structureId": "5VOF", "@chemicalID": "CA", "@type": "non-polymer", "@molecularWeight": "40.078", "chemicalName": "CALCIUM ION", "formula": "Ca 2", "InChI": "InChI=1S/Ca/q+2", "InChIKey": "BHPQYMZQTOCNFJ-UHFFFAOYSA-N", "smiles": "[Ca+2]"}, {"@structureId": "5VOF", "@chemicalID": "CFL", "@type": "DNA linking", "@molecularWeight": "325.188", "chemicalName": "4-amino-1-(2-deoxy-2-fluoro-5-O-phosphono-beta-D-arabinofuranosyl)pyrimidin-2(1H)-one", "formula": "C9 H13 F N3 O7 P", "InChIKey": "KTAATIGPZHTGOP-PXBUCIJWSA-N", "InChI": "InChI=1S/C9H13FN3O7P/c10-6-7(14)4(3-19-21(16,17)18)20-8(6)13-2-1-5(11)12-9(13)15/h1-2,4,6-8,14H,3H2,(H2,11,12,15)(H2,16,17,18)/t4-,6+,7-,8-/m1/s1", "smiles": "C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)F"}, {"@structureId": "5VOF", "@chemicalID": "MG", "@type": "non-polymer", "@molecularWeight": "24.305", "chemicalName": "MAGNESIUM ION", "formula": "Mg 2", "InChI": "InChI=1S/Mg/q+2", "InChIKey": "JLVVSXFLKOJNIY-UHFFFAOYSA-N", "smiles": "[Mg+2]"}, {"@structureId": "5VOF", "@chemicalID": "NA", "@type": "non-polymer", "@molecularWeight": "22.99", "chemicalName": "SODIUM ION", "formula": "Na 1", "InChIKey": "FKNQFGJONOIPTF-UHFFFAOYSA-N", "InChI": "InChI=1S/Na/q+1", "smiles": "[Na+]"}, {"@structureId": "5VOF", "@chemicalID": "RIV", "@type": "non-polymer", "@molecularWeight": "435.881", "chemicalName": "5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide", "formula": "C19 H18 Cl N3 O5 S", "InChIKey": "KGFYHTZWPPHNLQ-AWEZNQCLSA-N", "InChI": "InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1", "smiles": "c1cc(ccc1N2CCOCC2=O)N3C[C@@H](OC3=O)CNC(=O)c4ccc(s4)Cl"}, {"@structureId": "5VOF", "@chemicalID": "UFT", "@type": "DNA linking", "@molecularWeight": "326.172", "chemicalName": "2'-deoxy-2'-fluorouridine 5'-(dihydrogen phosphate)", "formula": "C9 H12 F N2 O8 P", "InChI": "InChI=1S/C9H12FN2O8P/c10-6-7(14)4(3-19-21(16,17)18)20-8(6)12-2-1-5(13)11-9(12)15/h1-2,4,6-8,14H,3H2,(H,11,13,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1", "InChIKey": "RTGGYPQTXNSBPD-XVFCMESISA-N", "smiles": "C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)F"}], "num_ligs": 6, "name_ligs": ["CA", "CFL", "MG", "NA", "RIV", "UFT"], "seq": "", "chain_id": "H", "seq_alg": "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHE--RQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM---------------------K", "covertura": 47.33606557377049, "gaps": {"num_gaps": 3, "gap_lengths": [235, 3, 22], "gap_list": [[1, 235], [370, 372], [467, 488]], "gap_window": [[1, 236], [369, 373], [466, 488]]}}}